<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Dexamethasone as an adjuvant to peripheral nerve block - Pehora, C - 2017 | Cochrane Library</title> <meta content="Dexamethasone as an adjuvant to peripheral nerve block - Pehora, C - 2017 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011770.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Dexamethasone as an adjuvant to peripheral nerve block - Pehora, C - 2017 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011770.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011770.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Dexamethasone as an adjuvant to peripheral nerve block" name="citation_title"/> <meta content="Carolyne Pehora" name="citation_author"/> <meta content="The Hospital for Sick Children, University of Toronto" name="citation_author_institution"/> <meta content="Carolyne.pehora@sickkids.ca" name="citation_author_email"/> <meta content="Annabel ME Pearson" name="citation_author"/> <meta content="The Hospital for Sick Children, University of Toronto" name="citation_author_institution"/> <meta content="Alka Kaushal" name="citation_author"/> <meta content="Max Rady College of Medicine, University of Manitoba" name="citation_author_institution"/> <meta content="Mark W Crawford" name="citation_author"/> <meta content="The Hospital for Sick Children, University of Toronto" name="citation_author_institution"/> <meta content="Bradley Johnston" name="citation_author"/> <meta content="Dalhousie University" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="11" name="citation_issue"/> <meta content="10.1002/14651858.CD011770.pub2" name="citation_doi"/> <meta content="2017" name="citation_date"/> <meta content="2017/11/09" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011770.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011770.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011770.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Anesthetics, Local [*administration &amp; dosage]; Arm [surgery]; Dexamethasone [*administration &amp; dosage]; Glucocorticoids [*administration &amp; dosage]; Injections, Intravenous; Leg [surgery]; Nerve Block [adverse effects, *methods]; Neuromuscular Blocking Agents [*administration &amp; dosage]; Pain, Postoperative [*prevention &amp; control]; Randomized Controlled Trials as Topic; Time Factors" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011770.pub2&amp;doi=10.1002/14651858.CD011770.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="FKeXZrqu";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011770\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011770\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ms","pl","zh_HANT","hr","fa","th","fr","ja","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011770.pub2",title:"Dexamethasone as an adjuvant to peripheral nerve block",firstPublishedDate:"Nov 9, 2017 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Anaesthesia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011770.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011770.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011770.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011770.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011770.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011770.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011770.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011770.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011770.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011770.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>23161 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011770.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-sec-0175"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-sec-0036"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-sec-0037"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-sec-0042"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-sec-0043"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-sec-0067"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-sec-0165"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/appendices#CD011770-sec-0180"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/table_n/CD011770StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/table_n/CD011770StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2017 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Dexamethasone as an adjuvant to peripheral nerve block</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#CD011770-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Carolyne Pehora</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#CD011770-cr-0003">Annabel ME Pearson</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#CD011770-cr-0004">Alka Kaushal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#CD011770-cr-0005">Mark W Crawford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information#CD011770-cr-0006">Bradley Johnston</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information/en#CD011770-sec-0200">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 09 November 2017 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011770.pub2">https://doi.org/10.1002/14651858.CD011770.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011770-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011770-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011770-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011770-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011770-abs-0015">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD011770-abs-0013">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011770-abs-0018">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011770-abs-0001" lang="en"> <section id="CD011770-sec-0001"> <h3 class="title" id="CD011770-sec-0001">Background</h3> <p>Peripheral nerve block (infiltration of local anaesthetic around a nerve) is used for anaesthesia or analgesia. A limitation to its use for postoperative analgesia is that the analgesic effect lasts only a few hours, after which moderate to severe pain at the surgical site may result in the need for alternative analgesic therapy. Several adjuvants have been used to prolong the analgesic duration of peripheral nerve block, including perineural or intravenous dexamethasone. </p> </section> <section id="CD011770-sec-0002"> <h3 class="title" id="CD011770-sec-0002">Objectives</h3> <p>To evaluate the comparative efficacy and safety of perineural dexamethasone versus placebo, intravenous dexamethasone versus placebo, and perineural dexamethasone versus intravenous dexamethasone when added to peripheral nerve block for postoperative pain control in people undergoing surgery. </p> </section> <section id="CD011770-sec-0003"> <h3 class="title" id="CD011770-sec-0003">Search methods</h3> <p>We searched the Cochrane Central Register of Controlled Trials, MEDLINE, Embase, DARE, Web of Science and Scopus from inception to 25 April 2017. We also searched trial registry databases, Google Scholar and meeting abstracts from the American Society of Anesthesiologists, the Canadian Anesthesiologists' Society, the American Society of Regional Anesthesia, and the European Society of Regional Anaesthesia. </p> </section> <section id="CD011770-sec-0004"> <h3 class="title" id="CD011770-sec-0004">Selection criteria</h3> <p>We included all randomized controlled trials (RCTs) comparing perineural dexamethasone with placebo, intravenous dexamethasone with placebo, or perineural dexamethasone with intravenous dexamethasone in participants receiving peripheral nerve block for upper or lower limb surgery. </p> </section> <section id="CD011770-sec-0005"> <h3 class="title" id="CD011770-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by Cochrane.</p> </section> <section id="CD011770-sec-0006"> <h3 class="title" id="CD011770-sec-0006">Main results</h3> <p>We included 35 trials of 2702 participants aged 15 to 78 years; 33 studies enrolled participants undergoing upper limb surgery and two undergoing lower limb surgery. Risk of bias was low in 13 studies and high/unclear in 22. </p> <p><b>Perineural dexamethasone versus placebo</b> </p> <p>Duration of sensory block was significantly longer in the perineural dexamethasone group compared with placebo (mean difference (MD) 6.70 hours, 95% confidence interval (CI) 5.54 to 7.85; participants1625; studies 27). Postoperative pain intensity at 12 and 24 hours was significantly lower in the perineural dexamethasone group compared with control (MD ‐2.08, 95% CI ‐2.63 to ‐1.53; participants 257; studies 5) and (MD ‐1.63, 95% CI ‐2.34 to ‐0.93; participants 469; studies 9), respectively. There was no significant difference at 48 hours (MD ‐0.61, 95% CI ‐1.24 to 0.03; participants 296; studies 4). The quality of evidence is very low for postoperative pain intensity at 12 hours and low for the remaining outcomes. Cumulative 24‐hour postoperative opioid consumption was significantly lower in the perineural dexamethasone group compared with placebo (MD 19.25 mg, 95% CI 5.99 to 32.51; participants 380; studies 6). </p> <p><b>Intravenous dexamethasone versus placebo</b> </p> <p>Duration of sensory block was significantly longer in the intravenous dexamethasone group compared with placebo (MD 6.21, 95% CI 3.53 to 8.88; participants 499; studies 8). Postoperative pain intensity at 12 and 24 hours was significantly lower in the intravenous dexamethasone group compared with placebo (MD ‐1.24, 95% CI ‐2.44 to ‐0.04; participants 162; studies 3) and (MD ‐1.26, 95% CI ‐2.23 to ‐0.29; participants 257; studies 5), respectively. There was no significant difference at 48 hours (MD ‐0.21, 95% CI ‐0.83 to 0.41; participants 172; studies 3). The quality of evidence is moderate for duration of sensory block and postoperative pain intensity at 24 hours, and low for the remaining outcomes. Cumulative 24‐hour postoperative opioid consumption was significantly lower in the intravenous dexamethasone group compared with placebo (MD ‐6.58 mg, 95% CI ‐10.56 to ‐2.60; participants 287; studies 5). </p> <p><b>Perinerual versus intravenous dexamethasone</b> </p> <p>Duration of sensory block was significantly longer in the perineural dexamethasone group compared with intravenous by three hours (MD 3.14 hours, 95% CI 1.68 to 4.59; participants 720; studies 9). We found that postoperative pain intensity at 12 hours and 24 hours was significantly lower in the perineural dexamethasone group compared with intravenous, however, the MD did not surpass our pre‐determined minimally important difference of 1.2 on the Visual Analgue Scale/Numerical Rating Scale, therefore the results are not clinically significant (MD ‐1.01, 95% CI ‐1.51 to ‐0.50; participants 217; studies 3) and (MD ‐0.77, 95% CI ‐1.47 to ‐0.08; participants 309; studies 5), respectively. There was no significant difference in severity of postoperative pain at 48 hours (MD 0.13, 95% CI ‐0.35 to 0.61; participants 227; studies 3). The quality of evidence is moderate for duration of sensory block and postoperative pain intensity at 24 hours, and low for the remaining outcomes. There was no difference in cumulative postoperative 24‐hour opioid consumption (MD ‐3.87 mg, 95% CI ‐9.93 to 2.19; participants 242; studies 4). </p> <p><b>Incidence of severe adverse events</b> </p> <p>Five serious adverse events were reported. One block‐related event (pneumothorax) occurred in one participant in a trial comparing perineural dexamethasone and placebo; however group allocation was not reported. Four non‐block‐related events occurred in two trials comparing perineural dexamethasone, intravenous dexamethasone and placebo. Two participants in the placebo group required hospitalization within one week of surgery; one for a fall and one for a bowel infection. One participant in the placebo group developed Complex Regional Pain Syndrome Type I and one in the intravenous dexamethasone group developed pneumonia. The quality of evidence is very low due to the sparse number of events. </p> </section> <section id="CD011770-sec-0007"> <h3 class="title" id="CD011770-sec-0007">Authors' conclusions</h3> <p>Low‐ to moderate‐quality evidence suggests that when used as an adjuvant to peripheral nerve block in upper limb surgery, both perineural and intravenous dexamethasone may prolong duration of sensory block and are effective in reducing postoperative pain intensity and opioid consumption. There is not enough evidence to determine the effectiveness of dexamethasone as an adjuvant to peripheral nerve block in lower limb surgeries and there is no evidence in children. The results of our review may not apply to participants at risk of dexamethasone‐related adverse events for whom clinical trials would probably be unsafe. </p> <p>There is not enough evidence to determine the effectiveness of dexamethasone as an adjuvant to peripheral nerve block in lower limb surgeries and there is no evidence in children. The results of our review may not be apply to participants who at risk of dexamethasone‐related adverse events for whom clinical trials would probably be unsafe. The nine ongoing trials registered at ClinicalTrials.gov may change the results of this review. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011770-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011770-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011770-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011770-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011770-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011770-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011770-abs-0010">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011770-abs-0017">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011770-abs-0006">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011770-abs-0007">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011770-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD011770-abs-0014">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011770-abs-0019">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011770-abs-0009">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011770-abs-0003" lang="en"> <h3>Dexamethasone and peripheral nerve block</h3> <p><b>What is a peripheral nerve block?</b> </p> <p>A nerve block prevents or relieves pain by interrupting pain signals that travel along a nerve to the brain. It involves an injection of local anaesthetic (a numbing agent) around a nerve either during or immediately after surgery. Pain relief from nerve block may last only a few hours after surgery, after which people may experience moderate to severe pain. </p> <p><b>What is dexamethasone?</b> </p> <p>Dexamethasone is a steroid that may reduce pain and the inflammatory response to tissue damage after surgery (heat, pain, redness and swelling). In people receiving nerve block, dexamethasone may be given with the local anaesthetic around the nerve (perineural) or into a vein (intravenous) to prolong the pain relief from the peripheral nerve block. </p> <p><b>What did the researchers investigate?</b> </p> <p>We looked for randomized controlled trials that investigated whether perineural or intravenous dexamethasone prolongs the length of time people experience pain relief from the peripheral nerve block when undergoing upper and lower limb surgery and reduces the intensity of pain after surgery. We also investigated whether perineural or intravenous dexamethasone cause any side effects or harms. We searched the medical literature for articles that included either adults or children undergoing upper or lower limb surgery with peripheral nerve block published up until 25 April 2017. We also assessed the quality of evidence for each outcome. </p> <p><b>What did the researchers find?</b> </p> <p>We included 35 studies involving 2702 aged 15 to 78 years.</p> <p>When compared with placebo, the duration of sensory block was prolonged in the perineural dexamethasone group by 6 and a half hours (27 studies, 1625 participants, low‐quality evidence) and in the intravenous dexamethasone group by six hours (8 studies, 499 participants, moderate‐quality evidence). When perineural and intravenous dexamethasone were compared, the duration of sensory block was longer in the perineural dexamethasone group by three hours (9 studies, 720 participants, moderate‐quality evidence). </p> <p>Postoperative pain intensity at 12 hours after surgery was lower in the perineural dexamethasone group compared with placebo (5 studies, 257 participants, very low‐quality evidence) and at 24 hours after surgery (9 studies, 469 participants, low‐quality evidence). When we compared intravenous dexamethasone with placebo, postoperative pain intensity was also lower in the intravenous dexamethasone group than in the placebo group at 12 hours (3 studies, 162 participants, low‐quality evidence) and 24 hours (5 studies, 257 participants, low‐quality evidence). The amount of opioid pain medication required was also lower in participants receiving perineural and intravenous dexamethasone. There was no difference in postoperative pain intensity or the amount of opioid pain medication required when perineural and intravenous dexamethasone were compared. We concluded that one way of administering dexamethasone does not provide better pain relief over the other. </p> <p>Five serious adverse events were reported in three studies. One block‐related adverse event (pneumothorax or collapsed lung) occurred in one participant in a trial comparing perineural dexamethasone and placebo; however group allocation was not reported. The remaining events were non‐block‐related and occurred in two trials comparing perineural dexamethasone, intravenous dexamethasone and placebo. Two participants in the control group required hospitalization within one week of surgery; one for a fall and one for a bowel infection. One participant in the placebo group developed a chronic pain syndrome called Complex Regional Pain Sydrome, and one participant in the intravenous dexamethasone group developed pneumonia. The quality of evidence for safety issues was very low. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011770-sec-0175" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011770-sec-0175">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011770-sec-0233">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011770-sec-0175"></div> <h3 class="title" id="CD011770-sec-0176">Implications for practice</h3> <section id="CD011770-sec-0176"> <p>Low‐ to moderate‐quality evidence suggests that when used as an adjuvant to peripheral nerve block in upper limb surgery, both perineural and intravenous dexamethasone may prolong the duration of sensory block and are effective in reducing postoperative pain intensity and opioid consumption. Perineural dexamethasone is not likely to be more effective than intravenous dexamethasone. There is not enough evidence to determine the effectiveness of dexamethasone as an adjuvant to peripheral nerve block in lower limb surgeries and there is no evidence in children. The results of our review may not apply to participants who are at risk of dexamethasone‐related adverse events in whom clinical trials would likely to be unsafe.The nine ongoing trials on ClinicalTrials.gov may change the results of this review. </p> </section> <h3 class="title" id="CD011770-sec-0177">Implications for research</h3> <section id="CD011770-sec-0177"> <p>Future trials would benefit from long‐term follow‐up to determine the safety of dexamethasone as an adjuvant to peripheral nerve block. Dose‐finding studies to determine the optimum intravenous and perineural dose of dexamethasone are needed. In addition, additional research should include the paediatric population. Future studies evaluating the duration of sensory block should also evaluate outcomes, such as, postoperative pain intensity and postoperative opioid consumption. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011770-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011770-sec-0036"></div> <div class="table" id="CD011770-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perineural dexamethasone versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> participants undergoing surgery with peripheral nerve block<br/> <b>Setting:</b> participants undergoing upper and lower limb surgery in hospitals in Australia, Bangledesh, Belgium, Brazil, India, Iran, Japan, Korea, Nepal, Turkey and USA </p> <p><b>Intervention</b>: perineural dexamethasone </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>№ of participants<br/> (studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of the evidence<br/> (GRADE) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with perineural dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of sensory block</p> <p>(we included all studies describing duration of sensory block, regardless of how it was described) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block was <b>10.2</b> hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block in the perineural dexamethasone group was 6.70 hours longer (5.54 longer to 7.85 longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1625<br/> (27 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incidence of serious adverse events</p> <p>(we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>In seven studies, authors reported that they assessed for serious adverse events. Five serious adverse events were reported in three studies: one block‐related adverse event (pneumothorax) occurred in one participant in a trial comparing perineural dexamethasone and placebo; however, group allocation was not reported. The remaining non‐block‐related events occurred in two trials comparing perineural dexamethasone, intravenous dexamethasone and placebo. Two participants in the placebo group required hospitalization within one week of surgery; one for a fall, and one for a bowel infection. One participant in the placebo group developed Complex Regional Pain Syndrome Type I and one in the intravenous dexamethasone group developed pneumonia. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620</p> <p>(7 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/> VERY </p> <p>LOW<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 12 hours</p> <p>(assessed by pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain intensity at 12 hours was <b>3.0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours in the perineural dexamethasone group was 2.08 points lower (1.52 lower to 2.63 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>257<br/> (5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/> VERY </p> <p>LOW<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 24 hours.</p> <p>(assessed by pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain intensity at 24 hours was <b>3.9</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours in the perineural dexamethasone group was 1.63 points lower (0.93 lower to 2.34 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>469<br/> (9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 48 hours</p> <p>(assessed by pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain intensity at 48 hours was <b>3.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours in the perineural dexamethasone group was 0.61 points lower (1.24 lower to 0.03 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>296<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>MD:</b> Mean difference; <b>NIH</b> : National Institute of Health; <b>RCT</b> : randomized controlled trial; <b>VAS:</b> Visual Analogue Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate‐quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low‐quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low‐quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias as 19 out of 27 studies are at unclear risk of bias. Reasons include lack of reporting on random sequence generation, concealment allocation, blinding, and attrition bias. Downgraded by one level for inconsistency (I<sup>2</sup> = 99%, P value for heterogeneity is &lt; 0.00001) and heterogeneity is not explained by subgroup analyses; point estimates vary widely among studies, confidence intervals show minimal overlap). </p> <p><sup>b</sup>Downgraded by one level for risk of bias as four out of the seven studies are at unclear risk of bias. Reasons include lack of reporting on random sequence generation, concealment allocation, blinding, and evidence of selective reporting bias. Downgraded by two levels for imprecision due to very low number of events. </p> <p><sup>c</sup> Downgraded by one level for risk of bias. Three out of five studies are at unclear risk of bias. Reasons include lack of </p> <p>reporting on random sequence generation and allocation concealment and evidence of attrition bias, selective reporting bias, and stopping early for benefit. Downgraded by one level for inconsistency (I<sup>2</sup> = 61%, P value for heterogeneity is 0.03) and heterogeneity is not explained by subgroup analyses; point estimates vary widely among studies, confidence intervals show minimal overlap </p> <p><sup>d</sup>Downgraded by one level for inconsistency (I<sup>2</sup> = 80%, P value for heterogeneity is &lt; 0.00001) and heterogeneity is not explained by subgroup analyses; point estimates vary widely across studies. Downgraded by one level for imprecision (95% confidence interval includes no clinical effect and a clinical effect). By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>e</sup> Downgraded by two levels for imprecision because of a sparse number of participants (n=296) and a very wide confidence interval demonstrating that the treatment effect is not statistically significant and of questionable clinical significance. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011770-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous dexamethasone versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> participants undergoing surgery with peripheral nerve block<br/> <b>Setting:</b> participants undergoing upper and lower limb surgery in hospitals in Australia, Belgium, Brazil, Canada, Japan, Korea, Thailand and USA </p> <p><b>Intervention</b>: intravenous dexamethasone </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outcomes</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>№ of participants<br/> (studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of the evidence<br/> (GRADE) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intravenous dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of sensory block</p> <p>(we included all studies describing duration of sensory block regardless of how it was described) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block was <b>16.1</b> hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block in the intravenous dexamethasone group was 6.21 hours longer (3.53 longer to 8.88 longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>499<br/> (8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯<br/> MODERATE <sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incidence of serious adverse events</p> <p>(we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Please see incidence of serious adverse events in the perineural dexamethasone versus placebo 'Summary of findings' table. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 12 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours was <b>2.6</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours in the intravenous dexamethasone group was 1.24 points lower (2.44 lower to 0.04 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>162<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 24 hours<br/> (measured using pain scores on an 11‐point VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours was <b>4.4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours in the intravenous dexamethasone group was 1.26 points lower (2.23 lower to 0.29 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>257<br/> (5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 48 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours was <b>3.7</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours in the intravenous dexamethasone group was 0.21 points lower (0.83 lower to 0.41 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>MD:</b> Mean difference; <b>NIH</b> : National Institute of Health; <b>RCT</b> : randomized controlled trial; <b>VAS:</b> Visual Analogue Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate‐quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low‐quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low‐quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for inconsistency (considerable heterogeneity (I<sup>2</sup> = 88% and P value for heterogeneity &lt;0.0001) and subgroup analyses did not explain observed heterogeneity. Downgraded by one level for imprecision because of a sparse number of participants (n=162). </p> <p><sup>b</sup>Downgraded by one level for inconsistency (I<sup>2</sup> = 61% and P value for heterogeneity 0.08) and subgroup analyses did not explain observed heterogeneity. Downgraded by one level for imprecision. Confidence interval includes both no clinical effect (minimally important difference 1.2 on VAS) and clinical effect (minimally important difference greater than 1.2 on VAS). </p> <p><sup>c</sup>Downgraded by one level for inconsistency(I<sup>2</sup> = 65% and P value for heterogeneity 0.02) and subgroup analyses did not explain observed heterogeneity. Point estimates vary widely across studies. Downgraded by one level for imprecision (95% confidence interval includes no clinical effect and a clinical effect). By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>d</sup>Downgraded by two levels for precision (small sample size (n=172) and confidence interval crosses the line of null effect).. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011770-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Perineural versus intravenous dexamethasone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population</b>: peripheral nerve block </p> <p><b>Setting</b>: people undergoing upper or lower limb surgery with peripheral nerve block in hospitals in Australia, Belgium, Brazil, Canada and USA </p> <p><b>Intervention</b>: perineural dexamethasone </p> <p><b>Comparison</b>: intravenous dexamethasone </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outcomes</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>№ of participants<br/> (studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of the evidence<br/> (GRADE) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intravenous dexamethasone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with perineural dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of sensory block</p> <p>(we included all studies describing duration of sensory block regardless of how it was described) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block was <b>20.6</b> hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block in the perineural dexamethasone group was 3.13 hours longer (1.68 longer to 4.58 longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>720<br/> (9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯<br/> MODERATE <sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incidence of serious adverse events</p> <p>(we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Please see incidence of serious adverse events in the perineural dexamethasone versus placebo 'Summary of findings' table. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 12 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours was <b>2.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours in the perineural dexamethasone group was 1.01 points lower (0.50 lower to 1.51 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>217<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 24 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours was <b>2.9</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours in the perineural dexamethasone group was 0.77 points lower (0.08 lower to 1.47 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>309<br/> (5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯<br/> MODERATE <sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 48 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours was <b>2.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours in the perineural dexamethasone group was 0.13 points higher (0.35 lower to 0.61 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>227<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>MD:</b> Mean difference; <b>NIH</b> : National Institute of Health; <b>RCT</b> : randomized controlled trial; <b>VAS:</b> Visual Analogue Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate‐quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low‐quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low‐quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for inconsistency (I<sup>2</sup> = 67% and P value for heterogeneity is 0.001). </p> <p><sup>b</sup>Downgraded by one level for risk of bias. Two out of the three studies are at unclear risk of bias. Reasons include unclear random sequence generation, unclear allocation concealment, and selective outcome reporting. Downgraded by one level for imprecision because of a sparse number of participants (n=217) and because the 95% confidence interval includes no clinical effect and a clinical effect. By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>c</sup>Downgraded by one level for imprecision (95% confidence interval includes no clinical effect and a clinical effect). By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>d</sup>Downgraded by one level for risk of bias. The one study that is at unclear risk of bias contributes half the data for this outcome. Downgraded by one level for imprecision because of a small sample size (n=227). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011770-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011770-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011770-sec-0209">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011770-sec-0037"></div> <section id="CD011770-sec-0038"> <h3 class="title" id="CD011770-sec-0038">Description of the condition</h3> <p>Peripheral nerve block is a technique whereby local anaesthetic solution is infiltrated perineurally to provide anaesthesia, or analgesia, or both. Peripheral nerve block for intraoperative and postoperative pain management is associated with improved analgesia, fewer opioid‐related adverse events, earlier ambulation, and shorter hospital stay when compared with intravenous opioid analgesia alone (<a href="./references#CD011770-bbs2-0055" title="BarreveldA , WitteJ , ChahalK , DurieuxME , StrichartzG . Preventative analgesia by local anesthetics: the reduction of postoperative pain by peripheral nerve blocks and intravenous drugs. Anesthesia and Analgesia2013;116(5):1141‐61. [PUBMED: 23408672] ">Barreveld 2013</a>; <a href="./references#CD011770-bbs2-0060" title="CharltonS , CynaAM , MiddletonP , GriffithsJD . Perioperative transversus abdominis plane (TAP) blocks for analgesia after abdominal surgery. Cochrane Database of Systematic Reviews2010, Issue 12. [DOI: 10.1002/14651858.CD007705.pub2; PUBMED: 21154380 ] ">Charlton 2010</a>; <a href="./references#CD011770-bbs2-0084" title="LinE , ChoiJ , HadzicA . Peripheral nerve blocks for outpatient surgery: evidence based indications. Current Opinion in Anesthesiology2013;26(4):467‐74. [PUBMED: 23820103] ">Lin 2013</a>). A limitation to the use of peripheral nerve blocks is that the analgesic effect of the block lasts only a few hours, resulting in early, moderate to severe pain, and thus the need for adjuvant therapies (<a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>). Peripheral nerve catheters that provide continuous infusion of local anaesthetic have been used to prolong the effects of local anaesthesia; however, continuous catheters require greater time and skill to insert than single‐shot peripheral block, may dislodge while in use, may be difficult to remove, and may add additional costs to health care (<a href="./references#CD011770-bbs2-0049" title="AdhikarySD , ArmstrongK , ChinKJ . Perineural entrapment of an interscalene stimulating catheter. Anaesthesia and Intensive Care2012;40(3):527‐30. [PUBMED: 22577921] ">Adhikary 2012</a>; <a href="./references#CD011770-bbs2-0058" title="BowensC , BriggsER , MalchowRJ . Brachial plexus entrapment of interscalene nerve catheter after uncomplicated ultrasound guided placement. Pain Medicine2011;12(7):1117‐20. [PUBMED: 21699651 ] ">Bowens 2011</a>; <a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>). Several adjuvants have been used to attempt to prolong the analgesia provided by peripheral nerve block, including perineural and intravenous dexamethasone (<a href="./references#CD011770-bbs2-0059" title="BrummettCM , WilliamsBA . Additives to local anesthetics for peripheral nerve blockade. International Anesthesiology Clinics2012;49(4):104‐16. [PUBMED: 21956081] ">Brummett 2012</a>; <a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>; <a href="./references#CD011770-bbs2-0093" title="PoppingDM , ElliaN , MarreE , WenkM , TramerMR . Clonidine as an adjuvant to local anesthetic for peripheral nerve block. A meta‐analysis of randomized trials. Anesthesiology2009;111(2):406‐15. [PUBMED: 19602964] ">Popping 2009</a>). </p> </section> <section id="CD011770-sec-0039"> <h3 class="title" id="CD011770-sec-0039">Description of the intervention</h3> <p>Dexamethasone is a corticosteroid drug that has been used as an adjuvant to reduce postoperative pain. Two systematic reviews have shown that study participants who received a single dose of intravenous dexamethasone perioperatively had lower pain scores and decreased opioid consumption after surgery compared with those given placebo (<a href="./references#CD011770-bbs2-0065" title="DeOliveiraGS , AlmeidaM , BenzonHT , McCarthyRJ . Perioperative single dose systemic dexamethasone for postoperative pain. A meta‐analysis of randomized controlled trials. Anesthesiology2011;115(3):575‐88. [PUBMED: 21799397 ] ">De Oliveira 2011</a>; <a href="./references#CD011770-bbs2-0100" title="WaldronNH , JonesCA , GanTJ , AllenTK , HabibAS . Impact of perioperative dexamethasone on postoperative analgesia and side‐effects: systematic review and meta‐analysis. British Journal of Anaesthesia2013;110(2):191‐200. [PUBMED: 23220857] ">Waldron 2013</a>). <a href="./references#CD011770-bbs2-0064" title="DeOliveriaGS , Castro‐AlvesLJ , AhmadS , KendallMC , McCarthyRJ . Dexamethasone to prevent postoperative nausea and vomiting. An updated meta‐analysis of randomized control trials. Anesthesia and Analgesia2013;116(1):58‐74. [PUBMED: 23223115] ">De Olivera 2013</a> studied three different intravenous doses: low‐dose (&lt; 0.10 mg/kg), intermediate‐dose (0.11 to 0.20 mg/kg) and high‐dose (≥ 0.21 mg/kg). Low‐dose dexamethasone was not effective in reducing pain and opioid consumption; however, intermediate and high doses were effective (<a href="./references#CD011770-bbs2-0064" title="DeOliveriaGS , Castro‐AlvesLJ , AhmadS , KendallMC , McCarthyRJ . Dexamethasone to prevent postoperative nausea and vomiting. An updated meta‐analysis of randomized control trials. Anesthesia and Analgesia2013;116(1):58‐74. [PUBMED: 23223115] ">De Olivera 2013</a>). <a href="./references#CD011770-bbs2-0100" title="WaldronNH , JonesCA , GanTJ , AllenTK , HabibAS . Impact of perioperative dexamethasone on postoperative analgesia and side‐effects: systematic review and meta‐analysis. British Journal of Anaesthesia2013;110(2):191‐200. [PUBMED: 23220857] ">Waldron 2013</a> performed a subgroup analysis of two doses of dexamethasone: 4 mg to 5 mg; and 8 mg to 10 mg, and did not find a dose‐response relationship. </p> <p>Several randomized control trials (RCTs) have studied the use of perineural dexamethasone (i.e. dexamethasone added to the local anaesthesia solution) as an adjuvant to peripheral nerve block to improve analgesia provided by local anaesthetic alone (<a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>). Perineural dexamethasone, as an adjuvant to peripheral nerve block, has been associated with faster onset of anaesthesia (<a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0097" title="ShresthaBR , MaharjanSK , TabedarS . Supraclavicular and brachial plexus block with and without dexamethasone ‐ a comparative study. Kathmandu University Medical Journal2003;1(3):158‐60. [PUBMED: 16388222] ">Shrestha 2003</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), longer duration of anaesthesia/analgesia (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a><a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>), decreased postoperative pain intensity (<a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), and decreased postoperative analgesia requirements compared with local anaesthetic alone (<a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>). </p> <p>Five systematic reviews have evaluated the efficacy of perineural dexamethasone versus placebo in participants undergoing surgery with peripheral nerve block. The number of trials and participants in each trial are as follows: <a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a> ‐ 29 trials, 1695 participants; <a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a> ‐ nine trials, 809 participants; <a href="./references#CD011770-bbs2-0066" title="DeOliveiraGS , Castro‐AlvesLJ , NaderA , KendallMC , RahangdaleR , McCarthyRJ . Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta‐analysis of randomized control trials. Pain Research and Treatment2014;2014:179029. [PUBMED: 25485150] ">De Oliveira 2014</a> ‐ nine trials, 760 participants; <a href="./references#CD011770-bbs2-0075" title="HuynhTM , MarretE , BonnetF . Combination of dexamethasone and local anesthetic solution in peripheral nerve blocks. A meta‐analysis of randomised placebo trials. European Journal of Anaesthesiology2015;32(11):751‐8. [PUBMED: 25774458] ">Huynh 2015</a> ‐ 12 trials, 512 participants; and <a href="./references#CD011770-bbs2-0081" title="KnezevicNN , AnantamongkolU , CandidoKD . Perinerual dexamethasone added to local anesthesia for brachial plexus block improves pain but delays block onset and motor blockade recovery. Pain Physcian2015;18(1):1‐14. [PUBMED: 25675053] ">Knezivic 2015</a> ‐ 14 trials, 1022 participants. </p> <p>In all five reviews, the use of perineural dexamethasone was associated with longer duration of sensory block compared with placebo (<a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a>; <a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>; <a href="./references#CD011770-bbs2-0066" title="DeOliveiraGS , Castro‐AlvesLJ , NaderA , KendallMC , RahangdaleR , McCarthyRJ . Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta‐analysis of randomized control trials. Pain Research and Treatment2014;2014:179029. [PUBMED: 25485150] ">De Oliveira 2014</a>; <a href="./references#CD011770-bbs2-0075" title="HuynhTM , MarretE , BonnetF . Combination of dexamethasone and local anesthetic solution in peripheral nerve blocks. A meta‐analysis of randomised placebo trials. European Journal of Anaesthesiology2015;32(11):751‐8. [PUBMED: 25774458] ">Huynh 2015</a>, <a href="./references#CD011770-bbs2-0081" title="KnezevicNN , AnantamongkolU , CandidoKD . Perinerual dexamethasone added to local anesthesia for brachial plexus block improves pain but delays block onset and motor blockade recovery. Pain Physcian2015;18(1):1‐14. [PUBMED: 25675053] ">Knezivic 2015</a>). Neither the <a href="./references#CD011770-bbs2-0066" title="DeOliveiraGS , Castro‐AlvesLJ , NaderA , KendallMC , RahangdaleR , McCarthyRJ . Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta‐analysis of randomized control trials. Pain Research and Treatment2014;2014:179029. [PUBMED: 25485150] ">De Oliveira 2014</a> review nor the <a href="./references#CD011770-bbs2-0075" title="HuynhTM , MarretE , BonnetF . Combination of dexamethasone and local anesthetic solution in peripheral nerve blocks. A meta‐analysis of randomised placebo trials. European Journal of Anaesthesiology2015;32(11):751‐8. [PUBMED: 25774458] ">Huynh 2015</a> review found a difference in intensity of postoperative pain among participants who received perineural dexamethasone compared with placebo. The <a href="./references#CD011770-bbs2-0081" title="KnezevicNN , AnantamongkolU , CandidoKD . Perinerual dexamethasone added to local anesthesia for brachial plexus block improves pain but delays block onset and motor blockade recovery. Pain Physcian2015;18(1):1‐14. [PUBMED: 25675053] ">Knezivic 2015</a> review found intensity of pain at 24 and 48 hours after surgery was lower with dexamethasone compared with block alone. The remaining reviews did not evaluate intensity of postoperative pain (<a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a>; <a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>). Opioid consumption was evaluated in three of five reviews. The <a href="./references#CD011770-bbs2-0066" title="DeOliveiraGS , Castro‐AlvesLJ , NaderA , KendallMC , RahangdaleR , McCarthyRJ . Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta‐analysis of randomized control trials. Pain Research and Treatment2014;2014:179029. [PUBMED: 25485150] ">De Oliveira 2014</a> and <a href="./references#CD011770-bbs2-0081" title="KnezevicNN , AnantamongkolU , CandidoKD . Perinerual dexamethasone added to local anesthesia for brachial plexus block improves pain but delays block onset and motor blockade recovery. Pain Physcian2015;18(1):1‐14. [PUBMED: 25675053] ">Knezivic 2015</a> reviews found a reduction in opioid consumption among participants who received perineural dexamethasone but the <a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a> review did not. Similarly, only two reviews evaluated postoperative nausea and vomiting, both reporting a reduction in the incidence of postoperative nausea and vomiting among participants who received perineural dexamethasone (<a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a>; <a href="./references#CD011770-bbs2-0075" title="HuynhTM , MarretE , BonnetF . Combination of dexamethasone and local anesthetic solution in peripheral nerve blocks. A meta‐analysis of randomised placebo trials. European Journal of Anaesthesiology2015;32(11):751‐8. [PUBMED: 25774458] ">Huynh 2015</a>). None of the reviews compared perineural dexamethasone with systemic dexamethasone, or systemic dexamethasone with placebo. </p> </section> <section id="CD011770-sec-0040"> <h3 class="title" id="CD011770-sec-0040">How the intervention might work</h3> <p>The exact mechanism by which dexamethasone reduces pain is not known. The decrease in pain intensity and the prolonged analgesia attained with the use of perineural dexamethasone may be the result of a local, or systemic action, or both (<a href="./references#CD011770-bbs2-0036" title="Fredrickson FranzcaMJ , Danesh‐CloughTK , WhiteR . Adjuvant dexamethasone for bupivacaine sciatic and ankle blocks. Results from 2 randomized‐controlled trials. Regional Anesthesia and Pain Medicine2013;38(4):300‐7. [PUBMED: 23698496] ">Fredrickson 2013</a>). Dexamethasone may act locally on glucocorticosteroid receptors to induce vasoconstriction, thereby decreasing systemic absorption of local anaesthetics (<a href="./references#CD011770-bbs2-0096" title="ShishidoH , KikuchiS , HeckmanH , MyersRR . Dexamethasone decreases blood flow in normal nerves and dorsal root ganglia. Spine2002;27(6):581‐6. [PUBMED: 11884905] ">Shishido 2002</a>; <a href="./references#CD011770-bbs2-0101" title="WangPH , TsaiCL , LeeJS , WuKC , ChengKI , JouIM . Effects of topical corticosteroids on the sciatic nerve: an experimental study to adduce the safety in treating carpel tunnel syndrome. Journal of Hand Surgery: European Volume2011;36(3):236‐43. [PUBMED: 21282223] ">Wang 2011</a>). Other potential mechanisms of action include suppression of C‐fibre transmission of pain signals and direct action on the nerve cell to reduce neural discharge (<a href="./references#CD011770-bbs2-0076" title="JohanssonA , HaoJ , SjölundB . Local corticosteroid application blocks transmission in normal nociceptive C‐fibres. Acta Anaesthesiologica Scandinavia1990;34(5):335‐8. [PUBMED: 2167604] ">Johansson 1990</a>). Dexamethasone may act systemically by reducing the inflammatory response caused by surgical tissue injury (<a href="./references#CD011770-bbs2-0062" title="Christiansson . Update on adjuvants in regional anaesthesia. Periodicum Biologorum2009;3:161‐70. [ISSN: 00315362] ">Christiansson 2009</a>). </p> </section> <section id="CD011770-sec-0041"> <h3 class="title" id="CD011770-sec-0041">Why it is important to do this review</h3> <p>It is important to treat postoperative pain effectively. People who experience severe pain in the early postoperative period are at risk for development of chronic pain (<a href="./references#CD011770-bbs2-0078" title="KehletH , JensenTS , WoolfC . Persistent postsurgical pain: risk factors and prevention. Lancet2006;367(9522):1618‐25. [PUBMED: 16698416] ">Kehlet 2006</a>; <a href="./references#CD011770-bbs2-0099" title="VandenkerkoffEG , HopmanWM , GoldsteinDH , WilsonRA , TowheedTE , LamM , et al. Impact of perioperative pain intensity, pain qualities and chronic pain after surgery. A prospective cohort study. Regional Anesthesia and Pain Medicine2012;37(1):19‐27. [PUBMED: 22157741] ">Vandenkerkoff 2012</a>), which can dramatically affect their quality of life (<a href="./references#CD011770-bbs2-0070" title="GalvezR , MarsalC , VidalJ , RuizM , RejasJ . Cross‐sectional evaluation of patients functioning and health‐related quality of life in patients with neuropathic pain under standard care conditions. European Journal of Pain2007;11(3):244‐55. [PUBMED: 16563819] ">Galvez 2007</a>; <a href="./references#CD011770-bbs2-0082" title="LameIE , PetersML , VlaeyenJW , KleefM , PatijnJ . Quality of life in chronic pain is more associated with beliefs about pain, than with pain intensity. European Journal of Pain2005;9(1):15‐24. [PUBMED: 15629870] ">Lame 2005</a>; <a href="./references#CD011770-bbs2-0098" title="SmithBH , TorranceN , BennettMI , LeeAJ . Health and quality of life associated with chronic pain of predominantly neuropathic origin in the community. Clinical Journal of Pain2007;23(2):143‐9. [PUBMED: 17237663] ">Smith 2007</a>), and increase healthcare costs (<a href="./references#CD011770-bbs2-0057" title="BlythFM , MarchLM , CousinsMJ . Chronic pain‐related disability and use of analgesia and health services in a Sydney community. Medical Journal of Australia2003;179(2):84‐7. [PUBMED: 12864718] ">Blyth 2003</a>). In an attempt to augment postoperative pain management, people are often treated with opioids, which are associated with adverse events such as respiratory depression, nausea, vomiting, constipation and pruritus. Adequate treatment of people with pain through the use of peripheral nerve block may result in reduced opioid use and fewer opioid‐related harms (<a href="./references#CD011770-bbs2-0054" title="AvidanA , DrengerB , GinosarY . Peripheral nerve block for ambulatory surgery and postoperative analgesia. Current Opinion in Anesthesiology2003;16:567‐73. [PUBMED: 17021512] ">Avidan 2003</a>; <a href="./references#CD011770-bbs2-0073" title="HadzicA , KaracaPE , HobeikaP , UnisG , DermksianJ , YufaM , et al. Peripheral nerve block results in superior recovery profile compared with general anesthesia in outpatient knee arthroscopy. Anesthesia and Analgesia2005;100(4):976‐81. [PUBMED: 15781509] ">Hadzic 2005</a>). </p> <p>Use of perineural dexamethasone as an adjuvant to peripheral nerve block for postoperative pain is controversial. Animal studies have suggested that perineural dexamethasone is neurotoxic to peripheral nerves and has the potential to cause peripheral nerve damage; however, data in humans are limited (<a href="./references#CD011770-bbs2-0085" title="MaR , WangX , LuC , LiC , ChengY , DingG , et al. Dexamethasone attenuated bupivacaine‐induced neuron injury in vitro through a threonine‐serine protein kinase B‐dependent mechanism. Neuroscience2010;167(2):329‐42. [PUBMED: 20038443] ">Ma 2010</a>). Although no symptoms of peripheral nerve damage were reported in four RCTs examining perineural versus intravenous dexamethasone (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>), these studies may have been underpowered to detect differences in potential neurotoxic events (<a href="./references#CD011770-bbs2-0102" title="WilliamsBA , SchottNJ , MangioneMP , IbinsonJW . Perineural dexamethasone and multimodal perineural analgesia: how much is too much?. Anesthesia and Analgesia2014;118(5):912‐4. [PUBMED: 24781562] ">Williams 2014</a>). Furthermore, in most studies, participants were followed for short periods (24 to 48 hours). Thus, adverse events such as persistent nerve palsy caused by peripheral nerve damage may not have been detected. </p> <p>Intravenous dexamethasone may be used as an alternative to perineural dexamethasone and as an adjuvant to peripheral nerve block. In four RCTs, the effects of perineural and intravenous dexamethasone in participants receiving peripheral nerve block were studied (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>). In three of these studies, both perineural and intravenous dexamethasone were associated with prolonged sensory block when compared with placebo (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014)</a>. In one study, perineural but not intravenous dexamethasone was associated with prolonged sensory block when compared with placebo (<a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>). In all four studies, no difference was observed in the duration of sensory block when perineural and intravenous dexamethasone were compared with each other. </p> <p>Single‐dose intravenous dexamethasone is associated with complications such as hyperglycaemia, perineal irritation, postoperative infection, and delayed wound healing (<a href="./references#CD011770-bbs2-0056" title="BartlettR , HartleAJ . Routine use of dexamethasone for postoperative nausea and vomiting: the case against. Anaesthesia2013;68(9):892‐6. [PUBMED: 23848377] ">Bartlett 2013</a>; <a href="./references#CD011770-bbs2-0063" title="CrandellJT . Perineal pruritus after the administration of iv dexamethasone. Canadian Journal of Anesthesia2004;51(4):398. [PUBMED: 15064273 ] ">Crandell 2004</a>; <a href="./references#CD011770-bbs2-0090" title="PasternakJJ , McGregorDG , LanierWL . Effect of single‐dose dexamethasone on blood glucose concentration in patients undergoing craniotomy. Journal of Neursurgical Anesthesiology2004;16(2):122‐5. [PUBMED: 15021280] ">Pasternak 2004</a>; <a href="./references#CD011770-bbs2-0091" title="PercivalVG , RiddellJ , CorcoranTB . Single dose dexamethasone for postoperative nausea and vomiting‐a matched case‐placebo study of postoperative infection risk. Anaesthesia and Intensive Care2010;38(4):661‐6. [PUBMED: 20715728] ">Percival 2010</a>; <a href="./references#CD011770-bbs2-0092" title="PerronG , DolbecP , GermainJ , BechardP . Perineal pruritis after i.v. dexamethasone administration. Canadian Journal of Anesthesia2003;50(7):749‐50. [PUBMED: 12944454 ] ">Perron 2003</a>; <a href="./references#CD011770-bbs2-0104" title="YaredJP , StarrNJ , TorresFK , BashourCA , BourdakosG , PiedmonteM , et al. Effects of single dose, post induction dexamethasone on recovery after cardiac surgery. Annals of Thoracic Surgery2000;69(5):1420‐4. [PUBMED: 10881816] ">Yared 2000</a>). Rare adverse events include tumour lysis syndrome and psychosis after a single dose and avascular necrosis of bone after short‐term use (<a href="./references#CD011770-bbs2-0069" title="FastA , AlonM , WeissS , Zer‐AvivFR . Avascular necrosis of bone following short‐term dexamethasone therapy for brain edema. Journal of Neurosurgery1984;61(5):983‐5. [PUBMED: 6491744] ">Fast 1984</a>; <a href="./references#CD011770-bbs2-0083" title="LerzaR , BottaM , BarsottoB , SchenoneE , MencoboniM , BoglioloG , et al. Dexamethazone‐induced acute tumor lysis syndrome in a T‐cell malignant lymphoma. Leukemia &amp; Lymphoma2002;43(5):1129‐32. [PUBMED: 12148896 ] ">Lerza 2002</a>; <a href="./references#CD011770-bbs2-0086" title="McDonnellC , BarlowR , CampisiP , GrantR , MalkinD . Fatal peri‐operative acute tumour lysis syndrome precipitated by dexamethasone. Anaesthesia2008;63(6):652‐5. [PUBMED: 18477278] ">Mc Donnell 2008</a>; <a href="./references#CD011770-bbs2-0087" title="McKeeMD , WaddellJP , KudoPA , SchemitschEH , RichardsRR . Osteonecrosis of the femoral head in men following short‐course corticosteroid therapy: a report of 15 cases. Canadian Medical Association Journal2001;164(2):205‐6. [PUBMED: 11332313 ] ">McKee 2001</a>). </p> <p>Although four systematic reviews have compared the efficacy of perineural dexamethasone versus placebo (<a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a>; <a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>; <a href="./references#CD011770-bbs2-0066" title="DeOliveiraGS , Castro‐AlvesLJ , NaderA , KendallMC , RahangdaleR , McCarthyRJ . Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta‐analysis of randomized control trials. Pain Research and Treatment2014;2014:179029. [PUBMED: 25485150] ">De Oliveira 2014</a>; <a href="./references#CD011770-bbs2-0075" title="HuynhTM , MarretE , BonnetF . Combination of dexamethasone and local anesthetic solution in peripheral nerve blocks. A meta‐analysis of randomised placebo trials. European Journal of Anaesthesiology2015;32(11):751‐8. [PUBMED: 25774458] ">Huynh 2015</a>), to date, no comprehensive review has compared each method of dexamethasone delivery versus placebo, or perineural versus intravenous dexamethasone. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011770-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011770-sec-0042">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011770-sec-0214">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011770-sec-0042"></div> <p>To evaluate the comparative efficacy and safety of perineural dexamethasone versus placebo, intravenous dexamethasone versus placebo, and perineural dexamethasone versus intravenous dexamethasone when added to peripheral nerve block for postoperative pain control in people undergoing surgery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011770-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011770-sec-0043">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011770-sec-0215">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011770-sec-0043"></div> <section id="CD011770-sec-0044"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011770-sec-0045"> <h4 class="title">Types of studies</h4> <p>We included all randomized controlled trials (RCTs) that evaluated the effectiveness of dexamethasone as an adjuvant to peripheral nerve block, irrespective of blinding and other design features (parallel or factorial). We did not exclude any study on the basis of language of publication or publication status. We excluded observational studies, quasi‐randomized trials and cluster‐randomized trials. </p> </section> <section id="CD011770-sec-0046"> <h4 class="title">Types of participants</h4> <p>We included children (aged 1 month to 18 years) and adults (aged 19 years and older) undergoing upper and lower limb surgery who received a peripheral nerve block or a peripheral nerve block with the addition of dexamethasone. We excluded neonates. </p> </section> <section id="CD011770-sec-0047"> <h4 class="title">Types of interventions</h4> <p>Our intervention groups included the following.</p> <p> <ol id="CD011770-list-0001"> <li> <p>Participants who received peripheral nerve block and perineural dexamethasone (dexamethasone mixed with the local anaesthetic solution) versus those receiving peripheral nerve block and a perineural placebo or a non‐active comparator. </p> </li> <li> <p>Participants who received peripheral nerve block and intravenous dexamethasone versus those receiving peripheral nerve block and intravenous placebo or a non‐active comparator. </p> </li> <li> <p>Participants who received peripheral nerve block and perineural dexamethasone versus those receiving peripheral nerve block and intravenous dexamethasone. </p> </li> </ol> </p> <p>We excluded participants who received local anaesthetic, or dexamethasone, or both, via more than one route (e.g. perineurally and subcutaneously). </p> </section> <section id="CD011770-sec-0048"> <h4 class="title">Types of outcome measures</h4> <section id="CD011770-sec-0049"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011770-list-0002"> <li> <p>Duration of sensory block. We included all studies describing duration of sensory block regardless of how it was described. </p> </li> <li> <p>Incidence of serious adverse events. We used the National Institutes of Health (NIH) definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly (<a href="./references#CD011770-bbs2-0088" title="National Institute of Health. Adverse events. https://www.nhlbi.nih.gov/research/funding/research‐support/crg/glossary.htm (accessed 26 September 2014). ">NIH 2013</a>). </p> </li> </ol> </p> </section> <section id="CD011770-sec-0050"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011770-list-0003"> <li> <p>Duration of motor block. We included all studies describing duration of motor block, regardless of how it was described. </p> </li> <li> <p>Incidence of mild to moderate adverse events such as nausea/vomiting, pruritus, somnolence, oxygen desaturation, urinary retention, numbness/tingling. </p> </li> <li> <p>Postoperative pain intensity (pain scores) at 12, 24 and 48 hours.</p> </li> <li> <p>Postoperative opioid consumption at 12, 24 and 48 hours. We converted all opioids to oral morphine equivalents. </p> </li> <li> <p>Participant satisfaction with pain control. Participant satisfaction is typically measured on a numerical rating scale (NRS). </p> </li> </ol> </p> </section> </section> </section> <section id="CD011770-sec-0051"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011770-sec-0052"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (inception to 25 April 2017), (<a href="./appendices#CD011770-sec-0181">Appendix 1</a>) MEDLINE via Ovid (1966 to 25 April 2017) (<a href="./appendices#CD011770-sec-0182">Appendix 2</a>), Embase via Ovid (1947 to 25 April 2017) (,<a href="./appendices#CD011770-sec-0183">Appendix 3</a>) the Database of Abstracts of Reviews of Effectiveness (DARE) (inception to 25 April 2017), and Web of Science (<a href="./appendices#CD011770-sec-0184">Appendix 4</a>) and Scopus (inception to 25 April 2017) . An experienced librarian assisted with the search strategy. The MEDLINE search strategy presented in <a href="./appendices#CD011770-sec-0182">Appendix 2</a> was adopted for searching the DARE and Scopus databases. We did not impose any language restrictions. </p> </section> <section id="CD011770-sec-0053"> <h4 class="title">Searching other resources</h4> <p>We reviewed the reference lists of all included trials for additional studies that met our criteria, as well as trial registry databases (ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov</a>), EU Cinical Trials Register (<a href="https://www.clinicaltrialsregister.eu/" target="_blank">clinicaltrialsregister.eu</a>), and Current Controlled Trials (<a href="https://www.isrctn.com/" target="_blank">isrctn.com</a>), Google Scholar and meeting abstracts from the American Society of Anesthesiologists, the Canadian Anesthesiologists' Society, the American Society of Regional Anesthesia, and the European Society of Regional Anaesthesia (2010 to April 2017). </p> </section> </section> <section id="CD011770-sec-0054"> <h3 class="title" id="CD011770-sec-0054">Data collection and analysis</h3> <section id="CD011770-sec-0055"> <h4 class="title">Selection of studies</h4> <p>Using the results of all searches, two review authors (AK and CP) independently screened titles and abstracts for eligibility according to the following criteria:. </p> <p> <ol id="CD011770-list-0004"> <li> <p>The study described was an RCT.</p> </li> <li> <p>Participants received a peripheral nerve block.</p> </li> <li> <p>Dexamethasone was given perineurally (mixed with the local anaesthetic) or intravenously.</p> </li> </ol> </p> <p>In cases of disagreement on eligibility, we consulted a third review author (BJ) to determine eligibility. If additional information was required, we contacted the first author of the trial. </p> </section> <section id="CD011770-sec-0056"> <h4 class="title">Data extraction and management</h4> <p>Two review authors (AP and CP) independently extracted data and assessed the quality of each trial using a standardized, pre‐piloted form (<a href="./appendices#CD011770-sec-0185">Appendix 5</a>). We resolved disagreements through discussion with a senior review author (BJ). </p> </section> <section id="CD011770-sec-0057"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Using the Cochrane 'Risk of bias' instrument, we assessed the risk of bias of each study using the following domains (<a href="./references#CD011770-bbs2-0074" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration. [Available from: www.cochrane‐handbook.org.] ">Higgins 2011</a>). </p> <p> <ol id="CD011770-list-0005"> <li> <p>Random sequence generation.</p> </li> <li> <p>Allocation concealment.</p> </li> <li> <p>Blinding of participants and personnel.</p> </li> <li> <p>Blinding of outcome assessment.</p> </li> <li> <p>Selective reporting.</p> </li> <li> <p>Missing participant data.</p> </li> </ol> </p> <p>For each study, we classified risk of bias of each domain as low, high or unclear. If risk of bias was low for all domains or was low for five out of the six domains then we classified the risk of bias as low for that study. If two or more domains were classified as high or unclear risk of bias, we determined the study to be at high or unclear risk of bias, respectively. </p> </section> <section id="CD011770-sec-0058"> <h4 class="title">Measures of treatment effect</h4> <p>We analysed continuous outcomes including pain scores, analgesic consumption, duration of sensory and motor block. and participant satisfaction by calculating the mean difference (MD) with corresponding 95% confidence interval (CI). We pooled dichotomous outcomes to calculate the risk ratio (RR) and the risk difference (RD) with corresponding 95% CI. We assumed a normal distribution of pain scores on the Visual Analogue Scale (VAS) or the numerical rating scale (NRS) among intervention and placebo groups, and we considered a 1.2 cm change/1.2 point change on the VAS/NRS as representative of a minimally important difference (MID) in acute pain (<a href="./references#CD011770-bbs2-0077" title="JohnstonBC , PatrickDL , ThorlundK , BusseJW , daCostaBR , SchünemannHJ , et al. Patient‐reported outcomes in meta‐analyses. Part 2: methods for improving interpretability for decision‐makers. Health and Quality of Life Outcomes2013;21(11):211. [PUBMED: 24359184] ">Johnston 2013</a>; <a href="./references#CD011770-bbs2-0079" title="KellyAM . The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emergency Medicine Journal2001;18(3):205‐7. [PUBMED: 11354213] ">Kelly 2001</a>). </p> </section> <section id="CD011770-sec-0059"> <h4 class="title">Unit of analysis issues</h4> <p>We avoided unit of analysis errors as follows: if included studies had more than two study arms, we combined relevant groups to create a single pair‐wise comparison, or, if not possible, we selected one pair of interventions and excluded the others. </p> </section> <section id="CD011770-sec-0060"> <h4 class="title">Dealing with missing data</h4> <p>We assessed the completeness of outcome data and determined whether missing outcome data may put continuous and dichotomous outcomes at risk of bias. If primary analyses for our critical outcome of interest suggested significant benefit (or harm), we conducted a sensitivity meta‐analysis to address missing participant data (<a href="./references#CD011770-bbs2-0050" title="AklEA , BrielM , YouJJ , SunX , JohnstonBC , BusseJW , et al. Potential impact on estimated treatment effects of information lost to follow‐up in randomised controlled trials (LOST‐IT): systematic review. BMJ2012;18(344):e2809. [PUBMED: 22611167] ">Akl 2012</a>; <a href="./references#CD011770-bbs2-0068" title="EbrahimS , AlkEA , MustafaRA , SunX , WalterSD , Heels‐AnsdellD , et al. Addressing continuous data for participants excluded from trial analysis. Journal of Clinical Epidemiology2013;66(9):1014‐21. [PUBMED: 23774111] ">Ebrahim 2013</a>). </p> <p>To determine whether missing participant data represented risk of bias for continuous outcomes (pain at 12, 24 and 48 hours), we used the method described by <a href="./references#CD011770-bbs2-0068" title="EbrahimS , AlkEA , MustafaRA , SunX , WalterSD , Heels‐AnsdellD , et al. Addressing continuous data for participants excluded from trial analysis. Journal of Clinical Epidemiology2013;66(9):1014‐21. [PUBMED: 23774111] ">Ebrahim 2013</a>. For each outcome with missing data, we used four progressively stringent data input strategies based on observed outcomes for those individuals in the intervention and placebo arms for whom data were not missing. </p> <p>If we found a significant difference in serious adverse events, to determine whether missing participant data represented risk of bias for dichotomous outcomes (serious adverse events), we conducted a sensitivity meta‐analysis using the worst‐case scenario assumption described by <a href="./references#CD011770-bbs2-0051" title="AklEA , JohnstonBC , Alonso‐CoelloP , NeumannI , EbrahimS , BrielM , et al. Addressing dichotomous data for participants excluded from trial analysis: a guide for systematic reviewers. PLoS One2013;8(2):e0057132. [PUBMED: 23451162] ">Akl 2013</a>. If results were robust to the worst‐case scenario (all missing participants in the treatment experienced the outcome of interest, and none of the participants in the placebo group did), we concluded that the missing data did not represent a source of bias. If results of the sensitivity meta‐analysis were not robust to the worst‐case scenario, we tested more plausible assumptions. For participants missing from the intervention group, we assumed a range of ratios of event rates for those with missing data compared with those successfully followed of 2:1, 3:1 and 5:1 (<a href="./references#CD011770-bbs2-0050" title="AklEA , BrielM , YouJJ , SunX , JohnstonBC , BusseJW , et al. Potential impact on estimated treatment effects of information lost to follow‐up in randomised controlled trials (LOST‐IT): systematic review. BMJ2012;18(344):e2809. [PUBMED: 22611167] ">Akl 2012</a>). </p> </section> <section id="CD011770-sec-0061"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the Cochran Q and I<sup>2</sup> tests to assess the potential for statistical heterogeneity between trials. For the Cochran Q, the null hypothesis is that the underlying effect is the same in each of the included studies. A P value less than 0.10 means that random error provides an unlikely explanation for observed differences in study results between trials. The I<sup>2</sup> statistic shows the percentage of variability due to differences between studies such that I<sup>2</sup> &gt; 75% indicates considerable heterogeneity (<a href="./references#CD011770-bbs2-0074" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration. [Available from: www.cochrane‐handbook.org.] ">Higgins 2011</a>; <a href="./references#CD011770-bbs2-0095" title="RileyRD , HigginsJ , DeeksJJ . Interpretation of random effects meta‐analyses. BMJ2011;342:964‐7. [PUBMED: 21310794] ">Riley 2011</a>). </p> </section> <section id="CD011770-sec-0062"> <h4 class="title">Assessment of reporting biases</h4> <p>For outcomes reported in 10 or more trials, we assessed publication biases using a funnel plot (<a href="./references#CD011770-bbs2-0074" title="HigginsJP , GreenS , editor(s) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from handbook.cochrane.org. The Cochrane Collaboration. [Available from: www.cochrane‐handbook.org.] ">Higgins 2011</a>). </p> </section> <section id="CD011770-sec-0063"> <h4 class="title">Data synthesis</h4> <p>We entered data into Review Manager statistical software and analysed data using the DerSimonian‐Laird random‐effects model (<a href="./references#CD011770-bbs2-0094" title="Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager 5 (RevMan 5). Version 5.3. Copenhagen: Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">Review Manager 2014</a>). </p> <p>If data for some outcomes were not amenable to meta‐analysis, we planned to use tables to describe the characteristics of each trial that contributed to our a priori outcomes. We planned to describe all trial populations, interventions, comparator(s), outcome(s) and follow‐up time points for outcomes not amenable to meta‐analysis. </p> </section> <section id="CD011770-sec-0064"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We analysed the following subgroups.</p> <p> <ol id="CD011770-list-0006"> <li> <p>Long‐acting local anaesthetics (e.g. ropivacaine, bupivacaine, levobupivacaine) versus medium‐acting local anaesthetics (e.g. lidocaine, mepivacaine). </p> </li> <li> <p>Additives to local anaesthetics (e.g. clonidine, epinephrine) versus no additives to local anaesthetics. </p> </li> <li> <p>Low‐dose dexamethasone (4 mg to 5 mg) versus high‐dose dexamethasone (8 mg to 10 mg).</p> </li> <li> <p>Adult versus paediatric participants. (See <a href="#CD011770-sec-0204">Differences between protocol and review</a>) </p> </li> <li> <p>Studies at high/unclear risk of bias versus studies at low risk of bias.</p> </li> </ol> </p> <p>Following are our a priori hypotheses for explaining heterogeneity between trials.</p> <p> <ol id="CD011770-list-0007"> <li> <p>For the outcome, duration of sensory block, we anticipated that participants receiving dexamethasone along with long‐acting local anaesthetics (e.g. ropivacaine, bupivacaine, levobupivacaine) would show larger effects than those receiving dexamethasone with medium‐acting local anaesthetics (e.g. lidocaine, mepivacaine). </p> <ol id="CD011770-list-0008"> <li> <p>Choi et al in a systematic review and meta‐analysis compared the effects of short‐acting local anaesthetics and medium‐acting anaesthetics and found that the duration of analgesia in participants receiving long‐acting anaesthetics was longer than those receiving medium‐acting local anaesthetics (<a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>). </p> </li> </ol> </li> <li> <p>For the outcome, duration of sensory block, we anticipated that participants who receive additives to local anaesthesia (e.g. clonidine, epinephrine) would show a larger effect than those who do not. </p> <ol id="CD011770-list-0009"> <li> <p>In a systematic review of 20 RCTs of 573 participants, Popping and colleagues found that the duration of intermediate and long‐acting local anaesthetics was longer in participants who received clonidine (<a href="./references#CD011770-bbs2-0093" title="PoppingDM , ElliaN , MarreE , WenkM , TramerMR . Clonidine as an adjuvant to local anesthetic for peripheral nerve block. A meta‐analysis of randomized trials. Anesthesiology2009;111(2):406‐15. [PUBMED: 19602964] ">Popping 2009</a>). </p> </li> </ol> </li> <li> <p>Although we conducted a subgroup analysis on dose of dexamethasone for the outcomes: pain intensity, duration of analgesia, and serious adverse events, we did not expect that participants who receive high‐dose dexamethasone would show any difference in effect when compared with those receiving low‐dose dexamethasone. </p> <ol id="CD011770-list-0010"> <li> <p>Albrecht and colleagues, in a systematic review of 29 RCTs of 1695 participants did not find a difference in duration of analgesia in participants who received 4 mg of dexamethasone compared with those who received 8 mg (<a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a>). Differences in other outcomes, including intensity of pain and adverse events were not reported. </p> </li> </ol> </li> <li> <p>For the outcome of adult versus paediatric participants, we did not anticipate a difference in duration of analgesia or intensity of pain. </p> <ol id="CD011770-list-0011"> <li> <p>Currently, no evidence supports that the pharmacokinetics of dexamethasone is different in children when compared with adults. </p> </li> </ol> </li> <li> <p>For the outcomes of intensity of pain and duration of sensory block, we expected that trials with high risk of bias would show a larger effect than those with low risk of bias. </p> <ol id="CD011770-list-0012"> <li> <p>Our subgroup on risk of bias is based on previous literature suggesting that studies at high risk of bias are more likely to overestimate treatment effects (<a href="./references#CD011770-bbs2-0089" title="NueschE , ReichenbackS , TrelleS , RutjesAWS , LiewaldK , SterchiR , et al. The importance of allocation concealment and patient blinding in osteoarthritis trials: a meta‐epidemiologic study. Arthritis and Rheumatism2009;61(12):1633‐41. [PUBMED: 19950329] ">Nuesch 2009</a>; <a href="./references#CD011770-bbs2-0103" title="WoodL , EggerM , GluudLL , SchulzKF , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. [PUBMED: 18316340] ">Wood 2008</a>). </p> </li> </ol> </li> </ol> </p> </section> <section id="CD011770-sec-0065"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted a sensitivity analysis to assess the completeness of outcome data and to determine whether missing outcome data put continuous and dichotomous outcomes at risk of bias, using the methods described in <a href="#CD011770-sec-0060">Dealing with missing data</a>. </p> <section id="CD011770-sec-0066"> <h5 class="title">'Summary of findings' table and GRADE</h5> <p>Two review authors (AP and CP) independently prepared a 'Summary of findings' table using GRADEprofiler software to assess the confidence of estimates of effect (<a href="./references#CD011770-bbs2-0071" title="McMaster University (developed by Evidence Prime). GRADEpro GDT. Version Date accessed: April 25, 2017. Hamilton (ON): McMaster University (developed by Evidence Prime), 2015. ">GRADEpro GDT 2015</a>), for the following outcomes of interest. </p> <p> <ol id="CD011770-list-0013"> <li> <p>Duration of sensory block.</p> </li> <li> <p>Incidence of serious adverse events</p> </li> <li> <p>Postoperative pain intensity at 12 hours.</p> </li> <li> <p>Postoperative pain intensity at 24 hours.</p> </li> <li> <p>Postoperative pain intensity at 48 hours.</p> </li> </ol> </p> <p>We used GRADE principles as described by <a href="./references#CD011770-bbs2-0072" title="GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchünemannHJ , et al. What is “quality of evidence” and why is it important to clinicians?. BMJ2008;336(7651):995‐8. [PUBMED: 18456631] ">Guyatt 2008</a>, to independently assess the confidence in our pooled estimates of effect (i.e. overall quality of evidence) using the following criteria. </p> <p> <ol id="CD011770-list-0014"> <li> <p>Risk of bias.</p> </li> <li> <p>Consistency.</p> </li> <li> <p>Directness.</p> </li> <li> <p>Precision.</p> </li> <li> <p>Reporting bias.</p> </li> </ol> </p> <p>For RCTs, we initially assigned high confidence ratings, but rated confidence as moderate, low or very low if we detected issues with risk of bias, consistency or other GRADE criteria. In particular, we categorized the quality of each pooled estimate as high (we are very confident that the true effect lies close to that of the estimate of the effect), moderate (we are moderately confident in the effect estimate ‐ the true effect is likely to be close to the estimate of the effect, but may be substantially different), low (our confidence in the effect estimate is limited ‐ the true effect may be substantially different from the estimate of the effect) or very low (we have very little confidence in the effect estimate ‐ the true effect is likely to be substantially different from the estimate of effect) (<a href="./references#CD011770-bbs2-0072" title="GuyattGH , OxmanAD , KunzR , VistGE , Falck‐YtterY , SchünemannHJ , et al. What is “quality of evidence” and why is it important to clinicians?. BMJ2008;336(7651):995‐8. [PUBMED: 18456631] ">Guyatt 2008</a>). </p> <p>We referred discrepancies in assessment of the quality of evidence to a third review author (BJ) for a final decision. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011770-sec-0067" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011770-sec-0067"></div> <section id="CD011770-sec-0068"> <h3 class="title">Description of studies</h3> <section id="CD011770-sec-0069"> <h4 class="title">Results of the search</h4> <p>Please see the PRISMA flowchart for the selection process of the included studies (<a href="#CD011770-fig-0001">Figure 1</a>): </p> <div class="figure" id="CD011770-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Flow diagram of included studies." data-id="CD011770-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Flow diagram of included studies.</p> </div> </div> </div> <p>We identified 3443 unique records in our literature search. Of these, 51 were potentially eligible. Nine were protocols found on ClinicalTrials.gov for which no results were available (<a href="./references#CD011770-bbs2-0040" title="NCT01277159 . Duration of analgesia after popliteal fossa nerve blockade: effects of dexamethasone and buprenophine. clinicaltrials.gov/show/NCT01277159 (first received 13 January 2011). ">NCT01277159</a>; <a href="./references#CD011770-bbs2-0041" title="NCT01495624 . The effect of systemic or perineural dexamethasone in the duration of interscalene nerve blocks with ropivacaine. clinicaltrials.gov/show/NCT1495624 (first received 12 December 2011). ">NCT01495624</a>; <a href="./references#CD011770-bbs2-0042" title="NCT01586806 . Comparing subsartorial saphenous nerve blocks with and without dexamethasone from anterior cruciate ligament reconstruction. clinicaltrials.gov/show/NCT01586806 (first received 25 April 2012). ">NCT01586806</a>; <a href="./references#CD011770-bbs2-0043" title="NCT01971645 . Decadon as adjuvant in femoral nerve blocks in knee arthroscopy. clinicaltrials.gov/show/NCT01971645 (first received 22 October 2013). ">NCT01971645</a>; <a href="./references#CD011770-bbs2-0044" title="NCT02178449 . Prolongation of pain free time by the use of dexamethasone in peripheral nerve blocks. clinicaltrials.gov/show/NCT02178449 (first received 26 May 2014). ">NCT02178449</a>; <a href="./references#CD011770-bbs2-0045" title="NCT02322242 . The effects of dexamethasone on low dose interscalene brachial plexus block (ISB‐Dex). clinicaltrials.gov/show/NCT02322242 (first received 16 December 2014). ">NCT02322242</a>; <a href="./references#CD011770-bbs2-0046" title="NCT02436694 . Nerve blocks with dexamethasone and local anaesthetic to improve postoperative analgesia. clinicaltrials.gov/show/NCT02436694 (first received 1 April 2015). ">NCT02436694</a>; <a href="./references#CD011770-bbs2-0047" title="NCT02462148 . Perineural steroids for peripheral nerve block. clinicaltrials.gov/show/NCT02462148 (first received 1 June 2015). ">NCT02462148</a>; <a href="./references#CD011770-bbs2-0048" title="NCT02506660 . Interscalene block with low‐dose IV vs. perineural dexamethasone for shoulder arthroscopy (Dex ISB). clinicaltrials.gov/show/NCT02506660 (first received 2 July 2015). ">NCT02506660</a>). We excluded seven studies: two because there was no placebo group (<a href="./references#CD011770-bbs2-0036" title="Fredrickson FranzcaMJ , Danesh‐CloughTK , WhiteR . Adjuvant dexamethasone for bupivacaine sciatic and ankle blocks. Results from 2 randomized‐controlled trials. Regional Anesthesia and Pain Medicine2013;38(4):300‐7. [PUBMED: 23698496] ">Fredrickson 2013</a>; <a href="./references#CD011770-bbs2-0039" title="ShesthraBR , MaharjanSK , ShresthaS , GautamB , ThapaC , ThapaPB , et al. Comparative study between tramadol and dexamethasone as an admixture to bupivacaine in supraclavicular brachial plexus block. Journal of the Napali Medical Association2007;46(168):158‐64. [PUBMED: 18340366] ">Shethra 2007</a>); one because participants received both perineural and intravenous dexamethasone (<a href="./references#CD011770-bbs2-0037" title="LuiJ , RichmanKA , GrodfskySR , BhattS , HuffmanGR , KellyJD , et al. Is there a dose relationship of dexamethasone as adjuvant for supraclavicular brachial plexus block? A prospective randomized double‐blinded clinical study. Journal of Clinical Anesthesia2015;27(3):237‐42. [PUBMED: 25637938] ">Lui 2015</a>): one because the authors reported only a means without any variances, therefore we could not enter the data into a meta‐analysis (<a href="./references#CD011770-bbs2-0038" title="PersecJ , PersecZ , KopljarM , ZupcicM , SakicL , ZrinjscakIK , et al. Low‐dose dexamethasone with levobupivacaine improves analgesia after supraclavicular brachial plexus blockade. International Orthopedics2014;38(1):101‐5. [PUBMED: 24173676] ">Percec 2014</a>); and three were secondary publications of included studies (<a href="./references#CD011770-bbs2-0053" title="AroraM , ShahD . Evaluation of dexamethasone versus clonidine as adjuvants to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Pain2010;11:S6. ">Arora 2010</a>; <a href="./references#CD011770-bbs2-0067" title="DesmetM , PottelH , MissantC , Van DeVeldeM . The effect of dexamethasone on the duration and quality of single shot interscalene block with ropivacaine for shoulder surgery: A prospective randomized control trial. Reginal Anesthesia and Pain Medicine2012;37(7):E188‐9. ">Desmet 2012</a>; <a href="./references#CD011770-bbs2-0080" title="KimYJ , HanJI , BaikHJ , LeeGY . 5 mg dexamathasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Regional Anesthesia and Pain Medicine2010;35(5):464. ">Kim 2010</a>), leaving 35 for inclusion in the review. </p> </section> <section id="CD011770-sec-0070"> <h4 class="title">Included studies</h4> <section id="CD011770-sec-0071"> <h5 class="title">Participants</h5> <p>The 35 included trials involved 2702 participants. All studies were in Americal Anesthesiology Society (ASA) I to III adolescent and adult participants aged 15 to 78 years. We did not find any studies in children aged less than 15 years. Length of follow‐up ranged from one day to six months after surgery. Surgical procedures included the forearm and hand (not including the elbow) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), forearm and hand (including the elbow) (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>), arthroscopic shoulder (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), both arthroscopic and open shoulder (<a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>), upper limb (<a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>), rotator cuff repair or subacromial decompression (<a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>), and foot and ankle (<a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>). </p> <p>Type of block included interscalene brachial plexus (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), supraclavicular brachial plexus (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), axillary brachial plexus (<a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>), infraclavicular brachial plexus (<a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>), sciatic nerve (<a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>), and ankle block (<a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>). </p> </section> <section id="CD011770-sec-0072"> <h5 class="title">Exclusion criteria</h5> <p>Exclusion criteria were: pregnancy (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), neurological deficit or neuropathy (<a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>), peptic ulcer (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), diabetes mellitus (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), hypertension (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), endocrine disorder (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>), cardiac disease (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), circulatory instability (<a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>), hepatic or renal disease (<a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>: <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>), lung disease (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a> , <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), respiratory disorder (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), psychiatric history (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>, <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), clavicular fracture (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>), electrolyte imbalance, (<a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>), head injury (<a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>), neuromuscular disease (<a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), drug/alcohol dependency (<a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), pre‐existing chronic pain (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>), preoperative opioid use (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), preoperative corticosteroid use (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), contraindication to peripheral nerve block (skin infection, coagulopathy, bleeding diathesis, deformities in the operative site (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), allergy/hypersensitivity to any of the study drugs (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>). </p> </section> <section id="CD011770-sec-0073"> <h5 class="title">Settings</h5> <p>All trials took place between 2006 and 2017 in hospital settings in Australia (<a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>), Bangledesh (<a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>), Belguim (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>), Brazil (<a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>), Canada (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>), India (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>), Iran (<a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>), Japan (<a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>), Korea (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), Nepal (<a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), Thailand (<a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>), Turkey (<a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>), and USA (<a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>). </p> </section> <section id="CD011770-sec-0074"> <h5 class="title">Interventions</h5> <p>Twenty‐three studies (1488 participants) compared perineural dexamethasone and placebo (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), two (n = 195) compared intravenous dexamethasone and control (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>), four (n = 460) compared perineural and intravenous dexamethasone (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>), and six (n = 564) compared perineural dexamethasone, intravenous dexamethasone and placebo (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). </p> <p>Techniques used for block placement included nerve stimulation (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), ultrasound guidance (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), both nerve stimulation and ultrasound guidance (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>), landmark method (<a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>), and paraesthesia technique (<a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>). </p> <p>Local anaesthetics included ropivacaine 0.5% (<a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), bupivacaine 0.5% (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>), lidocaine 1.5% (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), levobupivacaine 0.5 % (<a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>), bupivacaine 0.5% and lidocaine 1.5% mixture (<a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>), mepivacaine (<a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>), and prilocaine 2% (<a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>). </p> <p>Additives to local anaesthetic agent included epinephrine (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), and clonidine (<a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>). No additives were used in the remaining studies. </p> <p>Dexamethasone dose included 4 mg (<a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), 5 mg (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>), 7.5 mg (<a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), 8 mg (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>), and 10 mg (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>). </p> </section> <section id="CD011770-sec-0075"> <h5 class="title">Comparators</h5> <p>In all included studies, participants received a peripheral nerve block with local anaesthesia. In studies comparing perineural dexamethasone and placebo, participants received either perineural dexamethasone or an equal volume of perineural saline. In studies comparing intravenous dexamethasone and placebo, participants received either intravenous dexamethasone or an equal volume of intravenous saline. In studies comparing perineural and intravenous dexamethasone, participants in the perineural dexamethasone group received dexamethasone perineurally and intravenous saline. Those in the intravenous dexamethasone group received dexamethasone intravenously and perineural saline. </p> </section> <section id="CD011770-sec-0076"> <h5 class="title">Funding sources</h5> <p>Funding sources included: Merit Award form the Department of Anesthesia, Univerity of Toronto (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>), departmental sources (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>), Belgian Association for Regional Anesthesia (<a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>), Department of Anesthesiology, Northwestern University (<a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>), Buffalo Anesthesiology Associates (<a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>), and Department of Anesthesiology, Baystate Medical Center, Springfield, Massachutes (<a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>) (see <a href="./references#CD011770-sec-0206" title="">Characteristics of included studies</a>). </p> </section> <section id="CD011770-sec-0077"> <h5 class="title">Contact with authors</h5> <p>We attempted to contact 15 authors for additional information (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>), and were successful in obtaining data from seven (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>). </p> </section> </section> <section id="CD011770-sec-0078"> <h4 class="title">Excluded studies</h4> <p>We excluded four studies from our review. Two lacked a placebo group (<a href="./references#CD011770-bbs2-0036" title="Fredrickson FranzcaMJ , Danesh‐CloughTK , WhiteR . Adjuvant dexamethasone for bupivacaine sciatic and ankle blocks. Results from 2 randomized‐controlled trials. Regional Anesthesia and Pain Medicine2013;38(4):300‐7. [PUBMED: 23698496] ">Fredrickson 2013</a>; <a href="./references#CD011770-bbs2-0039" title="ShesthraBR , MaharjanSK , ShresthaS , GautamB , ThapaC , ThapaPB , et al. Comparative study between tramadol and dexamethasone as an admixture to bupivacaine in supraclavicular brachial plexus block. Journal of the Napali Medical Association2007;46(168):158‐64. [PUBMED: 18340366] ">Shethra 2007</a>), one reported data as median and range (minimum to maximum), therefore we could not enter the results in a meta‐analysis (<a href="./references#CD011770-bbs2-0038" title="PersecJ , PersecZ , KopljarM , ZupcicM , SakicL , ZrinjscakIK , et al. Low‐dose dexamethasone with levobupivacaine improves analgesia after supraclavicular brachial plexus blockade. International Orthopedics2014;38(1):101‐5. [PUBMED: 24173676] ">Percec 2014</a>), and in another, participants received both perineural and intravenous dexamethasone (<a href="./references#CD011770-bbs2-0037" title="LuiJ , RichmanKA , GrodfskySR , BhattS , HuffmanGR , KellyJD , et al. Is there a dose relationship of dexamethasone as adjuvant for supraclavicular brachial plexus block? A prospective randomized double‐blinded clinical study. Journal of Clinical Anesthesia2015;27(3):237‐42. [PUBMED: 25637938] ">Lui 2015</a>) (see <a href="./references#CD011770-sec-0207" title="">Characteristics of excluded studies</a>). </p> <section id="CD011770-sec-0079"> <h5 class="title">Ongoing studies</h5> <p>We found nine ongoing trials at ClinicalTrials.gov (<a href="./references#CD011770-bbs2-0040" title="NCT01277159 . Duration of analgesia after popliteal fossa nerve blockade: effects of dexamethasone and buprenophine. clinicaltrials.gov/show/NCT01277159 (first received 13 January 2011). ">NCT01277159</a>; <a href="./references#CD011770-bbs2-0041" title="NCT01495624 . The effect of systemic or perineural dexamethasone in the duration of interscalene nerve blocks with ropivacaine. clinicaltrials.gov/show/NCT1495624 (first received 12 December 2011). ">NCT01495624</a>; <a href="./references#CD011770-bbs2-0042" title="NCT01586806 . Comparing subsartorial saphenous nerve blocks with and without dexamethasone from anterior cruciate ligament reconstruction. clinicaltrials.gov/show/NCT01586806 (first received 25 April 2012). ">NCT01586806</a>; <a href="./references#CD011770-bbs2-0043" title="NCT01971645 . Decadon as adjuvant in femoral nerve blocks in knee arthroscopy. clinicaltrials.gov/show/NCT01971645 (first received 22 October 2013). ">NCT01971645</a>; <a href="./references#CD011770-bbs2-0044" title="NCT02178449 . Prolongation of pain free time by the use of dexamethasone in peripheral nerve blocks. clinicaltrials.gov/show/NCT02178449 (first received 26 May 2014). ">NCT02178449</a>; <a href="./references#CD011770-bbs2-0045" title="NCT02322242 . The effects of dexamethasone on low dose interscalene brachial plexus block (ISB‐Dex). clinicaltrials.gov/show/NCT02322242 (first received 16 December 2014). ">NCT02322242</a>; <a href="./references#CD011770-bbs2-0046" title="NCT02436694 . Nerve blocks with dexamethasone and local anaesthetic to improve postoperative analgesia. clinicaltrials.gov/show/NCT02436694 (first received 1 April 2015). ">NCT02436694</a>; <a href="./references#CD011770-bbs2-0047" title="NCT02462148 . Perineural steroids for peripheral nerve block. clinicaltrials.gov/show/NCT02462148 (first received 1 June 2015). ">NCT02462148</a>; <a href="./references#CD011770-bbs2-0048" title="NCT02506660 . Interscalene block with low‐dose IV vs. perineural dexamethasone for shoulder arthroscopy (Dex ISB). clinicaltrials.gov/show/NCT02506660 (first received 2 July 2015). ">NCT02506660</a>) (see <a href="./references#CD011770-sec-0208" title="">Characteristics of ongoing studies</a>). </p> </section> <section id="CD011770-sec-0080"> <h5 class="title">Studies awaiting classification</h5> <p>There are no studies awaiting classification.</p> </section> </section> </section> <section id="CD011770-sec-0081"> <h3 class="title">Risk of bias in included studies</h3> <p>The overall risk of bias was low in 13 studies (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>) and high/unclear in the remaining 22. <a href="#CD011770-fig-0002">Figure 2</a> shows authors' judgements about each risk of bias item presented as percentages across all included studies and <a href="#CD011770-fig-0003">Figure 3</a> shows review authors' judgements about each risk of bias item for each included study. </p> <div class="figure" id="CD011770-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011770-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011770-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011770-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011770-sec-0082"> <h4 class="title">Allocation</h4> <p>In 24 studies the method of random sequence generation was adequately described, and we judged the risk of bias to be low (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>). In the 11 remaining, we judged the risk of bias to be unclear because the random sequence was not described. </p> <p>In 15 studies the method of allocation concealment was adequately described, and we judged the risk of bias to be low (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). In the remaining 20 we judged the risk of bias to be unclear because the method of allocation concealment was not described. </p> </section> <section id="CD011770-sec-0083"> <h4 class="title">Blinding</h4> <p>Blinding of participants was adequately described in 16 studies (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>). </p> <p>Blinding of personnel was adequately described in 12 studies (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>). </p> <p>Bliding of outcome assessors was adequately described in 21 studies(<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>). </p> </section> <section id="CD011770-sec-0084"> <h4 class="title">Incomplete outcome data</h4> <p>We judged the risk for attrition bias to be low in 33 studies. There were no missing outcome data in 16 (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>), and in 17, the number of participants with missing outcome data was balanced between groups (<a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>). We judged two studies to be at high risk of attrition bias. In one, over 30% of participants in each group were excluded from the study (<a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>), and in the other, only 41 of 53 participants enrolled were included in the analysis (<a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>). </p> </section> <section id="CD011770-sec-0085"> <h4 class="title">Selective reporting</h4> <p>We judged 23 studies to be at low risk of reporting bias. Protocols were available for eight and all prespecified outcomes were reported (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>). In the remaining 15, protocols were not available, but all outcomes prespecified in the methods section were reported (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>). Twelve studies were at high risk of selective outcome bias. In two, protocols were available but not all outcomes were reported as per protocol (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>), and in 10, not all outcomes were reported as described in the methods section (<a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>). </p> </section> <section id="CD011770-sec-0086"> <h4 class="title">Other potential sources of bias</h4> <p>There were other potential sources of bias in two studies. Both were stopped early for benefit (<a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>), which may be a source of bias. </p> </section> </section> <section id="CD011770-sec-0087"> <h3 class="title" id="CD011770-sec-0087">Effects of interventions</h3> <p>See: <a href="./full#CD011770-tbl-0001"><b>Summary of findings for the main comparison</b> Perineural dexamethasone versus placebo</a>; <a href="./full#CD011770-tbl-0002"><b>Summary of findings 2</b> Intravenous dexamethasone versus placebo</a>; <a href="./full#CD011770-tbl-0003"><b>Summary of findings 3</b> Perineural versus intravenous dexamethasone</a> </p> <p>See: <a href="./full#CD011770-tbl-0001">summary of findings Table for the main comparison</a>, <a href="./full#CD011770-tbl-0002">summary of findings Table 2</a>, <a href="./full#CD011770-tbl-0003">summary of findings Table 3</a> </p> <section id="CD011770-sec-0088"> <h4 class="title">Perineural dexamethasone verus placebo</h4> <section id="CD011770-sec-0089"> <h5 class="title">Primary outcomes</h5> <section id="CD011770-sec-0090"> <h6 class="title">1. Duration of sensory block</h6> <p>Duration of sensory block was defined inconsistently across studies. Definitions included the following. </p> <p>The interval between administration of block and:</p> <p> <ol id="CD011770-list-0015"> <li> <p>first report of pain (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>); </p> </li> <li> <p>participant detected complete resolution of block (<a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>); </p> </li> <li> <p>Visual Analogue Scale (VAS) greater than three (<a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>); </p> </li> <li> <p>VAS greater than four (<a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>); </p> </li> <li> <p>VAS three to six (<a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>); </p> </li> <li> <p>VAS eight to ten (<a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>); </p> </li> <li> <p>first analgesia request or administration (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>). </p> </li> </ol> </p> <p>The interval between onset of sensory block and:</p> <p> <ol id="CD011770-list-0016"> <li> <p>first administration of analgesia after discharge from the recovery room (<a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>); </p> </li> <li> <p>first report of pain (<a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>). </p> </li> </ol> </p> <p>Duration of sensory block also included the interval between completion of surgery and numerical rating scale (NRS) greater than three (<a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>), and the interval between hospital discharge until VAS greater than three (<a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>). </p> <p>The duration of sensory block was significantly longer in the perineural dexamethasone group compared with placebo (MD 6.70 hours, 95% CI 5.54 to 7.85) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0019" title="LeeMJ , KooDJ , ChouYS , LeeKC , KimHY . Dexamethasone or dexmedetomidine as local anesthetic agents for ultrasound‐guided axillary brachial plexus blocks with nerve stimulation. Korean Jounal of Pain2016;29:29‐33. [PUBMED: 26839668 ] ">Lee 2016</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>; <a href="./references#CD011770-bbs2-0035" title="YadovRK , SahBP , KumarP , SinghSN . Effectiveness of addition of neostigmine or dexamethasone to local anaesthetic in providing perioperative analgesia for brachial plexus block: a prospective, randomized, double blinded, controlled study. Kathmandu University Medical Journal2008;6(23):302‐9. [PUBMED: 20071811] ">Yadov 2008</a>); (<a href="#CD011770-fig-0004">Figure 4</a>), (<a href="./references#CD011770-fig-0010" title="">Analysis 1.1</a>). </p> <div class="figure" id="CD011770-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 1 Duration of sensory block: perineural dexamethasone versus placebo, outcome: 1.1 Duration of sensory block [hours]." data-id="CD011770-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG04.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 1 Duration of sensory block: perineural dexamethasone versus placebo, outcome: 1.1 Duration of sensory block [hours]. </p> </div> </div> </div> <section id="CD011770-sec-0091"> <p><b>Subgroup analysis</b></p> <p>The duration of sensory block was significantly longer in the long‐ versus short‐acting local anaesthetic subgroup (P = 0.00) (<a href="./references#CD011770-fig-0011" title="">Analysis 1.2</a>), and in the high‐ versus low‐dose dexamethasone subgroup (P = 0.06) (<a href="./references#CD011770-fig-0013" title="">Analysis 1.4</a>). There was no significant difference between the remaining subgroups: additives versus no additives (P = 0.72) (<a href="./references#CD011770-fig-0012" title="">Analysis 1.3</a>); or high/unclear versus low risk of bias (P = 0.33) (<a href="./references#CD011770-fig-0014" title="">Analysis 1.5</a>). </p> </section> <section id="CD011770-sec-0092"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence as low. We downgraded by one level for risk of bias because the majority of studies are at unclear risk of bias and by one level for inconsistency because of considerable heterogeneity (I<sup>2</sup> = 99%, P &lt; 0.00001); point estimates vary widely across studies and confidence intervals show minimal overlap. Our subgroup analyses did not explain the observed heterogeneity. </p> </section> </section> <section id="CD011770-sec-0093"> <h6 class="title">2. Incidence of serious adverse events</h6> <p>We used the National Institutes of Health (NIH) definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, or disability (<a href="./references#CD011770-bbs2-0088" title="National Institute of Health. Adverse events. https://www.nhlbi.nih.gov/research/funding/research‐support/crg/glossary.htm (accessed 26 September 2014). ">NIH 2013</a>). Seven studies reported that they assessed for serious adverse events (<a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>). Five serious adverse events were reported among three trials (<a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011)</a>. One block‐related event (pneumothorax) was reported in a study comparing perineural dexamethasone and placebo; however, the group allocation was not reported (<a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>). The four remaining events were non‐block‐related. In a study comparing intravenous dexamethasone and placebo, one participant in the placebo group developed Chronic Regional Pain syndrome Type I (<a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>). In a study comparing perineural dexamethasone, intravenous dexamethasone and placebo, one participant in the placebo group developed pneumonia and two participants in the placebo group required hospitalization within one week of surgery; one for a bowel infection and one for a fall (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). </p> <section id="CD011770-sec-0094"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence as very low. We downgraded by one level for risk of bias because over half the studies reporting serious adverse events are at unclear risk of bias, and by two levels for imprecision because of an extremely small number of events. </p> </section> </section> </section> <section id="CD011770-sec-0095"> <h5 class="title">Secondary outcomes</h5> <section id="CD011770-sec-0096"> <h6 class="title">1. Duration of motor block</h6> <p>Duration of motor block was defined inconsistently across studies. Definitions included the following. </p> <p>The interval between completion of block and:</p> <p> <ol id="CD011770-list-0017"> <li> <p>modified Brommage score of 0 (<a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>); </p> </li> <li> <p>return to baseline motor strength in the operative limb (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0002" title="AlarassanAK , AgrawalJ , ChoudharyB , MelhortraA , UikeS , MukherjiA , et al. Effect of dexamethasone in low volume supraclavicular brachial plexus block: a double‐blinded randomized clinical study. Journal of Anesthesiology, Clinical Pharmacology2017;32:234‐9. [PUBMED: PMC4874081 ] ">Alarasan 2017</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>); </p> </li> <li> <p>complete recovery of motor functions in all distributions (<a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>); </p> </li> <li> <p>participant was able to lift operated limb (<a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>); </p> </li> <li> <p>participant was able to move great toe (<a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>). </p> </li> </ol> </p> <p>The interval between onset of motor block and:</p> <p> <ol id="CD011770-list-0018"> <li> <p>time finger movement was regained (<a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>); </p> </li> <li> <p>complete recovery of motor functions in all distributions (<a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>). </p> </li> </ol> </p> <p>Duration of motor block also included the interval between successful block and recovery of all movements in the arm (<a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>). </p> <p>The duration of motor block was significantly longer in the perineural dexamethasone compared with control (MD 5.87 hours, 95% CI 4.44 to 7.30; participants = 912; studies = 16; I<sup>2</sup> = 99) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0004" title="BaisD , GeethaC , KawaleA . Effectiveness of addition of dexamethasone to 0.5% ropivacaine in providing perioperative analgesia for supraclavicular brachial plexus block. Journal of Evolution of Medical and Dental Sciences2014;3(10):2456‐64. [DOI: 10.14260/jemds/2014/2158] ">Bias 2014</a>; <a href="./references#CD011770-bbs2-0005" title="BiradarPA , KaimarP , GopalakrishnaK . Effect of dexamethasone added to lidocaine in supraclavicular brachial plexus block: a prospective randomized, double blind study. Indian Journal of Anaesthesia2013;57(2):180‐4. [PUBMED: 23825819] ">Biradar 2013</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0013" title="GanvitKS , AkshayHM , SinghalI , UpadhyayMR . The efficacy of dexamethasone added as an adjuvant to ropivacaine (0.5%) for brachial plexus block. International Journal of Research in Medicine2014;3(1):71‐4. [ISSN: 2320‐2734] ">Ganvit 2014</a>; <a href="./references#CD011770-bbs2-0018" title="KumarS , PalariaU , SinhaAK , PuneraDC , PandeyV . Comparative evaluation of ropivacaine and ropivacaine with dexamethasone in supraclavicular brachial plexus block for postoperative analgesia. Anesthesia: Essays and Researches2014;8(2):202‐8. [PUBMED: 25886227] ">Kumar 2014</a>; <a href="./references#CD011770-bbs2-0021" title="MovafeghA , RazazianM , HajimaohamadiF , MeysamieA . Dexamethasone added to lidocaine prolongs axillary brachial plexus blockade. Anesthesia and Analgesia2006;102(1):263‐7. [PUBMED: 16368840] ">Movafegh 2006</a>; <a href="./references#CD011770-bbs2-0022" title="NallamSR . Interscalene brachial plexus block: Comparison of efficacy of varying doses of dexamethasone combined with levobupivacaine: A double‐blind randomized trial. Journal of Evolution of Medical and Dental Sciences2014;3(25):6900‐8. ">Nallam 2014</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0027" title="SaritasA , SabuncuC . Comparison of clinical effects of prilocaine, dexamethasone added to prilocaine and levobupivacaine on brachial plexus block. Journal of the Pakistani Medical Association2014;64(4):433‐6. [PUBMED: 24864639] ">Saritas 2014</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0031" title="TandocMN , FanL , KolesnikovS , KruglovA , NaderND . Adjuvant dexamethasone with bupivacaine prolongs the duration of interscalene block: a prospective randomized trial. Journal of Anesthesia2011;25(5):704‐9. [PUBMED: 21681533] ">Tandoc 2011</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>); (<a href="./references#CD011770-fig-0015" title="">Analysis 2.1</a>). </p> <section id="CD011770-sec-0097"> <p><b>Subgroup analysis</b></p> <p>The duration of motor block was significantly longer in the long‐acting local anaesthetic versus medium‐acting local anaesthesia subgroup (P = 0.00) (<a href="./references#CD011770-fig-0016" title="">Analysis 2.2</a>); however, there was no statistically significant difference between the remaining subgroups: additive versus no additive (P = 0.33) (<a href="./references#CD011770-fig-0017" title="">Analysis 2.3</a>), high‐ versus low‐dose dexamethasone and P = 0.22) (<a href="./references#CD011770-fig-0018" title="">Analysis 2.4</a>), and high/unclear versus low risk of bias (P = 0.41) (<a href="./references#CD011770-fig-0019" title="">Analysis 2.5</a>). </p> </section> </section> <section id="CD011770-sec-0098"> <h6 class="title">2. Incidence of mild to moderate adverse events such as nausea/vomiting, pruritus, somnolence, oxygen desaturation, urinary retention, numbness/tingling </h6> <section id="CD011770-sec-0099"> <p><b>Bock‐related adverse events</b></p> <p>Ten studies reported that they assessed for block‐related adverse events (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>). In one study, the authors reported that numbness/tingling had resolved in all participants at eight weeks after surgery (<a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>). None of the other studies described whether block‐related complications had resolved. There was no significant difference between perineural dexamethasone and control in the incidence of overall adverse or each individual adverse event. Overall block‐related adverse events occurred in 97 out of 340 participants in the perineural dexamethasone group versus 81 out of 337 in the control group (risk ratio (RR) 1.17, 95% CI 0.99 to 1.39; participants = 677; studies = 10; I<sup>2</sup> = 0%) (<a href="./references#CD011770-fig-0020" title="">Analysis 3.1</a>). The incidence of each event is as follows. </p> <p> <ol id="CD011770-list-0019"> <li> <p><b>Numbness/tingling 14 days after surgery</b>: 12 out of 160 in the perineural dexamethasone group versus seven out of 163 in the placebo group (RR 1.76, 95% CI 0.80 to 3.89; participants = 323; studies = 5; I<sup>2</sup> = 0%); (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="./references#CD011770-fig-0021" title="">Analysis 3.2</a>). </p> </li> <li> <p><b>Residual motor block/muscle weakness 24 hours after surgery</b>: five out of 130 in the perineural dexamethasone group versus one out of 129 in the placebo group (RR 4.69, 95% CI 0.57 to 38.68; participants = 259; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0008" title="CummingsKC , NapierkowskiDE , Parra‐SanchezI , KurzA , DaltonJE , BremsJJ , et al. Effect of dexamethasone on the duration of interscalene nerve blocks with ropivacaine or bupivacaine. British Journal of Anaesthesia2011;107(3):446‐53. [PUBMED: 21676892] ">Cummings 2011</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>); (<a href="./references#CD011770-fig-0022" title="">Analysis 3.3</a>). </p> </li> <li> <p><b>Horner syndrome:</b> 47 out of 162 in the perineural dexamethasone group versus 47 out of 159 in the placebo group (RR 0.99, 95% CI 0.73 to 1.36; participants = 321; studies = 4; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="./references#CD011770-fig-0023" title="">Analysis 3.4</a>). </p> </li> <li> <p><b>Hoarseness</b>: 16 out of 177 in the perineural dexamethasone versus 13 out of 176 in the placebo group (RR 1.23, 95% CI 0.65 to 2.34; participants = 353; studies = 4; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0029" title="ShaikhMR , MajumdarS , DasA , SahaTK , BandyopadhyaySN , MikherjeeD , et al. Role of dexamethasone in supraclavicular brachial plexus block. IOSR Journal of Dental and Medical Sciences2013;12(1):1‐7. ">Shaikh 2013</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="./references#CD011770-fig-0024" title="">Analysis 3.5</a>). </p> </li> <li> <p><b>Diaphragmatic paresis</b>: 14 out of 86 in the perineural versus 9 out of 86 in the placebo group (RR 1.46, 95% CI 0.66 to 3.23; participants = 172; studies = 2; I<sup>2</sup> = 1%) (<a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="./references#CD011770-fig-0025" title="">Analysis 3.6</a>). </p> </li> <li> <p><b>Dyspnoea</b>: zero out of 138 in the perineural dexamethasone group versus one out of 136 in the placebo group (RR 0.34, 95% CI 0.01 to 8.14; participants = 274; studies = 4; I<sup>2</sup> = 100%) (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="./references#CD011770-fig-0026" title="">Analysis 3.7</a>). </p> </li> <li> <p><b>Vascular injury</b>: two out of 50 in the perineural dexamethasone group versus one out of 50 in the placebo group (RR 2.00, 95% CI 0.19 to 21.36; participants = 100; studies = 1) (<a href="./references#CD011770-bbs2-0015" title="JadonA , DixitS , KediaSK , ChakrabortyS , AgrawalA , SinhaN . Interscalene brachial plexus block for shoulder surgery: Prospective randomized controlled study of effects of 0.5% ropivacaine and 0.5% ropivacaine with dexamethasone. Indian Journal of Anaesthesia2015;59(3):171‐6. [DOI: 10.4103%2F0019‐5049.153039] ">Jadon 2015</a>); (<a href="./references#CD011770-fig-0027" title="">Analysis 3.8</a>). </p> </li> <li> <p><b>Cranial nerve 12 palsy</b>: zero out of 42 in the perineural dexamethasone group versus 1 out of 41 in the placebo group (RR 0.33, 95% CI 0.01 to 7.77; participants = 83; studies = 1) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0028" title="">Analysis 3.9</a>) </p> </li> <li> <p><b>Bruising at the injection site</b>: one out of 18 in the perineural dexamethasone group versus one out of 19 in the placebo group (RR 1.06, 95% CI 0.07 to 15.64; participants = 37; studies = 1) (<a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>); (<a href="./references#CD011770-fig-0029" title="">Analysis 3.10</a>). </p> </li> </ol> </p> </section> <section id="CD011770-sec-0100"> <p><b>Non‐block‐related adverse events</b></p> <p>In 10 studies, non‐block‐related adverse events were assessed (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>). There was no significant difference between perineural dexamethasone and placebo in the incidence overall or individual non‐block‐related events (<a href="./references#CD011770-fig-0020" title="">Analysis 3.1</a>). The overall incidence was 33 out of 313 in the perineural dexamethasone group versus 38 out of 312 in the placebo group (RR 0.76, 95% CI 0.35 to 1.68; participants = 625; studies = 10; I<sup>2</sup> = 49%). The incidence of individual events is as follows: </p> <p> <ol id="CD011770-list-0020"> <li> <p><b>Postoperative nausea and vomiting</b>: 13 out of 293 in the perineural dexamethasone versus 26 out of 292 in the placebo group ((RR 0.55, 95% CI 0.26 to 1.14; participants = 585; studies = 10; I<sup>2</sup> = 10%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0014" title="GolwalaMP , SwadiaVN , DhimarAA , SridharNV . Pain relief by dexamethasone as an adjuvant to local anaesthetics in supraclavicular brachial plexus blocks. Journal of Anaesthesiology and Clinical Pharmacology2009;25(3):285‐8. ">Golwala 2009</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0033" title="VishnuVA , VishnuMB , SaiNL . Effect of dexamethasone with bupivacaine on duration of supra clavicular block compared to bupivacaine with normal saline: A prospective, randomized and double blind study. Journal of Evolution of Medical and Dental Sciences2014;3(28):7861‐9. [DOI: 10.14260/jemds/2014/2984] ">Vishnu 2014</a>); (<a href="./references#CD011770-fig-0031" title="">Analysis 3.12</a>). </p> </li> <li> <p><b>Deep sedation:</b> three out of 30 in the perineural dexamethasone group versus zero out of 30 in the placebo group (RR 7.00, 95% CI 0.38 to 129.93; participants = 60; studies = 1) (<a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>); (<a href="./references#CD011770-fig-0032" title="">Analysis 3.13</a>). </p> </li> <li> <p><b>Dermatological symptoms (pruritus/rash</b>): three out of 42 in the perineural dexamethasone group versus one out of 41 in the placebo group (RR 2.93, 95% CI 0.32 to 27.02; participants = 83; studies = 1) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0033" title="">Analysis 3.14</a>). </p> </li> <li> <p><b>Syncope/fainting:</b> two out of 42 in the perineural dexamethasone group versus one out of 41 in the placebo group (RR 1.95, 95% CI 0.18 to 20.71; participants = 83; studies = 1) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0034" title="">Analysis 3.15</a>). </p> </li> <li> <p><b>Bradycardia</b>: two out of 30 in the perineural dexamethasone group versus three out of 30 in the placebo group; (RR 0.67, 95% CI 0.12 to 3.71; participants = 60; studies = 1; I<sup>2</sup> = 0%); (<a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>); (<a href="./references#CD011770-fig-0035" title="">Analysis 3.16</a>). </p> </li> <li> <p><b>Hypotension</b>: four out of 70 in the perineural dexamethasone group versus six out of 70 in the control group; (RR 0.67, 95% CI 0.21 to 2.13; participants = 140; studies = 2; I<sup>2</sup> = 0%); (<a href="./references#CD011770-bbs2-0009" title="DarFA , NajarMR , JanN . Effect of addition of dexamethasone to ropivacaine in supraclavicular brachial plexus block. Indian Journal of Pain2013;27(3):165‐9. [DOI: 10.4103/0970‐5333.124602] ">Dar 2013</a>; <a href="./references#CD011770-bbs2-0030" title="TalukdarM , BegumH , ShomanMM , KhatunUHS . Anaesthetic and analgesic effects of adding dexamethasone to bupivacaine in supraclavicular brachial plexus block ‐ a comparative study. Journal of Bangladesh College of Physicans and Surgeons2013;31(1):11‐7. ">Talukdar 2013</a>); <a href="./references#CD011770-fig-0036" title="">Analysis 3.17</a> </p> </li> <li> <p>Each of the following outcomes occurred in one out of 42 in the perineural dexamethasone group versus zero out of 41 in the placebo group (RR 2.93, 95% CI 0.12 to 69.92; participants = 83; studies = 1): <b>headache, 10‐pound fluid gain over 24 hours, diarrhoea, frequent urination, and muscle soreness</b> (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0037" title="">Analysis 3.18</a>). </p> </li> </ol> </p> </section> </section> <section id="CD011770-sec-0101"> <h6 class="title">3a Postoperative pain intensity at 12 hours</h6> <p>Postoperative pain scores at 12 hours were significantly lower in the dexamethasone group compared with placebo (MD ‐2.08, 95% CI ‐2.63 to ‐1.52; participants = 257; studies = 5; I<sup>2</sup> = 62%) (<a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0028" title="ShahDM , AroraM , TrikhaA , PrasadG , SunderR , KotwalP , et al. Comparison of dexamethasone and clonidine as an adjuvant to 1.5% lignocaine with adrenaline in infraclavicular brachial plexus block for upper limb surgeries. Journal of Anaesthesiology Clinical Pharmacology2015;13(3):354‐9. [PUBMED: 26330715 ] ">Shah 2015</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="#CD011770-fig-0005">Figure 5</a>), (<a href="./references#CD011770-fig-0038" title="">Analysis 4.1</a>). </p> <div class="figure" id="CD011770-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, outcome: 4.1 Postoperative pain intensity at12 hours." data-id="CD011770-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG05.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, outcome: 4.1 Postoperative pain intensity at12 hours. </p> </div> </div> </div> <section id="CD011770-sec-0102"> <p><b>Subgroup analysis</b></p> <p>There was no significant difference in effect size between any of the subgroups: long‐ versus medium‐acting local anaesthetic (P = 0.13) (<a href="./references#CD011770-fig-0039" title="">Analysis 4.2</a>); additive versus no additive (P = 0.12) (<a href="./references#CD011770-fig-0040" title="">Analysis 4.3</a>); high‐ versus low‐dose dexamethasone (P = 0.79) (<a href="./references#CD011770-fig-0041" title="">Analysis 4.4</a>); or high/unclear versus low risk of bias (P = 0.28) (<a href="./references#CD011770-fig-0042" title="">Analysis 4.5</a>). </p> </section> <section id="CD011770-sec-0103"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence as very low. We downgraded by one level for risk of bias because three out of five of the studies are at unclear risk of bias; we downgraded by one level for inconsistency because of substantial heterogeneity (I<sup>2</sup> = 62%, P = 0.03). Our subgroup analyses did not explain observed heterogeneity. We also downgraded by one level for imprecision. For continuous outcomes, Cochrane guidelines suggest downgrading if fewer than 400 participants. </p> </section> </section> <section id="CD011770-sec-0104"> <h6 class="title">3b Postoperative pain intensity at 24 hours</h6> <p>Postoperative pain scores at 24 hours were significantly lower in the dexamethasone group compared with placebo (MD ‐1.63, 95% CI ‐2.34 to ‐0.93; participants = 469; studies = 9; I<sup>2</sup> = 79%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0017" title="KimYJ , LeeGY , KimDY , KimCH , BaikHJ , HeoS . Dexamethasone added to levobupivacaine improves postoperative analgesia in ultrasound guided interscalene brachial plexus blockade for arthroscopic shoulder surgery. Korean Journal of Anesthesiology2012;62(2):130‐4. [PUBMED: 22379567] ">Kim 2012</a>; <a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="#CD011770-fig-0006">Figure 6</a>), (<a href="./references#CD011770-fig-0043" title="">Analysis 5.1</a>). </p> <div class="figure" id="CD011770-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, outcome: 5.1 Postoperative pain intensity at 24 hours." data-id="CD011770-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, outcome: 5.1 Postoperative pain intensity at 24 hours. </p> </div> </div> </div> <section id="CD011770-sec-0105"> <p><b>Subgroup analysis</b></p> <p>Three was no significant difference in effect size between any of the subgroups: long‐ versus medium‐acting local anaesthetic (P = 0.31) (<a href="./references#CD011770-fig-0044" title="">Analysis 5.2</a>); additive versus no additive (P = 0.37) (<a href="./references#CD011770-fig-0045" title="">Analysis 5.3</a>); high‐ versus low‐dose dexamethasone (P = 0.76) (<a href="./references#CD011770-fig-0046" title="">Analysis 5.4</a>); and high/unclear versus low risk of bias (P = 0.60) (<a href="./references#CD011770-fig-0047" title="">Analysis 5.5</a>). </p> </section> <section id="CD011770-sec-0106"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence to be low. We downgraded by one level for inconsistency because of considerable heterogeneity (I<sup>2</sup> = 80% and P &lt; 0.00001) not explained by subgroup analyses and by one level for imprecision because the confidence interval includes both no clinical effect (minimally important difference (MID) less than 1.2) and clinical effect (MID greater than 1.2). </p> </section> </section> <section id="CD011770-sec-0107"> <h6 class="title">3c Postoperative pain intensity at 48 hours</h6> <p>There was no significant difference in postoperative pain scores at 48 hours between perineural dexamethasone and placebo (MD ‐0.61, 95% CI ‐1.24 to 0.03; participants = 296; studies = 4; I<sup>2</sup> = 41%) (<a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>; <a href="./references#CD011770-bbs2-0034" title="WooJH , KimYJ , KImDY , ChoS . Dose‐dependency of dexamethasone on th analgesic effect of interscalene block for arthroscopic should surgery using ropivacaine 0.5%. European Journal of Anaesthesiology2015;32(9):650‐5. [PUBMED: 25603389] ">Woo 2015</a>); (<a href="./references#CD011770-fig-0048" title="">Analysis 6.1</a>). </p> <section id="CD011770-sec-0108"> <p><b>Subgroup analysis</b></p> <p>There was no statistically significant difference in effect size between the additive and no additive subgroups (P = 0.45) (<a href="./references#CD011770-fig-0049" title="">Analysis 6.2</a>); and the high/unclear risk of bias subgroups (P = 0.47) (<a href="./references#CD011770-fig-0050" title="">Analysis 6.3</a>). In all four studies, long‐acting local anaesthetic and high‐dose dexamethasone were used. </p> </section> <section id="CD011770-sec-0109"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence to be low. We downgraded by two levels for imprecision because the confidence interval includes both no clinical effect (MID less than 1.2 on VAS) and clinical effect (MID greater than 1.2 on VAS). </p> </section> </section> <section id="CD011770-sec-0110"> <h6 class="title">4a Postoperative opioid consumption at 12 hours</h6> <p>No studies evaluated postoperative opioid consumption at 12 hours.</p> </section> <section id="CD011770-sec-0111"> <h6 class="title">4b Postoperative opioid consumption at 24 hour</h6> <p>Cummulative opioid administration at 24 hours was reported in six studies. Reasons for opioid administration varied across studies and included VAS greater than four (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>), and "as needed" (<a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). No criteria for opioid administration was provided in the remaining two studies (<a href="./references#CD011770-bbs2-0023" title="ParringtonSJ , O'DonnellD , ChanVW , Brown‐ShrevesD , SubramanyamR , QuM , et al. Dexamethasone added to mepivacaine prolongs the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2010;35(5):422‐6. [PUBMED: 20814282 ] ">Parrington 2010</a>; <a href="./references#CD011770-bbs2-0032" title="VieraPA , PulaiI , TsaoGC , ManikantanP , KellerB , ConnellyNR . Dexamethasone with bupivacaine increases duration of analgesia in ultrasound‐guided interscalene brachial plexus block. European Journal of Anaesthesiology2010;27(3):285‐8. [PUBMED: 20009936] ">Viera 2010</a>). Postoperative opioid consumption (oral morphine equivalents) at 24 hours in the perineural dexamethasone group was significantly lower compared with placebo (MD 19.25 mg, 95% CI 5.99 to 32.51; participants = 380; studies = 6; I<sup>2</sup> = 88%) (<a href="./references#CD011770-fig-0051" title="">Analysis 7.1</a>). </p> <section id="CD011770-sec-0112"> <p><b>Subgroup analysis</b></p> <p>There was no significant difference in effect size between the long‐ versus medium‐acting local anaesthetic subgroups (P = 0.22) or the additive versus no additive subgroups (P = 0.28). Opioid consumption was significantly higher in the high/unclear risk of bias subgroup (P = 0.00001) (<a href="./references#CD011770-fig-0052" title="">Analysis 7.2</a>; <a href="./references#CD011770-fig-0053" title="">Analysis 7.3</a>; <a href="./references#CD011770-fig-0054" title="">Analysis 7.4</a>). In all six studies, high‐dose dexamethasone was used. </p> </section> </section> <section id="CD011770-sec-0113"> <h6 class="title">4c Postoperative opioid consumption at 48 hours</h6> <p>No studies reported cumulative opioid consumption at 48 hours.</p> </section> <section id="CD011770-sec-0114"> <h6 class="title">5 Participant satisfaction with pain control</h6> <p>There was no statistically significant difference in satisfaction scores on an 11‐point VAS between perineural dexamethasone and placebo (MD 0.83, 95% CI ‐0.05 to 1.71; participants = 224; studies = 4; I<sup>2</sup> = 0%) (<a href="./references#CD011770-fig-0055" title="">Analysis 8.1</a>) </p> </section> </section> </section> <section id="CD011770-sec-0115"> <h4 class="title">Intravenous dexamethasone versus placebo</h4> <section id="CD011770-sec-0116"> <h5 class="title">Primary outcomes</h5> <section id="CD011770-sec-0117"> <h6 class="title">1. Duration of sensory block</h6> <p>Duration of sensory block was defined inconsistently across six studies. Definitions included the following. </p> <p>The interval between administration of block and:</p> <p> <ol id="CD011770-list-0021"> <li> <p>first report of pain (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>); </p> </li> <li> <p>participant detected complete resolution of block (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); </p> </li> <li> <p>first analgesia request or administration (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>). </p> </li> </ol> </p> <p>Duration of sensory block also included the interval between onset of sensory block and first analgesic request (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>), and the time interval between successful block and complete recovery of all senses in the operative limb (<a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>). </p> <p>Duration of sensory block was significantly longer in the intravenous group compared with placebo (MD 6.21, 95% CI 3.53 to 8.88; participants = 499; studies = 8; I<sup>2</sup> = 88%); (<a href="#CD011770-fig-0007">Figure 7</a>), (<a href="./references#CD011770-fig-0056" title="">Analysis 9.1</a>). </p> <div class="figure" id="CD011770-fig-0007"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 7</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 9 Duration of sensory block: intravenous dexamethasone versus placebo , outcome: 9.1 Duration of sensory block." data-id="CD011770-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG07.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 9 Duration of sensory block: intravenous dexamethasone versus placebo , outcome: 9.1 Duration of sensory block. </p> </div> </div> </div> <section id="CD011770-sec-0118"> <p><b>Subgroup analysis</b></p> <p>The duration of sensory block was significantly longer in the high‐dose versus low‐dose dexamethasone subgroup (P = 0.00) <a href="./references#CD011770-fig-0058" title="">Analysis 9.3</a>), and the low risk of bias versus high risk of bias subgroup (P = 0.00); <a href="./references#CD011770-fig-0059" title="">Analysis 9.4</a>). There was no statistically significant difference in the duration of sensory block between the additive and no additive subgroups (P = 1.0) (<a href="./references#CD011770-fig-0057" title="">Analysis 9.2</a>). In all studies, long‐acting local anaesthetic was used. </p> </section> <section id="CD011770-sec-0119"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence as moderate. We downgraded by one level for inconsistency because of considerable heterogeneity (I<sup>2</sup> = 88%, P &lt; 0.00001). Our subgroup analyses did not explain the observed heterogeneity. </p> </section> </section> <section id="CD011770-sec-0120"> <h6 class="title">2. Incidence of severe adverse events</h6> <p>See incidence of severe events in the perineural dexamethasone versus placebo section.</p> </section> </section> <section id="CD011770-sec-0121"> <h5 class="title">Secondary outcomes</h5> <section id="CD011770-sec-0122"> <h6 class="title">1. Duration of motor block</h6> <p>Duration of motor block was defined as the interval between completion of block until return to baseline motor strength in the operative limb (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>), the time interval between successful block and complete recovery of all movements of the arm (<a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>), or when the participant was able to move the great toe (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). Duration of motor block was significantly longer in the intravenous dexamethasone group compared with placebo (MD 5.04 hours, 95% CI 3.07 to 7.00; participants = 139; studies = 3; I<sup>2</sup> = 27%) (<a href="./references#CD011770-fig-0060" title="">Analysis 10.1</a>). </p> <section id="CD011770-sec-0123"> <p><b>Subgroup analysis</b></p> <p>There was no significant difference in the duration of motor block between the additive and no additive subgroup (P = 0.46) (<a href="./references#CD011770-fig-0061" title="">Analysis 10.2</a>); in the high‐ versus low‐dose subgroups (P = 0.11) (<a href="./references#CD011770-fig-0062" title="">Analysis 10.3</a>); or in the high versus low risk of bias subgroups (P = 0.11) (<a href="./references#CD011770-fig-0063" title="">Analysis 10.4</a>). In all three studies, long‐acting local anaesthetic was used. </p> </section> </section> <section id="CD011770-sec-0124"> <h6 class="title">2. Incidence of mild to moderate adverse events such as nausea/vomiting, pruritus, somnolence, oxygen desaturation, urinary retention, numbness/tingling </h6> <section id="CD011770-sec-0125"> <p><b>Block‐related adverse events</b></p> <p>Five studies reported that they assessed for block‐related adverse events. There was no significant difference between intravenous dexamethasone and control in the overall incidence of events or each individual event. The incidence of overall block‐related events was 75 out of 195 in the intravenous dexamethasone group versus 70 out of 198 in the control group (RR 1.09, 95% CI 0.69 to 1.70; I<sup>2</sup> = 59%). </p> <p>The incidence of each adverse event is as follows.</p> <p> <ol id="CD011770-list-0022"> <li> <p><b>Numbness/tingling 14 days after surgery</b>: three out of 49 in the intravenous group versus two out of 52 in the placebo group (RR 1.69, 95% CI 0.31 to 9.26; participants = 101; studies = 2; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>); (<a href="./references#CD011770-fig-0065" title="">Analysis 11.2</a>). </p> </li> <li> <p><b>Residual motor block/muscle weakness 24 hours after surgery</b>: nine out of 133 in the intravenous dexamethasone group versus three out of 132 in the placebo group (RR 2.68, 95% CI 0.80 to 8.90; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>); (<a href="./references#CD011770-fig-0066" title="">Analysis 11.3</a>). </p> </li> <li> <p><b>Horner syndrome</b>: 38 out of 109 in the intravenous dexamethasone group versus 41 out of 105 in the placebo group (RR 0.89, 95% CI 0.63 to 1.26; participants = 214; studies = 2) (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>); (<a href="./references#CD011770-fig-0067" title="">Analysis 11.4</a>). </p> </li> <li> <p><b>Hoarseness</b>: 16 out of 109 in the intravenous versus 17 out of 106 in the placebo group (RR 0.88, 95% CI 0.45 to 1.71; participants = 215; studies = 2; I<sup>2</sup> = 8%) (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>); (<a href="./references#CD011770-fig-0068" title="">Analysis 11.5</a>). </p> </li> <li> <p><b>Dyspnoea</b>: one out of 107 in the intravenous dexamethasone group versus three out of 112 in the placebo group (RR 0.63, 95% CI 0.11 to 3.74; participants = 219; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0012" title="DesmetM , VannesteB , ReynovoetM , VanCauwelaertJ , VerhelstL , PottellH , et al. A randomized controlled trial of intravenous dexamethasone combined with interscalene brachial plexus block for shoulder surgery. Anaesthesia2015;70(10):1180‐5. [PUBMED: 26082203] ">Desmet 2015</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0069" title="">Analysis 11.6</a>). </p> </li> <li> <p><b>Cranial nerve 12 palsy</b>: zero out of 37 in the intravenous group versus one out of 41 in the placebo group (RR 0.37, 95% CI 0.02 to 8.77; participants = 78; studies = 1; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0070" title="">Analysis 11.7</a>). </p> </li> </ol> </p> </section> <section id="CD011770-sec-0126"> <p><b>Non block‐related adverse events</b></p> <p>Five studies reported that they assessed for non‐block‐related adverse events (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0071" title="">Analysis 11.8</a>). There was no significant difference between intravenous dexamethasone and placebo (8 out of 128 in the intravenous group versus 5 out of 122 in the placebo group (RR 1.23, 95% CI 0.38 to 3.97; participants = 258; studies = 5; I<sup>2</sup> = 0%). </p> <p> <ol id="CD011770-list-0023"> <li> <p><b>Postoperative nausea and vomiting</b>: two out of 67 in the intravenous group versus three out of 67 in the placebo group (RR 0.66, 95% CI 0.12 to 3.78; participants = 134; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>); (<a href="./references#CD011770-fig-0072" title="">Analysis 11.9</a>). </p> </li> <li> <p><b>Dermatological symptoms (pruritus/rash)</b>: four out of 61 in the intravenous dexamethasone group versus one out of 63 in the placebo group (RR 1.88, 95% CI 0.09 to 40.62; participants = 124; studies = 2; I<sup>2</sup> = 52%) (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0073" title="">Analysis 11.10</a>). </p> </li> <li> <p>Each of the following adverse events occurred in one out of 37 in the intravenous dexamethasone group versus zero out of 41 in the placebo group: <b>dizziness, wrist, hand or finger pain, constipation</b> (RR 0.37, 95% CI 0.02 to 8.77; participants = 78; studies = 1) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0074" title="">Analysis 11.11</a>). </p> </li> </ol> </p> </section> </section> <section id="CD011770-sec-0127"> <h6 class="title">3a. Postoperative pain intensity at 12 hours</h6> <p>Pain scores were significantly lower in the intravenous dexamethasone group compared with placebo (MD ‐1.24, 95% CI ‐2.44 to ‐0.04; participants = 162; studies = 3; I<sup>2</sup> = 61%) (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>); (<a href="#CD011770-fig-0008">Figure 8</a>), (<a href="./references#CD011770-fig-0075" title="">Analysis 12.1</a>). </p> <div class="figure" id="CD011770-fig-0008"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 8</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, outcome: 12.1 Postoperative pain intensity at 12 hours." data-id="CD011770-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG08.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, outcome: 12.1 Postoperative pain intensity at 12 hours. </p> </div> </div> </div> <section id="CD011770-sec-0128"> <p><b>Subgroup analysis</b></p> <p>There was no difference in effect size between the low‐ and high‐dose dexamethasone subgroups (P = 0.12) (<a href="./references#CD011770-fig-0110" title="">Analysis 21.2</a>); or between the high/unclear versus low risk of bias subgroups (P = 0.12) (<a href="./references#CD011770-fig-0114" title="">Analysis 22.3</a>). In all three studies, long‐acting local anaesthetic was used, and none used additives. </p> </section> <section id="CD011770-sec-0129"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence to be low. We downgraded by one level due to moderate heterogeneity (I<sup>2</sup>= 61%, P = 0.08) not explained by subgroup analyses, and by one level for imprecision because the CI includes both no clinical effect (MID less than 1.2 on VAS) and clinical effect (MID greater than 1.2 on VAS). </p> </section> </section> <section id="CD011770-sec-0130"> <h6 class="title">3b. Postoperative pain intensity at 24 hours</h6> <p>Pain scores were significantly lower in the intravenous dexamethasone group compared with placebo (MD ‐1.26, 95% CI ‐2.23 to ‐0.29; participants = 257; studies = 5; I<sup>2</sup> = 65%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>); (<a href="#CD011770-fig-0009">Figure 9</a>), (<a href="./references#CD011770-fig-0078" title="">Analysis 13.1</a>). </p> <div class="figure" id="CD011770-fig-0009"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 9</div> </div> <hr class="top"/><img alt="Forest plot of comparison: 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, outcome: 13.1 Postoperative pain intensity at 24 hours." data-id="CD011770-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG09.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Forest plot of comparison: 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, outcome: 13.1 Postoperative pain intensity at 24 hours. </p> </div> </div> </div> <section id="CD011770-sec-0131"> <p><b>Subgroup analysis</b></p> <p>There was no significant difference in effect size between the additive or no additive subgroups (P = 0.70) (<a href="./references#CD011770-fig-0079" title="">Analysis 13.2</a>); the high‐ versus low‐dose dexamethasone subgroups (P = 0.83) (<a href="./references#CD011770-fig-0080" title="">Analysis 13.3</a>); or the high/unclear versus low risk of bias subgroups (P = 0.83) (<a href="./references#CD011770-fig-0081" title="">Analysis 13.4</a>). In all studies, long‐acting local anaesthetic was used. </p> </section> <section id="CD011770-sec-0132"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence to be low. We downgraded by one level for inconsistency because of considerable heterogeneity (I<sup>2</sup> = 65 %, P = 0.02) not explained by subgroup analyses, and by one level for imprecision because the CI includes both no clinical effect (MID less than 1.2 on VAS) and clinical effect (MID greater than 1.2 on VAS). </p> </section> </section> <section id="CD011770-sec-0133"> <h6 class="title">3c. Postoperative pain intensity at 48 hours</h6> <p>There was no significant difference in postoperative pain intensity at 48 hours between intravenous dexamethasone and placebo (MD ‐0.18, 95% CI ‐0.80 to 0.44; participants = 172; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0082" title="">Analysis 14.1</a>). </p> <section id="CD011770-sec-0134"> <p><b>Subgroup analysis</b></p> <p>There was no significant difference in effect size between the additive and no additive subgroups (P = 0.97) (<a href="./references#CD011770-fig-0083" title="">Analysis 14.2</a>). In all studies, long‐acting local anaesthetic and high‐dose dexamethasone were used, and all were at low risk of bias. </p> </section> <section id="CD011770-sec-0135"> <p><b>Quality of evidence</b></p> <p>We assessed the quality of evidence to be low. We downgraded by two levels for imprecision because of small sample size and the CI crosses the line of null effect. </p> </section> </section> <section id="CD011770-sec-0136"> <h6 class="title">4a Postoperative opioid consumption at 12 hours</h6> <p>One study in 46 participants reported the cumulative opioid consumption at 12 hours. Median and interquartile range of opioid consumption was zero in both the intravenous dexamethasone and control groups (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>). </p> </section> <section id="CD011770-sec-0137"> <h6 class="title">4b Postoperative opioid consumption at 24 hours</h6> <p>Cummulative opioid consumption at 24 hours was reported in five studies. Postoperative opioids were administered for VAS greater than four (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>), or as needed (<a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). Twenty‐four hour opioid consumption was significantly lower in the intravenous dexamethasone group compared with control (MD ‐6.58 mg, 95% CI ‐10.56 to ‐2.60; participants = 287; studies = 5; I<sup>2</sup> = 60%) (<a href="./references#CD011770-fig-0084" title="">Analysis 15.1</a>). </p> <section id="CD011770-sec-0138"> <p><b>Subgroup analysis</b></p> <p>There was no significant difference in effect size between the additive and no additive subgroups (P = 0.58) (<a href="./references#CD011770-fig-0085" title="">Analysis 15.2</a>). In all three studies, long‐acting local anaesthesia and high‐dose dexamethasone were used, and all were at low risk of bias. </p> </section> </section> <section id="CD011770-sec-0139"> <h6 class="title">4c Postoperative opioid consumption at 48 hours</h6> <p>In one study (46 participants), postoperative opioid consumption was significantly lower in the intravenous dexamethasone group versus placebo (MD 22.50 mg, 95% CI 5.15 to 39.85) (<a href="./references#CD011770-bbs2-0006" title="ChalifouxF , ColinF , St‐PierreP , GodinN , BrulotteV . Low dose intravenous dexamethasone (4 mg and 10 mg) significantly prolongs the analgesic duration of single‐shot interscalene block after arthroscopic shoulder surgery: a prospective randomized placebo‐controlled study. Canadian Journal of Anesthesia2017;64:280‐9. [PUBMED: 28050801] ">Chalifoux 2017</a>); (<a href="./references#CD011770-fig-0086" title="">Analysis 16.1</a>). </p> </section> <section id="CD011770-sec-0140"> <h6 class="title">5 Participant satisfaction with pain control</h6> <p>There was no statistically significant difference between intravenous dexamethasone and placebo in participant satisfaction with pain control (MD 1.07, 95% CI ‐0.08 to 2.22; participants = 181; studies = 3; I<sup>2</sup> = 27%) (<a href="./references#CD011770-fig-0087" title="">Analysis 17.1</a>). </p> </section> </section> </section> <section id="CD011770-sec-0141"> <h4 class="title">Perineural versus intravenous dexamethasone</h4> <section id="CD011770-sec-0142"> <h5 class="title">1. Duration of sensory block</h5> <p>We identified nine trials that compared perineural versus intravenous dexamethasone. The duration of sensory block was defined inconsistently across studies. Definitions included the following. </p> <p>The interval between administration of block and:</p> <p> <ol id="CD011770-list-0024"> <li> <p>first report of pain (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0020" title="LeurcharusmeeP , AlisteJ , VanZundertCRV , EngsusophonP , ArnuntasupakulV , TiyaprasertkulW , et al. A multicenter randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided infraclavicular block. Regional Anesthesia and Pain Medicine2016;41:328‐33. [PUBMED: 27015546] ">Leurcharusmee 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>); </p> </li> <li> <p>participant detected complete resolution of block (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); </p> </li> <li> <p>first analgesia request or administration (<a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>). </p> </li> <li> <p>Time of completion of surgery to first analgesic request (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>) </p> </li> <li> <p>Time of successful block to recovery of sensation (<a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>). </p> </li> </ol> </p> <p>The duration of sensory block was significantly longer in the perineural dexamethasone group compared with intravenous dexamethasone (MD 3.13 hours, 95% CI 1.68 to 4.58; participants = 720; studies = 9; I<sup>2</sup> = 63%) (<a href="./references#CD011770-fig-0088" title="">Analysis 18.1</a>). </p> <section id="CD011770-sec-0143"> <h6 class="title">Subgroup analysis</h6> <p>There was no significant difference in the duration of sensory block between the additive and no additive subgroups (P = 0.40) (<a href="./references#CD011770-fig-0089" title="">Analysis 18.2</a>); between the high‐ versus low‐dose dexamethasone subgroups (P = 0.22) (<a href="./references#CD011770-fig-0090" title="">Analysis 18.3</a>); or between the high/unclear risk of bias subgroups (P = 0.14). In all studies, long‐acting local anaesthesia was used. </p> </section> <section id="CD011770-sec-0144"> <h6 class="title">Quality of evidence</h6> <p>We assessed the quality of evidence as moderate. We downgraded by one level for inconsistency because of considerable heterogeneity (I<sup>2</sup> = 63%, P = 0.006) and point estimates vary widely. Subgroup analyses did not explain observed heterogeneity. </p> </section> </section> <section id="CD011770-sec-0145"> <h5 class="title">2. Incidence of serious adverse events</h5> <p>See incidence of serious adverse events in perineural versus control section.</p> <section id="CD011770-sec-0146"> <h6 class="title">Secondary outcomes</h6> </section> </section> <section id="CD011770-sec-0147"> <h5 class="title">1. Duration of motor block</h5> <p>Duration of motor block was defined as the interval between administration of block until return to baseline motor strength in the operative limb (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>), or the participant was able to move the great toe (<a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>). The duration of motor block was significantly longer in the perineural dexamethasone group compared with the intravenous dexamethasone group (MD 3.13 hours, 95% CI 0.99 to 5.27; participants = 421; studies = 5; I<sup>2</sup> = 71%) (<a href="./references#CD011770-fig-0092" title="">Analysis 19.1</a>). </p> <section id="CD011770-sec-0148"> <h6 class="title">Subgroup analysis</h6> <p>There was no significant difference in motor block between the additive versus no additive subgroups (P = 0.53) (<a href="./references#CD011770-fig-0093" title="">Analysis 19.2</a>); between the high‐ versus low‐dose dexamethasone subgroups (P = 0.18) (<a href="./references#CD011770-fig-0094" title="">Analysis 19.3</a>); or between the high/unclear versus low risk of bias subgroups (P = 0.18) (<a href="./references#CD011770-fig-0095" title="">Analysis 19.4</a>). In all studies, long‐acting local anaesthesia was used. </p> </section> </section> <section id="CD011770-sec-0149"> <h5 class="title">2. Incidence of mild to moderate adverse events such as nausea/vomiting, pruritus, somnolence, oxygen desaturation, urinary retention, numbness/tingling </h5> <section id="CD011770-sec-0150"> <h6 class="title">Block‐related adverse events</h6> <p>Five studies reported that they assessed for block‐related adverse events (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). There was no statistically significant difference between perineural and intravenous dexamethasone in the overall or individual incidence of block‐related adverse events (42 out of 207 in the perineural dexamethasone group versus 36 out of 199 in the intravenous dexamethasone group (RR 1.20, 95% CI 0.93 to 1.55; participants = 406; studies = 5; I<sup>2</sup> = 0%) (<a href="./references#CD011770-fig-0096" title="">Analysis 20.1</a>). Individual events are as follows. </p> <p> <ol id="CD011770-list-0025"> <li> <p><b>Numbness/tingling 14 days after surgery</b>: four out of 116 in the perineural group versus four out of 116 in the intravenous group (RR 0.97, 95% CI 0.27 to 3.49; participants = 232; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0003" title="AlisteJ , LeurcharusmeeP , EngsusophonP , GordonA , MichelagnoliG , SriparkdeeC , et al. A randomized comparison between intravenous and perineural dexamethasone for ultrasound‐guided axillary block. Canadian Journal of Anesthesia2017;64:29‐36. [PUBMED: 27663451] ">Aliste 2017</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>); (<a href="./references#CD011770-fig-0097" title="">Analysis 20.2</a>). </p> </li> <li> <p><b>Residual motor block/muscle weakness at 24 hours</b>: 16 out of 126 in the perineural dexamethasone group versus 13 out of 122 in the intravenous dexamethasone group (RR 1.22, 95% CI 0.62 to 2.37; participants = 248; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>); (<a href="./references#CD011770-fig-0098" title="">Analysis 20.3</a>). </p> </li> <li> <p><b>Horner syndrome</b>: 24 out of 99 in the perineural versus 20 out of 98 in the intravenous dexamethasone group (RR 1.20, 95% CI 0.77 to 1.87; participants = 197; studies = 2; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>); (<a href="./references#CD011770-fig-0099" title="">Analysis 20.4</a>). </p> </li> <li> <p><b>Hoarseness</b>: 11 out of 99 in the perineural versus 11 out of 98 in the intravenous dexamethasone group (RR 1.00, 95% CI 0.48 to 2.09; participants = 197; studies = 2; I<sup>2</sup> = 0%)(RR 1.00, 95% CI 0.48 to 2.09; participants = 98; studies = 1; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0011" title="DesmetC , BraemsH , ReynvoetM , PlasschaertS , VanCauwelaertJ , PottelH , et al. I.V. and perineural dexamethasone are equivalent in increasing the analgesic duration of a single‐shot interscalene block with ropivacaine for shoulder surgery: a prospective, randomized, placebo‐controlled study. British Journal of Anaesthesia2013;111(3):445‐52. [PUBMED: 23587875] ">Desmet 2013</a>); (<a href="./references#CD011770-fig-0100" title="">Analysis 20.5</a>). </p> </li> <li> <p><b>Cranial nerve 12 palsy</b>: zero out of 42 in the perineural dexamethasone group versus one out of 41 in the intravenous dexamethasone group (RR 0.31, 95% CI 0.01 to 7.39; participants = 81; studies = 1; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0101" title="">Analysis 20.6</a>). </p> </li> </ol> </p> </section> <section id="CD011770-sec-0151"> <h6 class="title">Non‐block‐related adverse events</h6> <p>Five studies reported that they assessed for non‐block‐related adverse events (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). There was no statistically significant difference between perineural and intravenous dexamethasone (26 out of 159 in the perineural dexamethasone group versus 21 out of 157 in the intravenous dexamethasone group ((RR 1.34, 95% CI 0.37 to 4.78; participants = 316; studies = 5; I<sup>2</sup> = 63%) (<a href="./references#CD011770-fig-0102" title="">Analysis 20.7</a>). The incidence for each event is as follows. </p> <p> <ol id="CD011770-list-0026"> <li> <p><b>Postoperative nausea and vomiting</b>: five out of 159 in the perineural dexamethasone group versus eight out of 153 in the intravenous dexamethasone group (RR 0.63, 95% CI 0.22 to 1.80; participants = 312; studies = 5; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0016" title="KawanishiR , YamamotoK , TobettoY , NomuraK , KatoM , GoR , et al. Perineural but not systemic low‐dose dexamethasone prolongs the duration of interscalene block with ropivacaine: a prospective randomized trial. Local and Regional Anesthesia2014;7:5‐9. [PUBMED: 24817819] ">Kawanishi 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0103" title="">Analysis 20.8</a>). </p> </li> <li> <p><b>Dermatological symptoms (pruritus/rash)</b>: two out of 42 in the perineural dexamethasone group versus zero out of 37 in the intravenous dexamethasone group (RR 4.42, 95% CI 0.22 to 89.18; participants = 79; studies = 1) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0104" title="">Analysis 20.9</a>). </p> </li> <li> <p><b>Syncope/fainting</b>: two out of 42 in the perineural dexamethasone group versus zero out of 37 in the intravenous dexamethasone group (RR 4.42, 95% CI 0.22 to 89.18; participants = 79; studies = 1; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0105" title="">Analysis 20.10</a>). </p> </li> <li> <p><b>Dizziness</b>: one out of 92 in the perineural dexamethasone group versus three out of 86 in the intravenous dexamethasone group (RR 0.41, 95% CI 0.06 to 2.72; participants = 178; studies = 2; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0106" title="">Analysis 20.11</a>). </p> </li> <li> <p><b>Wrist, hand or finger pain</b>: zero out of 42 in the perineural dexamethasone group versus one out of 37 in the intravenous dexamethasone group (RR 0.29, 95% CI 0.01 to 7.02; participants = 79; studies = 1) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0107" title="">Analysis 20.12</a>). </p> </li> <li> <p>Each of the following outcomes occurred in one out of 42 in the perineural dexamethasone group versus zero out of 37 in the intravenous dexamethasone group<b>: 10‐lb weight gain in 24 hours, headache, diarrhoea, frequent urination and muscle soreness</b> (RR 2.65, 95% CI 0.11 to 63.16; participants = 79; studies = 1) (<a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0108" title="">Analysis 20.13</a>). </p> </li> </ol> </p> </section> </section> <section id="CD011770-sec-0152"> <h5 class="title">3a. Postoperative pain intensity at 12 hours</h5> <p>Pain scores were significantly lower in the perineural dexamethasone group compared with intravenous dexamethasone. The MD did not surpass the MID of 1.2, therefore the difference in effect size is not clinically significant (MD ‐1.01, 95% CI ‐1.51 to ‐0.50; participants = 217; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>); (<a href="./references#CD011770-fig-0109" title="">Analysis 21.1</a>). </p> <p><i>Subgroup analysis</i> </p> <p>There was no significant difference in effect size between the high‐and low‐dose dexamethasone subgroups (P = 0.83) (<a href="./references#CD011770-fig-0110" title="">Analysis 21.2</a> or between the high/unclear and low risk of bias subgroups (P = 0.83) <a href="./references#CD011770-fig-0111" title="">Analysis 21.3</a>. In all three studies, long‐acting local anaesthetic was used and no additives were used. </p> <section id="CD011770-sec-0153"> <h6 class="title">Quality of evidence</h6> <p>We assessed the quality of evidence to be low. We downgraded by one level for risk of bias because two of the three studies are at unclear risk of bias, and by one level for imprecision because the CI includes both no clinical effect (MID less than 1.2 on VAS) and clinical effect (MID greater than 1.2 on VAS). </p> </section> </section> <section id="CD011770-sec-0154"> <h5 class="title">3b. Postoperative pain intensity at 24 hours</h5> <p>Pain scores were significantly lower in the perineural dexamethasone group compared with intravenous dexamethasone. The MD did not surpass the MID of 1.2 on the VAS, therefore the difference in effect size is not clinically significant (MD ‐0.79, 95% CI ‐1.51 to ‐0.07; participants = 309; studies = 5; I<sup>2</sup> = 46%) (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>; <a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>; <a href="./references#CD011770-bbs2-0026" title="SakaeTM , MarchioroP , Schuelter‐TrevisolF , TrevisonDJ . Dexamethasone as a ropivacaine adjuvant for ultrasound‐guided interscalene brachial plexus block: A randomized, double‐blinded clinical trial. Journal of Clinical Anesthesia2017;38:113‐6. ">Sakae 2017</a>); (<a href="./references#CD011770-fig-0112" title="">Analysis 22.1</a>). </p> <section id="CD011770-sec-0155"> <h6 class="title">Subgroup analysis</h6> <p>There was no significant difference in effect size between the additive and no additive subgroups (P = 0.24) (<a href="./references#CD011770-fig-0113" title="">Analysis 22.2</a>), the low‐versus high‐dose dexamethasone subgroups (P = 0.75) (<a href="./references#CD011770-fig-0114" title="">Analysis 22.3</a>) or the high/unclear versus low risk of bias subgroups (P = 0.75) (<a href="./references#CD011770-fig-0115" title="">Analysis 22.4</a>). In all five studies, long‐acting local anaesthetic was used. </p> </section> <section id="CD011770-sec-0156"> <h6 class="title">Quality of evidence</h6> <p>We assessed the quality of evidence to be moderate. We downgraded by one level for imprecision because the CI includes both no clinical effect (MID less than 1.2 on VAS) and clinical effect (MID greater than 1.2 on VAS). </p> </section> </section> <section id="CD011770-sec-0157"> <h5 class="title">3c. Postoperative pain intensity at 48 hours</h5> <p>There was no significant difference in pain scores at 48 hours between perineural and intravenous dexamethasone (MD 0.13, 95% CI ‐0.35 to 0.61; participants = 227; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-bbs2-0007" title="ChunEH , KimYJ , WooJH . Which is your choice for prolonging the analgesic duration of single‐shot interscalene brachial plexus block for arthroscopic shoulder surgery? intravenous dexamethasone 5 mg vs. perineural dexamethasone 5 mg randomized controlled, clinical trial. Medicine2006;95(23):e3828. [PUBMED: 27281084] ">Chun 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>); (<a href="./references#CD011770-fig-0116" title="">Analysis 23.1</a>). </p> <section id="CD011770-sec-0158"> <h6 class="title">Subgroup analysis</h6> <p>There was no significant difference in effect size between the additive and the no additive subgroups (P = 0.28) (<a href="./references#CD011770-fig-0117" title="">Analysis 23.2</a>), the low‐versus high‐dose dexamethasone subgroups (P = 0.46) (<a href="./references#CD011770-fig-0118" title="">Analysis 23.3</a>) and the high/unclear versus low risk of bias subgroups (P = 0.46) (<a href="./references#CD011770-fig-0119" title="">Analysis 23.4</a>). In all three studies, long‐acting local anaesthetic was used. </p> </section> <section id="CD011770-sec-0159"> <h6 class="title">Quality of evidence</h6> <p>We assessed the quality of evidence to be low. We downgraded by one level for risk of bias because the one study that is at unclear risk of bias contributes half the data for this outcome, and by one level for imprecision because of small sample size. </p> </section> </section> <section id="CD011770-sec-0160"> <h5 class="title">4a. Postoperative opioid consumption at 12 hours</h5> <p>No studies evaluated postoperative opioid consumption at 12 hours.</p> </section> <section id="CD011770-sec-0161"> <h5 class="title">4b. Postoperative opioid consumption at 24 hours</h5> <p>Cummulative postoperative consumption at 24 hours was reported in four studies. Postoperative opioids were administered for VAS greater than four (<a href="./references#CD011770-bbs2-0001" title="AbadallahFW , JohnsonJ , ChanV , MurgatroydH , GhafariM , AmiN , et al. Intravenous dexamethasone and perineural dexamethasone similarly prolong the duration of analgesia after supraclavicular brachial plexus block. Regional Anesthesia and Pain Medicine2015;40:125‐32. [PUBMED: 25629321 ] ">Abdallah 2015</a>), or as needed (<a href="./references#CD011770-bbs2-0010" title="DawsonRL , McLeodDH , KoerberJP , PlummerJL , DracopoulosGC . A randomized controlled trial of perineural vs intravenous dexamethasone for foot surgery. Anaesthesia2016;71(3):285‐90. [PUBMED: 26682721] ">Dawson 2016</a>; <a href="./references#CD011770-bbs2-0024" title="RahangdaleR , KendallMC , McCarthyRJ , TureanuL , DotyR , WeingartA , et al. The effects of perineural versus intravenous dexamethasone on sciatic nerve blockade outcomes: a randomized, double‐blind, placebo controlled study. Anesthesia and Analgesia2014;118(5):1113‐9. [PUBMED: 24686045] ">Rahangdale 2014</a>; <a href="./references#CD011770-bbs2-0025" title="RosenfeldDM , IvancicMG , HattrupSJ , RenfreeKJ , WatkinsAR , HentzJG , et al. Perineural versus intravenous dexamethasone as adjuncts to local anaesthetic brachial plexus block for shoulder surgery. Anaesthesia2016;71(4):380‐8. [PUBMED: 26899862] ">Rosenfeld 2016</a>). There was no significant difference in the 24‐hour opioid consumption between perineural and intravenous dexamethasone (MD ‐3.87 mg, 95% CI ‐9.93 to 2.19; participants = 242; studies = 4; I<sup>2</sup> = 44%) (<a href="./references#CD011770-fig-0120" title="">Analysis 24.1</a>). </p> <section id="CD011770-sec-0162"> <h6 class="title">Subgroup analysis</h6> <p>There was no significant difference in effect size between the additive or no additive subgroups (P = 0.11) (<a href="./references#CD011770-fig-0121" title="">Analysis 24.2</a>). In all four studies, long‐acting local anaesthetic and high‐dose dexamethasone were used, and all four studies were at low risk of bias. </p> </section> </section> <section id="CD011770-sec-0163"> <h5 class="title">4c. Postoperative opioid consumption at 48 hours</h5> <p>No studies reported the cumulative opioid consumption at 48 hours.</p> </section> <section id="CD011770-sec-0164"> <h5 class="title">5. Participant satisfaction with pain control</h5> <p>There was no significant difference in participant satisfaction between perineural and intravenous dexamethasone (MD 0.19, 95% CI ‐0.33 to 0.70; participants = 181; studies = 3; I<sup>2</sup> = 0%) (<a href="./references#CD011770-fig-0122" title="">Analysis 25.1</a>). The SD was zero in both the perineural and intravenous dexamethasone groups in one of the two studies, therefore the 95% CI was not estimable and the analysis was based on one study in 50 participants. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011770-sec-0165" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011770-sec-0165">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011770-sec-0223">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011770-sec-0165"></div> <section id="CD011770-sec-0166"> <h3 class="title" id="CD011770-sec-0166">Summary of main results and quality of evidence</h3> <p>The objective of this review was to evaluate the comparative efficacy and safety of perineural dexamethasone and intravenous dexamethasone as adjuvants to peripheral nerve block for postoperative pain control in people undergoing upper or lower limb surgery. Our primary outcomes were duration of sensory block and incidence of severe adverse events. We conducted a comprehensive search for trials evaluating our study objectives. We assessed the quality of evidence for outcomes important for clinical decision‐making, including duration of sensory block, intensity of postoperative pain at 12, 24 and 48 hours, and incidence of severe adverse events. In total, we found 35 eligible trials involving 2707 participants. We describe our findings and provide a summary of the quality of evidence for each comparison below. </p> <section id="CD011770-sec-0167"> <h4 class="title">Perineural dexamethasone verus placebo</h4> <p>Among 27 trials (1625 participants) the duration of sensory block was longer in the perineural dexamethasone group by approximately six and a half hours. The quality of evidence is low. We downgraded by one level for risk of bias because the majority of studies are at unclear risk of bias and by one level for inconsistency because of considerable heterogeneity not explained by subgroup analyses; point estimates varied widely among studies and confidence intervals showed minimal overlap. Motor block was also longer in the perineural dexamethasone group compared with control by approximately six hours (16 studies, 912 participants). </p> <p>Among five studies (257 participants), postoperative pain intensity at 12 hours in the perineural dexamethasone group was 2.1 points lower on an 11‐point numeric rating scale. The quality of evidence is very low; we downgraded by one level for risk of bias because half of the studies were at high/unclear risk of bias, by one level for inconsistency due to considerable heterogeneity not explained by subgroup analyses, and by one level for imprecision due to small sample size. At 24 hours, perineural dexamethasone reduced postoperative pain intensity by 1.6 points (9 studies, 469 participants). The quality of evidence is low; we downgraded by one level for inconsistency because of considerable heterogeneity not explained by subgroup analysis, and by one level for imprecision because the confidence interval includes both no clinical effect and clinical effect. For postoperative pain intensity at 12 and 24 hours, the minimally important difference (MID) of 1.2 points was surpassed. There was no difference in postoperative pain intensity between perineural dexamethasone and placebo at 48 hours (3 studies, 296 participants). The quality of evidence is low; we downgraded by one level for inconsistency due to moderate heterogeneity not explained by subgroup analyses, and by one level for imprecision because the confidence interval includes both no clinical effect and clinical effect. Cumulative opioid consumption 24 hours postoperatively was lower in the perineural dexamethasone group compared with placebo by 19 mg oral morphine equivalents. </p> <p>Based on our a priori hypotheses, the duration of sensory block was significantly longer in long‐ versus medium‐acting local anaesthetic subgroup and the high‐ versus low‐dose dexamethasone subgroup. There was no significant difference in effect size between the high‐ and low‐dose dexamethasone subgroups in postoperative pain intensity at 12‐ and 24‐hour outcomes; therefore, the longer duration of sensory block in the long‐acting local anaesthetic and high‐dose dexamethasone subgroups are likely not clinically significant. </p> </section> <section id="CD011770-sec-0168"> <h4 class="title">Intravenous dexamethasone versus placebo</h4> <p>Among eight trials (499 participants), the duration of sensory block was longer in the intravenous dexamethasone group by approximately six hours. The quality of evidence is moderate; we downgraded by one level for inconsistency because of considerable heterogeneity not explained by subgroup analyses. The duration of motor block was also longer in the intravenous dexamethasone group compared with control by approximately five hours. </p> <p>Among three studies (162 participants), postoperative pain intensity at 12 hours was lower in the intravenous dexamethasone group compared with placebo by 1.2 points on an 11‐point numeric rating scale. The quality of evidence is low; we downgraded by one level for inconsistency because of considerable heterogeneity not explained by subgroup analyses, and by one level for imprecision because the confidence interval included both no clinical effect and clinical effect. At 24 hours (5 studies, 257 participants), postoperative pain intensity was lower in the intravenous dexamethasone group by 1.3 points. The quality of evidence is low; we downgraded by one level for inconsistency for considerable heterogeneity not explained by subgroup analyses, and by one level for imprecision because the confidence interval includes both no clinical benefit and clinical benefit. The MID of 1.2 points was surpassed in postoperative pain intensity at 12‐ and 24‐hour outcomes. Among three trials (172 participants) there was no difference in postoperative pain intensity at 48 hours. The quality of evidence is low; we downgraded by two levels for imprecision because the confidence interval crosses the line of null effect, and because of the small sample size. Opioid consumption 24 hours postoperatively was lower in the intravenous dexamethasone group. </p> <p>Based on our a priori hypotheses, the duration of sensory block was significantly longer in the high‐ versus low‐dose dexamethasone subgroup. There was no significant difference in effect size between the high‐ and low‐dose dexamethasone subgroups in the intensity of postoperative pain at 12‐ and 24‐hour outcomes, therefore the longer duration of sensory block in the high‐dose dexamethasone is likely not clinically significant. </p> </section> <section id="CD011770-sec-0169"> <h4 class="title">Perineural versus intravenous dexamethasone</h4> <p>Among nine studies (720 participants) the duration of sensory block was longer in the perineural dexamethasone group compared with intravenous dexamethasone by approximately three hours. The quality of evidence is moderate; we downgraded by one level for considerable heterogeneity not explained by subgroup analysis. Duration of motor block was also longer in the perineural dexamethasone group by approximately three hours (3 studies, 139 participants). </p> <p>Postoperative pain intensity at 12 hours was lower in the perineural dexamethasone group compared with intravenous dexamethasone (3 studies, 217 participants). The MID of 1.2 was not surpassed; therefore the lower intensity of pain is not clinically significant. The quality of evidence is very low; we downgraded by one level for risk of bias because two out of the three included studies are at unclear risk of bias, and by one level for imprecision because the confidence interval includes both no clinical effect and clinical effect. At 24 hours, although the postoperative pain intensity was significantly higher in the perineural dexamethasone group compared with intravenous dexamethasone, the MID of 1.2 was not surpassed; therefore the lower intensity of pain is not clinically significant (5 studies, 309 participants). The quality of evidence is moderate; we downgraded by one level for imprecision because the confidence interval includes both clinical effect and no clinical effect. At 48 hours postoperatively, there was no difference in postoperative pain intensity between perineural and intravenous dexamethasone. The quality of evidence is low; we downgraded by one level for risk of bias because half the data comes from one study at unclear risk of bias and by one level for imprecision because of the small sample size. There was no difference between perineural and intravenous dexamethasone in 24‐hour postoperative opioid consumption. We did not find any difference in effect size between any of our subgroups. </p> <section id="CD011770-sec-0170"> <h5 class="title">Incidence of severe adverse events</h5> <p>Authors reported that they assessed for serious adverse events in seven studies. Five serious adverse events were reported in three studies including pneumothorax, pneumonia, development of Chronic Regional Pain Syndrome Type I, and two unexpected hospitalizations within one week of surgery; one for a fall, the other for a bowel infection. The quality of evidence is very low, downgraded by one level for risk of bias because the majority of studies were at high/unclear risk of bias, and by two levels for imprecision due to the small sample size. </p> </section> <section id="CD011770-sec-0171"> <h5 class="title">Mild to moderate adverse events</h5> <p>We categorized mild to moderate adverse events into block‐related and non‐block‐related adverse events. Block‐related adverse events included numbness/tingling, residual motor block and muscle weakness, Horner's syndrome, hoarseness, diaphragmatic paresis, dyspnoea, cranial nerve 12 motor palsy, vascular injury, and bruising at the injection site. Non‐block‐related adverse events included bradycardia/hypotension, postoperative nausea and vomiting, pruritus/rash, syncope, dizziness, headache, fluid gain, diarrhoea, frequent urination, muscle soreness, wrist, hand or finger pain, and constipation. </p> <p>We found no difference between the incidence of block‐related or non‐block‐related adverse events in any of the three comparisons. Because the incidence of severe and block‐related adverse events associated with the use of peripheral nerve block is rare, our review may not have included enough participants to detect a difference in any of the comparisons, therefore our confidence in the estimate is low (sparse number of participants and events). In only two studies did the authors report that block‐related symptoms had resolved, therefore it is not possible to determine whether participants reporting block‐related adverse events in other studies were later diagnosed with nerve injury. </p> </section> </section> </section> <section id="CD011770-sec-0172"> <h3 class="title" id="CD011770-sec-0172">Overall completeness and applicability of evidence</h3> <p>The majority of studies included in our review were conducted in upper limb surgery; as only two studies were conducted in lower limb surgery, we cannot draw any meaningful conclusions about the effectiveness of dexamethasone as an adjuvant to lower limb blocks. More studies for lower limb surgery are needed in order to determine whether our results are applicable in this population. The nine ongoing trials on ClinicalTrials.gov may change the results of this review. </p> <p>The results of our review may not be applicable to participants who are at risk for dexamethasone‐related adverse events in whom clinical trials would likely to be unsafe. People with diabetes mellitus, peptic ulcer and psychiatric disorders were excluded from many of the trials. Additionally, our results may also not be applicable to those at risk for postoperative infection and delayed wound healing, including people with immunodeficiency disorders, those undergoing radiation therapy, people with circulatory disorder, obesity, poor nutritional status, or the elderly. Other populations excluded from some of the trials include those with renal, liver, cardiac or lung disease, head injury, hypertension, drug/alcohol dependence, pregnant women, and those who had used steroids or opioids preoperatively. Finally, there were no studies in infants and children under the age of 15 years, and so our results are not directly applicable to this population. </p> <p>We found that the duration of sensory block was longer in the high‐ versus low‐dose dexamethasone subgroups in the perineural versus control and in the intravenous versus control comparisons, but the longer duration in the high‐dose dexamethasone subgroups was not associated with lower postoperative pain intensity. There were fewer studies using low‐dose than high‐dose dexamethasone. It is possible that the sample size was too small to detect a difference between high‐ and low‐dose dexamethasone. Dose‐finding studies would be beneficial to determine the ideal perineural and intravenous doses. </p> <p>For the duration of sensory block outcome, we did not determine a priori the minimally important difference (MID) that would be clinically significant. In the perineural dexamethasone versus control and the intravenous dexamethasone versus control comparisons, the longer duration of sensory block in the dexamethasone groups was also associated with lower postoperative pain intensity and opioid consumption. In the perineural versus intravenous dexamethasone comparison, the longer duration of sensory block in the perineural dexamethasone was not associated with a reduction in postoperative pain intensity or opioid consumption, and we concluded that the longer duration of sensory block was unlikely to be clinically significant. In 10 of the included studies, duration of sensory block was reported without also reporting pain outcomes; therefore it is not known whether the longer duration of sensory block in the dexamethasone groups was effective in reducing postoperative pain and opioid consumption. In all future studies, duration of sensory block should be reported in conjunction with other pain outcomes to determine the efficacy of dexamethasone in reducing postoperative pain. </p> </section> <section id="CD011770-sec-0173"> <h3 class="title" id="CD011770-sec-0173">Potential biases in the review process</h3> <p>In order to reduce potential bias in the review process, two review authors independently assessed each trial for eligibility, extracted the data, assessed risk of bias, and assessed the quality of evidence. Furthermore, we did not impose any language restrictions. With the assistance of an experienced librarian, we did an extensive literature review of six databases and we searched Google Scholar and found additional studies we had not found through scientific databases. There were no marginal decisions around the inclusion or exclusion of studies or use and analysis of data. We made minor changes to the protocol, however, it is unlikely that any changes would have been a source of bias. </p> <p>We conducted subgroup analyses to explore heterogeneity for all outcomes regardless of the observed heterogeneity (I<sup>2</sup>). In particular, we explored whether the type of local anaesthetic (long‐acting versus medium‐acting), the dose of dexamethasone (high‐ versus low‐dose), whether additives to local anaesthetics were used, and whether risk of bias (high/unclear versus low) could explain the observed heterogeneity. Our subgroup hypotheses were determined as possible factors that may influence the results based on the literature. There may be other reasons for heterogeneity that we did not explore. </p> <p>Among our 35 eligible trials, 14 had incomplete reports (e.g. missing variance data, unclear presentation of data on figures). We attempted to obtain unpublished data for our meta‐analyses, but we were only able to obtain data from six of the 15 study authors we contacted. The missing information may have introduced a source of bias. With respect to publication bias, only two of the outcomes in the perineural versus placebo comparison included 10 or more trials (duration of sensory block and duration of motor block). Because our remaining outcomes in all three comparisons included fewer than 10 trials we were not able to adequately assess publication bias. Published protocols were available for 10 of the studies. For the remaining 25, because we relied on the information provided in the methods section to assess risk of selection bias, we could not ascertain whether all outcomes were reported as planned, so our assessment of selection bias is limited. </p> </section> <section id="CD011770-sec-0174"> <h3 class="title" id="CD011770-sec-0174">Agreements and disagreements with other studies or reviews</h3> <p>We found five reviews evaluating the effectiveness of perineural dexamethasone on postoperative outcomes that are in agreement with our findings. Two reviews were in participants undergoing upper limb surgery with brachial plexus block (<a href="./references#CD011770-bbs2-0061" title="ChoiS , RodsethR , McCartneyCJ . Effects of dexamethasone as a local anaesthetic adjuvant for brachial plexus block: a systematic review and meta‐analysis of randomized trials. British Journal of Anaesthesia2014;112(3):427‐39. [PUBMED: 24413428] ">Choi 2014</a>; <a href="./references#CD011770-bbs2-0081" title="KnezevicNN , AnantamongkolU , CandidoKD . Perinerual dexamethasone added to local anesthesia for brachial plexus block improves pain but delays block onset and motor blockade recovery. Pain Physcian2015;18(1):1‐14. [PUBMED: 25675053] ">Knezivic 2015</a>), and the remaining three were in participants undergoing surgery with a variety of nerve blocks, including peribulbar, transversus abdominis, axillary, supraclavicular, sciatic, and interscalene (<a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a>; <a href="./references#CD011770-bbs2-0066" title="DeOliveiraGS , Castro‐AlvesLJ , NaderA , KendallMC , RahangdaleR , McCarthyRJ . Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta‐analysis of randomized control trials. Pain Research and Treatment2014;2014:179029. [PUBMED: 25485150] ">De Oliveira 2014</a>; <a href="./references#CD011770-bbs2-0075" title="HuynhTM , MarretE , BonnetF . Combination of dexamethasone and local anesthetic solution in peripheral nerve blocks. A meta‐analysis of randomised placebo trials. European Journal of Anaesthesiology2015;32(11):751‐8. [PUBMED: 25774458] ">Huynh 2015</a>). In all five reviews, the duration of sensory and motor block was longer after perineural dexamethasone compared with placebo. <a href="./references#CD011770-bbs2-0052" title="AlbrechtE , KernC , KirkhamKR . A systematic review and meta‐analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia2015;70:71‐83. [MEDLINE: 25123271] ">Albrecht 2015</a> and <a href="./references#CD011770-bbs2-0066" title="DeOliveiraGS , Castro‐AlvesLJ , NaderA , KendallMC , RahangdaleR , McCarthyRJ . Perineural dexamethasone to improve postoperative analgesia with peripheral nerve blocks: a meta‐analysis of randomized control trials. Pain Research and Treatment2014;2014:179029. [PUBMED: 25485150] ">De Oliveira 2014</a> found that 24‐hour postoperative opioid consumption was lower after perineural dexamethasone compared with placebo. </p> <p>We found two systematic reviews that evaluated the effectiveness of intravenous dexamethasone for postoperative pain (<a href="./references#CD011770-bbs2-0065" title="DeOliveiraGS , AlmeidaM , BenzonHT , McCarthyRJ . Perioperative single dose systemic dexamethasone for postoperative pain. A meta‐analysis of randomized controlled trials. Anesthesiology2011;115(3):575‐88. [PUBMED: 21799397 ] ">De Oliveira 2011</a>; <a href="./references#CD011770-bbs2-0100" title="WaldronNH , JonesCA , GanTJ , AllenTK , HabibAS . Impact of perioperative dexamethasone on postoperative analgesia and side‐effects: systematic review and meta‐analysis. British Journal of Anaesthesia2013;110(2):191‐200. [PUBMED: 23220857] ">Waldron 2013</a>). Neither of these reviews included studies in participants undergoing peripheral nerve block. Postoperative pain intensity at 24 hours, opioid consumption, and the incidence of postoperative nausea and vomiting was lower in the intravenous dexamethasone group compared with placebo (<a href="./references#CD011770-bbs2-0065" title="DeOliveiraGS , AlmeidaM , BenzonHT , McCarthyRJ . Perioperative single dose systemic dexamethasone for postoperative pain. A meta‐analysis of randomized controlled trials. Anesthesiology2011;115(3):575‐88. [PUBMED: 21799397 ] ">De Oliveira 2011</a>; <a href="./references#CD011770-bbs2-0100" title="WaldronNH , JonesCA , GanTJ , AllenTK , HabibAS . Impact of perioperative dexamethasone on postoperative analgesia and side‐effects: systematic review and meta‐analysis. British Journal of Anaesthesia2013;110(2):191‐200. [PUBMED: 23220857] ">Waldron 2013</a>). We did not find any difference between intravenous dexamethasone and placebo in postoperative pain intensity at 24 hours or the incidence of postoperative nausea and vomiting; however, our review included fewer participants than the previous reviews. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011770-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Flow diagram of included studies." data-id="CD011770-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Flow diagram of included studies.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011770-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011770-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG04.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 1 Duration of sensory block: perineural dexamethasone versus placebo, outcome: 1.1 Duration of sensory block [hours]." data-id="CD011770-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Forest plot of comparison: 1 Duration of sensory block: perineural dexamethasone versus placebo, outcome: 1.1 Duration of sensory block [hours]. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG05.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, outcome: 4.1 Postoperative pain intensity at12 hours." data-id="CD011770-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Forest plot of comparison: 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, outcome: 4.1 Postoperative pain intensity at12 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG06.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, outcome: 5.1 Postoperative pain intensity at 24 hours." data-id="CD011770-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Forest plot of comparison: 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, outcome: 5.1 Postoperative pain intensity at 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG07.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 9 Duration of sensory block: intravenous dexamethasone versus placebo , outcome: 9.1 Duration of sensory block." data-id="CD011770-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 7</div> <div class="figure-caption"> <p>Forest plot of comparison: 9 Duration of sensory block: intravenous dexamethasone versus placebo , outcome: 9.1 Duration of sensory block. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG08.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, outcome: 12.1 Postoperative pain intensity at 12 hours." data-id="CD011770-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 8</div> <div class="figure-caption"> <p>Forest plot of comparison: 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, outcome: 12.1 Postoperative pain intensity at 12 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-AFig-FIG09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-AFig-FIG09.png" target="_blank"><b></b></a></p> </div><img alt="Forest plot of comparison: 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, outcome: 13.1 Postoperative pain intensity at 24 hours." data-id="CD011770-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 9</div> <div class="figure-caption"> <p>Forest plot of comparison: 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, outcome: 13.1 Postoperative pain intensity at 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-AFig-FIG09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-001-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 1 Duration of sensory block." data-id="CD011770-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 1 Duration of sensory block. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 2 Duration of sensory block: long‐ versus medium‐acting local anaesthetic subgroups." data-id="CD011770-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 2 Duration of sensory block: long‐ versus medium‐acting local anaesthetic subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 3 Duration of sensory block: additive versus no additive subgroups." data-id="CD011770-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 3 Duration of sensory block: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 4 Duration of sensory block: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 4 Duration of sensory block: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 5 Duration of sensory block: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Duration of sensory block: perineural dexamethasone versus placebo, Outcome 5 Duration of sensory block: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 1 Duration of motor block." data-id="CD011770-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 1 Duration of motor block. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 2 Duration of motor block: long‐ versus medium‐acting local anaesthetic subgroups." data-id="CD011770-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 2 Duration of motor block: long‐ versus medium‐acting local anaesthetic subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 3 Duration of motor block: additives verus no additives subgroups." data-id="CD011770-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 3 Duration of motor block: additives verus no additives subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 4 Duration of motor block: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 4 Duration of motor block: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-002-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-002-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 5 Duration of motor block: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Duration of motor block: perineural dexamethasone versus placebo, Outcome 5 Duration of motor block: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-002-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 1 Overall incidence of block‐related adverse events." data-id="CD011770-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 1 Overall incidence of block‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 2 Numbness/tingling 14 days after surgery." data-id="CD011770-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 2 Numbness/tingling 14 days after surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 3 Residual motor block/weakness 24 hours after surgery." data-id="CD011770-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 3 Residual motor block/weakness 24 hours after surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 4 Horner Syndrome." data-id="CD011770-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 4 Horner Syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 5 Hoarseness." data-id="CD011770-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 5 Hoarseness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 6 Diaphragmatic paresis." data-id="CD011770-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 6 Diaphragmatic paresis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 7 Dyspnoea." data-id="CD011770-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 7 Dyspnoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 8 Vascular injury." data-id="CD011770-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 8 Vascular injury. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 9 Cranial nerve 12 palsy." data-id="CD011770-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 9 Cranial nerve 12 palsy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 10 Bruising." data-id="CD011770-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 10 Bruising. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 11 Overall non‐block‐related adverse events." data-id="CD011770-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 11 Overall non‐block‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 12 Postoperative nausea and vomiting." data-id="CD011770-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 12 Postoperative nausea and vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 13 Deep sedation." data-id="CD011770-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 13 Deep sedation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 14 Dermatological symptoms (pruritus/rash)." data-id="CD011770-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 14 Dermatological symptoms (pruritus/rash). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 15 Syncope/fainting." data-id="CD011770-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 15 Syncope/fainting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 16 Bradycardia." data-id="CD011770-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 16 Bradycardia. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 17 Hypotension." data-id="CD011770-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 17 Hypotension. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-003-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-003-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 18 Headache/10‐pound fluid gain/diarrhoea/frequent urination/muscle soreness." data-id="CD011770-fig-0037" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3 Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo, Outcome 18 Headache/10‐pound fluid gain/diarrhoea/frequent urination/muscle soreness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-003-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-004-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at12 hours." data-id="CD011770-fig-0038" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at12 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 12 hours: medium‐ versus long‐acting local anaesthetic subgroups." data-id="CD011770-fig-0039" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 12 hours: medium‐ versus long‐acting local anaesthetic subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 12 hours: additive versus no additive subgroups." data-id="CD011770-fig-0040" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 12 hours: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 4 Postoperative pain intensity at 12 hours: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0041" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 4 Postoperative pain intensity at 12 hours: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 5 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0042" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo, Outcome 5 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-005-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 24 hours." data-id="CD011770-fig-0043" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 24 hours: long‐ versus medium‐acting local anaesthetic subgroups." data-id="CD011770-fig-0044" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 24 hours: long‐ versus medium‐acting local anaesthetic subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 24 hours: additive versus no additive subgroups." data-id="CD011770-fig-0045" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 24 hours: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 4 Postoperative pain intensity at 24 hours: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0046" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 4 Postoperative pain intensity at 24 hours: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 5 Postoperative pain intensity at 24 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0047" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo, Outcome 5 Postoperative pain intensity at 24 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 48 hours." data-id="CD011770-fig-0048" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 48 hours: additives versus no additives subgroups." data-id="CD011770-fig-0049" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 48 hours: additives versus no additives subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 48 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0050" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 48 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative opioid consumption at 24 hours." data-id="CD011770-fig-0051" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 1 Postoperative opioid consumption at 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 2 Opioid consumption at 24 hours medium‐ versus long‐acting local anaesthetic subgroups." data-id="CD011770-fig-0052" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 2 Opioid consumption at 24 hours medium‐ versus long‐acting local anaesthetic subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 3 Opioid consumption at 24 hours: additive versus no additive subgroups." data-id="CD011770-fig-0053" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 3 Opioid consumption at 24 hours: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 4 Opioid consumption at 24 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0054" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo, Outcome 4 Opioid consumption at 24 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Participant satisfaction with pain control; perineural dexamethasone versus placebo, Outcome 1 Participant satisfaction with pain control: perineural dexamethasone versus placebo." data-id="CD011770-fig-0055" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Participant satisfaction with pain control; perineural dexamethasone versus placebo, Outcome 1 Participant satisfaction with pain control: perineural dexamethasone versus placebo. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-009-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 1 Duration of sensory block." data-id="CD011770-fig-0056" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 1 Duration of sensory block. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 2 Duration sensory block: additive versus no additive subgroups." data-id="CD011770-fig-0057" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 2 Duration sensory block: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 3 Duration of sensory block: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0058" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 3 Duration of sensory block: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 4 Duration of sensory block: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0059" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Duration of sensory block: intravenous dexamethasone versus placebo, Outcome 4 Duration of sensory block: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 1 Duration of motor block." data-id="CD011770-fig-0060" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 1 Duration of motor block. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 2 Duration of motor block: additive versus no additive subgroups." data-id="CD011770-fig-0061" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 2 Duration of motor block: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-010-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-010-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 3 Duration of motor block high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0062" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.3</div> <div class="figure-caption"> <p>Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 3 Duration of motor block high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-010-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-010-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 4 Duration of motor block: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0063" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.4</div> <div class="figure-caption"> <p>Comparison 10 Duration of motor block: intravenous dexamethasone versus placebo, Outcome 4 Duration of motor block: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-010-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 1 Overall incidence of block‐related adverse events." data-id="CD011770-fig-0064" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 1 Overall incidence of block‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 2 Numbness/tingling 14 days after surgery." data-id="CD011770-fig-0065" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 2 Numbness/tingling 14 days after surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 3 Residual motor block/muscle weakness 24 hours after surgery." data-id="CD011770-fig-0066" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 3 Residual motor block/muscle weakness 24 hours after surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 4 Horner syndrome." data-id="CD011770-fig-0067" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 4 Horner syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 5 Hoarsenss." data-id="CD011770-fig-0068" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.5</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 5 Hoarsenss. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 6 Dyspnoea." data-id="CD011770-fig-0069" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.6</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 6 Dyspnoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 7 Cranial nerve 12 palsy." data-id="CD011770-fig-0070" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.7</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 7 Cranial nerve 12 palsy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 8 Overall non‐block‐related adverse events." data-id="CD011770-fig-0071" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.8</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 8 Overall non‐block‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 9 Postoperative nausea and vomiting." data-id="CD011770-fig-0072" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.9</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 9 Postoperative nausea and vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 10 Dermatological symptoms." data-id="CD011770-fig-0073" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.10</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 10 Dermatological symptoms. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-011-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-011-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 11 Dizziness/wrist, hand or finger pain, constipation." data-id="CD011770-fig-0074" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.11</div> <div class="figure-caption"> <p>Comparison 11 Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo, Outcome 11 Dizziness/wrist, hand or finger pain, constipation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-011-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-012-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 12 hours." data-id="CD011770-fig-0075" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 12 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 12 hours: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0076" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 12 hours: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0077" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-013-01.png" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 24 hours." data-id="CD011770-fig-0078" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 24 hours: additive versus no additive subgroups." data-id="CD011770-fig-0079" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 24 hours: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 24 hours: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0080" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 3 Postoperative pain intensity at 24 hours: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-013-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-013-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 4 Postoperative pain intensity at 24 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0081" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.4</div> <div class="figure-caption"> <p>Comparison 13 Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo, Outcome 4 Postoperative pain intensity at 24 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-013-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Postoperative pain intensity at 48 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 48 hours." data-id="CD011770-fig-0082" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Postoperative pain intensity at 48 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative pain intensity at 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Postoperative pain intensity at 48 hours: intravenous dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 48 hours: additive versus no additive subgroups." data-id="CD011770-fig-0083" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Postoperative pain intensity at 48 hours: intravenous dexamethasone versus placebo, Outcome 2 Postoperative pain intensity at 48 hours: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Postoperative opioid consumption at 24 hours: intravenous dexamethasone versus placebo, Outcome 1 24‐hour opioid consumption." data-id="CD011770-fig-0084" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Postoperative opioid consumption at 24 hours: intravenous dexamethasone versus placebo, Outcome 1 24‐hour opioid consumption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Postoperative opioid consumption at 24 hours: intravenous dexamethasone versus placebo, Outcome 2 24‐hour opioid consumption: additive verus no additive subgroups." data-id="CD011770-fig-0085" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Postoperative opioid consumption at 24 hours: intravenous dexamethasone versus placebo, Outcome 2 24‐hour opioid consumption: additive verus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Postoperative opioid consumption at 48 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative opioid consumption at 48 hours opioid consumption." data-id="CD011770-fig-0086" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Postoperative opioid consumption at 48 hours: intravenous dexamethasone versus placebo, Outcome 1 Postoperative opioid consumption at 48 hours opioid consumption. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Participant satisfaction with pain control: intravenous dexamethasone versus placebo, Outcome 1 Participant satisfaction with pain control." data-id="CD011770-fig-0087" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Participant satisfaction with pain control: intravenous dexamethasone versus placebo, Outcome 1 Participant satisfaction with pain control. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 1 Duration of sensory block." data-id="CD011770-fig-0088" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 1 Duration of sensory block. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 2 Duration of sensory block additive versus no additive subgroups." data-id="CD011770-fig-0089" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 2 Duration of sensory block additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-018-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-018-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 3 Duration sensory block high‐dose versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0090" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 3 Duration sensory block high‐dose versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-018-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-018-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 4 Duration sensory block high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0091" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18 Duration of sensory block: perineural versus intravenous dexamethasone, Outcome 4 Duration sensory block high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-018-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 1 Duration of motor block." data-id="CD011770-fig-0092" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 1 Duration of motor block. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 2 Duration of motor block: additive versus no additive subgroups." data-id="CD011770-fig-0093" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 2 Duration of motor block: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-019-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-019-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 3 Duration of motor block: high‐ versus low‐dose dexamethasone subgroups." data-id="CD011770-fig-0094" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 3 Duration of motor block: high‐ versus low‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-019-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-019-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 4 Duration of motor block: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0095" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.4</div> <div class="figure-caption"> <p>Comparison 19 Duration of motor block: perineural versus intravenous dexamethasone, Outcome 4 Duration of motor block: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-019-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 1 Overall incidence of block‐related adverse events." data-id="CD011770-fig-0096" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 1 Overall incidence of block‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 2 Numbness/tingling 14 days after surgery." data-id="CD011770-fig-0097" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 2 Numbness/tingling 14 days after surgery. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 3 Residual motor block/weakness at 24 hours." data-id="CD011770-fig-0098" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 3 Residual motor block/weakness at 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 4 Horner syndrome." data-id="CD011770-fig-0099" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.4</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 4 Horner syndrome. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 5 Hoarsness." data-id="CD011770-fig-0100" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.5</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 5 Hoarsness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 6 Cranial nerve 12 motor palsy." data-id="CD011770-fig-0101" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.6</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 6 Cranial nerve 12 motor palsy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 7 Overall incidence of non block‐related adverse events." data-id="CD011770-fig-0102" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.7</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 7 Overall incidence of non block‐related adverse events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 8 Postoperative nausea and vomiting." data-id="CD011770-fig-0103" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.8</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 8 Postoperative nausea and vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 9 Dermatologicial symptoms (pruritus/rash)." data-id="CD011770-fig-0104" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.9</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 9 Dermatologicial symptoms (pruritus/rash). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 10 Syncope/fainting." data-id="CD011770-fig-0105" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.10</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 10 Syncope/fainting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 11 Dizziness." data-id="CD011770-fig-0106" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.11</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 11 Dizziness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 12 Wrist, hand or finger pain." data-id="CD011770-fig-0107" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.12</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 12 Wrist, hand or finger pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-020-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-020-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 13 Headache, 10‐pound fluid gain/diarrhoea/frequent urination/ muscle soreness." data-id="CD011770-fig-0108" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.13</div> <div class="figure-caption"> <p>Comparison 20 Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone, Outcome 13 Headache, 10‐pound fluid gain/diarrhoea/frequent urination/ muscle soreness. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-020-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone, Outcome 1 Postoperative pain intensity at 12 hours." data-id="CD011770-fig-0109" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone, Outcome 1 Postoperative pain intensity at 12 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-021-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-021-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone, Outcome 2 Postoperative pain intensity at 12 hours: low‐ versus high‐dose dexamethasone subgroups." data-id="CD011770-fig-0110" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-021-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone, Outcome 2 Postoperative pain intensity at 12 hours: low‐ versus high‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-021-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-021-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-021-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone, Outcome 3 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0111" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-021-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21 Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone, Outcome 3 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-021-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 1 Postoperative pain intensity at 24 hours." data-id="CD011770-fig-0112" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 1 Postoperative pain intensity at 24 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-022-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-022-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 2 Postoperative pain intensity at 24 hours: additive versus no additive subgroups." data-id="CD011770-fig-0113" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.2</div> <div class="figure-caption"> <p>Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 2 Postoperative pain intensity at 24 hours: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-022-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-022-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 3 Postoperative pain intensity at 24 hours: low‐ versus high‐dose dexamethasonesubgroups." data-id="CD011770-fig-0114" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.3</div> <div class="figure-caption"> <p>Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 3 Postoperative pain intensity at 24 hours: low‐ versus high‐dose dexamethasonesubgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-022-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-022-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 4 Intensity of postoperative pain at 24 hours: high/unclear risk of bias versus low risk of bias subgroups." data-id="CD011770-fig-0115" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.4</div> <div class="figure-caption"> <p>Comparison 22 Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone, Outcome 4 Intensity of postoperative pain at 24 hours: high/unclear risk of bias versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-022-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-023-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-023-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 1 Postoperative pain intensity at 48 hours." data-id="CD011770-fig-0116" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.1</div> <div class="figure-caption"> <p>Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 1 Postoperative pain intensity at 48 hours. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-023-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-023-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 2 Postoperative pain intensity at 48 hours: additive versus no additive subgroups." data-id="CD011770-fig-0117" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.2</div> <div class="figure-caption"> <p>Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 2 Postoperative pain intensity at 48 hours: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-023-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-023-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 3 Postoperative pain intensity at 48 hours: low‐ versus high‐dose dexamethasone subgroups." data-id="CD011770-fig-0118" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.3</div> <div class="figure-caption"> <p>Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 3 Postoperative pain intensity at 48 hours: low‐ versus high‐dose dexamethasone subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-023-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-023-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 4 Postoperative pain intensity at 48 hours: high/unclear versus low risk of bias subgroups." data-id="CD011770-fig-0119" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.4</div> <div class="figure-caption"> <p>Comparison 23 Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone, Outcome 4 Postoperative pain intensity at 48 hours: high/unclear versus low risk of bias subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-023-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-024-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-024-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Postoperative opioid consumption at 24 hours: perineural versus intravenous dexamethasone opioid consumption: perineural versus intravenous dexamethasone subgroups, Outcome 1 Opioid consumption at 24 hours: perineural versus intravenous dexamethasone." data-id="CD011770-fig-0120" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-024-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.1</div> <div class="figure-caption"> <p>Comparison 24 Postoperative opioid consumption at 24 hours: perineural versus intravenous dexamethasone opioid consumption: perineural versus intravenous dexamethasone subgroups, Outcome 1 Opioid consumption at 24 hours: perineural versus intravenous dexamethasone. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-024-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-024-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-024-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 24 Postoperative opioid consumption at 24 hours: perineural versus intravenous dexamethasone opioid consumption: perineural versus intravenous dexamethasone subgroups, Outcome 2 24‐hour opioid consumption: additive versus no additive subgroups." data-id="CD011770-fig-0121" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-024-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 24.2</div> <div class="figure-caption"> <p>Comparison 24 Postoperative opioid consumption at 24 hours: perineural versus intravenous dexamethasone opioid consumption: perineural versus intravenous dexamethasone subgroups, Outcome 2 24‐hour opioid consumption: additive versus no additive subgroups. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-024-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011770-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/urn:x-wiley:14651858:media:CD011770:CD011770-CMP-025-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_t/tCD011770-CMP-025-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 25 Participant satisfaction with pain control: perineural versus intravenous dexamethasone, Outcome 1 Participant satisfaction with pain control." data-id="CD011770-fig-0122" src="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-025-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 25.1</div> <div class="figure-caption"> <p>Comparison 25 Participant satisfaction with pain control: perineural versus intravenous dexamethasone, Outcome 1 Participant satisfaction with pain control. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/media/CDSR/CD011770/image_n/nCD011770-CMP-025-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011770-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perineural dexamethasone versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> participants undergoing surgery with peripheral nerve block<br/> <b>Setting:</b> participants undergoing upper and lower limb surgery in hospitals in Australia, Bangledesh, Belgium, Brazil, India, Iran, Japan, Korea, Nepal, Turkey and USA </p> <p><b>Intervention</b>: perineural dexamethasone </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>№ of participants<br/> (studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of the evidence<br/> (GRADE) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with perineural dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of sensory block</p> <p>(we included all studies describing duration of sensory block, regardless of how it was described) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block was <b>10.2</b> hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block in the perineural dexamethasone group was 6.70 hours longer (5.54 longer to 7.85 longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1625<br/> (27 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incidence of serious adverse events</p> <p>(we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p>In seven studies, authors reported that they assessed for serious adverse events. Five serious adverse events were reported in three studies: one block‐related adverse event (pneumothorax) occurred in one participant in a trial comparing perineural dexamethasone and placebo; however, group allocation was not reported. The remaining non‐block‐related events occurred in two trials comparing perineural dexamethasone, intravenous dexamethasone and placebo. Two participants in the placebo group required hospitalization within one week of surgery; one for a fall, and one for a bowel infection. One participant in the placebo group developed Complex Regional Pain Syndrome Type I and one in the intravenous dexamethasone group developed pneumonia. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620</p> <p>(7 RCTs)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/> VERY </p> <p>LOW<sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 12 hours</p> <p>(assessed by pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain intensity at 12 hours was <b>3.0</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours in the perineural dexamethasone group was 2.08 points lower (1.52 lower to 2.63 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>257<br/> (5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁◯◯◯<br/> VERY </p> <p>LOW<sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 24 hours.</p> <p>(assessed by pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain intensity at 24 hours was <b>3.9</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours in the perineural dexamethasone group was 1.63 points lower (0.93 lower to 2.34 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>469<br/> (9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 48 hours</p> <p>(assessed by pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain intensity at 48 hours was <b>3.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours in the perineural dexamethasone group was 0.61 points lower (1.24 lower to 0.03 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>296<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>e</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>MD:</b> Mean difference; <b>NIH</b> : National Institute of Health; <b>RCT</b> : randomized controlled trial; <b>VAS:</b> Visual Analogue Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate‐quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low‐quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low‐quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for risk of bias as 19 out of 27 studies are at unclear risk of bias. Reasons include lack of reporting on random sequence generation, concealment allocation, blinding, and attrition bias. Downgraded by one level for inconsistency (I<sup>2</sup> = 99%, P value for heterogeneity is &lt; 0.00001) and heterogeneity is not explained by subgroup analyses; point estimates vary widely among studies, confidence intervals show minimal overlap). </p> <p><sup>b</sup>Downgraded by one level for risk of bias as four out of the seven studies are at unclear risk of bias. Reasons include lack of reporting on random sequence generation, concealment allocation, blinding, and evidence of selective reporting bias. Downgraded by two levels for imprecision due to very low number of events. </p> <p><sup>c</sup> Downgraded by one level for risk of bias. Three out of five studies are at unclear risk of bias. Reasons include lack of </p> <p>reporting on random sequence generation and allocation concealment and evidence of attrition bias, selective reporting bias, and stopping early for benefit. Downgraded by one level for inconsistency (I<sup>2</sup> = 61%, P value for heterogeneity is 0.03) and heterogeneity is not explained by subgroup analyses; point estimates vary widely among studies, confidence intervals show minimal overlap </p> <p><sup>d</sup>Downgraded by one level for inconsistency (I<sup>2</sup> = 80%, P value for heterogeneity is &lt; 0.00001) and heterogeneity is not explained by subgroup analyses; point estimates vary widely across studies. Downgraded by one level for imprecision (95% confidence interval includes no clinical effect and a clinical effect). By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>e</sup> Downgraded by two levels for imprecision because of a sparse number of participants (n=296) and a very wide confidence interval demonstrating that the treatment effect is not statistically significant and of questionable clinical significance. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011770-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous dexamethasone versus placebo</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population:</b> participants undergoing surgery with peripheral nerve block<br/> <b>Setting:</b> participants undergoing upper and lower limb surgery in hospitals in Australia, Belgium, Brazil, Canada, Japan, Korea, Thailand and USA </p> <p><b>Intervention</b>: intravenous dexamethasone </p> <p><b>Comparison</b>: placebo </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outcomes</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>№ of participants<br/> (studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of the evidence<br/> (GRADE) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intravenous dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of sensory block</p> <p>(we included all studies describing duration of sensory block regardless of how it was described) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block was <b>16.1</b> hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block in the intravenous dexamethasone group was 6.21 hours longer (3.53 longer to 8.88 longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>499<br/> (8 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯<br/> MODERATE <sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incidence of serious adverse events</p> <p>(we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Please see incidence of serious adverse events in the perineural dexamethasone versus placebo 'Summary of findings' table. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 12 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours was <b>2.6</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours in the intravenous dexamethasone group was 1.24 points lower (2.44 lower to 0.04 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>162<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 24 hours<br/> (measured using pain scores on an 11‐point VAS) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours was <b>4.4</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours in the intravenous dexamethasone group was 1.26 points lower (2.23 lower to 0.29 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>257<br/> (5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 48 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours was <b>3.7</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours in the intravenous dexamethasone group was 0.21 points lower (0.83 lower to 0.41 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>172<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>MD:</b> Mean difference; <b>NIH</b> : National Institute of Health; <b>RCT</b> : randomized controlled trial; <b>VAS:</b> Visual Analogue Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate‐quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low‐quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low‐quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for inconsistency (considerable heterogeneity (I<sup>2</sup> = 88% and P value for heterogeneity &lt;0.0001) and subgroup analyses did not explain observed heterogeneity. Downgraded by one level for imprecision because of a sparse number of participants (n=162). </p> <p><sup>b</sup>Downgraded by one level for inconsistency (I<sup>2</sup> = 61% and P value for heterogeneity 0.08) and subgroup analyses did not explain observed heterogeneity. Downgraded by one level for imprecision. Confidence interval includes both no clinical effect (minimally important difference 1.2 on VAS) and clinical effect (minimally important difference greater than 1.2 on VAS). </p> <p><sup>c</sup>Downgraded by one level for inconsistency(I<sup>2</sup> = 65% and P value for heterogeneity 0.02) and subgroup analyses did not explain observed heterogeneity. Point estimates vary widely across studies. Downgraded by one level for imprecision (95% confidence interval includes no clinical effect and a clinical effect). By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>d</sup>Downgraded by two levels for precision (small sample size (n=172) and confidence interval crosses the line of null effect).. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011770-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Perineural versus intravenous dexamethasone</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Patient or population</b>: peripheral nerve block </p> <p><b>Setting</b>: people undergoing upper or lower limb surgery with peripheral nerve block in hospitals in Australia, Belgium, Brazil, Canada and USA </p> <p><b>Intervention</b>: perineural dexamethasone </p> <p><b>Comparison</b>: intravenous dexamethasone </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Outcomes</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> </b> (95% CI) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>№ of participants<br/> (studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Quality of the evidence<br/> (GRADE) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with intravenous dexamethasone</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with perineural dexamethasone</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Duration of sensory block</p> <p>(we included all studies describing duration of sensory block regardless of how it was described) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block was <b>20.6</b> hours </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean duration of sensory block in the perineural dexamethasone group was 3.13 hours longer (1.68 longer to 4.58 longer) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>720<br/> (9 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯<br/> MODERATE <sup>a</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Incidence of serious adverse events</p> <p>(we used the NIH definition of adverse events. A serious event includes death, a life‐threatening event that requires hospitalization or prolonged hospitalization, disability or congenital anomaly) </p> </td> <td align="" class="table-tint table-highlight" colspan="4" rowspan="1" valign="top"> <p>Please see incidence of serious adverse events in the perineural dexamethasone versus placebo 'Summary of findings' table. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 12 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours was <b>2.3</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 12 hours in the perineural dexamethasone group was 1.01 points lower (0.50 lower to 1.51 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>217<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>b</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 24 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours was <b>2.9</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 24 hours in the perineural dexamethasone group was 0.77 points lower (0.08 lower to 1.47 lower) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>309<br/> (5 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁⨁◯<br/> MODERATE <sup>c</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Postoperative pain intensity at 48 hours</p> <p>(measured using pain scores on an 11‐point VAS)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours was <b>2.8</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean postoperative pain score at 48 hours in the perineural dexamethasone group was 0.13 points higher (0.35 lower to 0.61 higher) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>227<br/> (3 RCTs) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⨁⨁◯◯<br/> LOW <sup>d</sup> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>MD:</b> Mean difference; <b>NIH</b> : National Institute of Health; <b>RCT</b> : randomized controlled trial; <b>VAS:</b> Visual Analogue Scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High‐quality:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/> <b>Moderate‐quality:</b> we are moderately confident in the effect estimate; the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/> <b>Low‐quality:</b> our confidence in the effect estimate is limited; the true effect may be substantially different from the estimate of the effect.<br/> <b>Very low‐quality:</b> we have very little confidence in the effect estimate; the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p><sup>a</sup>Downgraded by one level for inconsistency (I<sup>2</sup> = 67% and P value for heterogeneity is 0.001). </p> <p><sup>b</sup>Downgraded by one level for risk of bias. Two out of the three studies are at unclear risk of bias. Reasons include unclear random sequence generation, unclear allocation concealment, and selective outcome reporting. Downgraded by one level for imprecision because of a sparse number of participants (n=217) and because the 95% confidence interval includes no clinical effect and a clinical effect. By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>c</sup>Downgraded by one level for imprecision (95% confidence interval includes no clinical effect and a clinical effect). By no clinical effect we mean the lower bound of the CI did not surpass our chosen MID threshold of 1.2 on VAS. </p> <p><sup>d</sup>Downgraded by one level for risk of bias. The one study that is at unclear risk of bias contributes half the data for this outcome. Downgraded by one level for imprecision because of a small sample size (n=227). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/full#CD011770-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Duration of sensory block: perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of sensory block <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.70 [5.54, 7.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of sensory block: long‐ versus medium‐acting local anaesthetic subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1572</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.78 [5.62, 7.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long‐acting local anaesthetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.81 [6.40, 9.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium‐acting local anaesthetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.98 [1.76, 6.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Duration of sensory block: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.70 [5.54, 7.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>336</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.29 [3.77, 10.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1289</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.60 [5.30, 7.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration of sensory block: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1627</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.70 [5.53, 7.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.09 [5.81, 8.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.32 [1.80, 6.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Duration of sensory block: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.70 [5.54, 7.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 High or unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1037</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.28 [5.01, 7.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>588</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.21 [4.56, 11.85]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Duration of sensory block: perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Duration of motor block: perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of motor block <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>912</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [4.44, 7.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of motor block: long‐ versus medium‐acting local anaesthetic subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>912</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [4.44, 7.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long‐acting local anaesthetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.61 [4.58, 8.65]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium‐acting local anaesthetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.59 [2.42, 2.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Duration of motor block: additives verus no additives subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>912</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [4.44, 7.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>280</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.47 [3.58, 11.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>632</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.26 [3.17, 7.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration of motor block: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>912</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [4.44, 7.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>872</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.75 [4.29, 7.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.1 [4.69, 11.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Duration of motor block: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>912</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.87 [4.44, 7.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>809</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.67 [4.18, 7.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.93 [2.74, 13.13]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Duration of motor block: perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall incidence of block‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>677</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.99, 1.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Numbness/tingling 14 days after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>323</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.76 [0.80, 3.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Residual motor block/weakness 24 hours after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.69 [0.57, 38.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Horner Syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>321</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.73, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Hoarseness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.65, 2.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Diaphragmatic paresis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.46 [0.66, 3.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Dyspnoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Vascular injury <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.19, 21.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Cranial nerve 12 palsy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Bruising <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.07, 15.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Overall non‐block‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>625</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.35, 1.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Postoperative nausea and vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>585</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.55 [0.26, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Deep sedation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.0 [0.38, 129.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Dermatological symptoms (pruritus/rash) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.93 [0.32, 27.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Syncope/fainting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.95 [0.18, 20.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Bradycardia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.12, 3.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Hypotension <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>140</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.21, 2.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Headache/10‐pound fluid gain/diarrhoea/frequent urination/muscle soreness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.93 [0.12, 69.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Incidence of mild to moderate adverse events: perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at12 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.08 [‐2.63, ‐1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 12 hours: medium‐ versus long‐acting local anaesthetic subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.08 [‐2.63, ‐1.53]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long‐acting local anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.21 [‐2.77, ‐1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium‐acting local anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.22 [‐2.38, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 12 hours: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.08 [‐2.63, ‐1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.20 [‐2.36, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.21 [‐2.77, ‐1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative pain intensity at 12 hours: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.08 [‐2.63, ‐1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.17 [‐3.29, ‐1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.99 [‐2.75, ‐1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.08 [‐2.63, ‐1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 High/unclear versus low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.81 [‐2.53, ‐1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.61 [‐3.88, ‐1.34]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Postoperative pain intensity at 12 hours: perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.34, ‐0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 24 hours: long‐ versus medium‐acting local anaesthetic subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.34, ‐0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long‐acting local anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>409</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.75 [‐2.60, ‐0.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium‐acting local anaesthesia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.08 [‐2.07, ‐0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 24 hours: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.34, ‐0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.13 [‐3.43, ‐0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.41 [‐2.31, ‐0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative pain intensity at 24 hours: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.34, ‐0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.59 [‐2.71, ‐0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.87 [‐3.21, ‐0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Postoperative pain intensity at 24 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.63 [‐2.34, ‐0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>185</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐2.79, ‐1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>284</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.43 [‐2.91, 0.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Postoperative pain intensity at 24 hours: perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.24, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 48 hours: additives versus no additives subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.24, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.86 [‐1.36, ‐0.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>141</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.23 [‐1.80, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 48 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>296</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.61 [‐1.24, 0.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐2.24, 0.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.45 [‐1.30, 0.40]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Postoperative pain intensity at 48 hours: perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative opioid consumption at 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.25 [‐32.51, ‐5.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Opioid consumption at 24 hours medium‐ versus long‐acting local anaesthetic subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.25 [‐32.51, ‐5.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Long‐acting local anaesthetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>335</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐21.22 [‐35.20, ‐7.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Medium‐acting local anaesthetic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [‐33.91, 41.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Opioid consumption at 24 hours: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.25 [‐32.51, ‐5.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐30.17 [‐58.58, ‐1.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.98 [‐26.28, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Opioid consumption at 24 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐19.25 [‐32.51, ‐5.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐45.0 [‐57.58, ‐32.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>292</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐13.55 [‐23.36, ‐3.75]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Postoperative opioid consumption at 24 hours: perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Participant satisfaction with pain control; perineural dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Participant satisfaction with pain control: perineural dexamethasone versus placebo <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>224</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [‐0.05, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Participant satisfaction with pain control; perineural dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Duration of sensory block: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of sensory block <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [3.53, 8.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration sensory block: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [3.53, 8.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.20 [0.68, 11.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>450</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [3.33, 9.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Duration of sensory block: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [3.53, 8.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High‐dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.45 [5.55, 9.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low‐dose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.25 [1.21, 3.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration of sensory block: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>499</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.21 [3.53, 8.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.25 [1.21, 3.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.45 [5.55, 9.35]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Duration of sensory block: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Duration of motor block: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of motor block <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.04 [3.07, 7.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of motor block: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.54 [3.11, 7.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.60 [2.32, 10.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additives</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.67 [‐2.77, 10.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Duration of motor block high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.04 [3.07, 7.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.96 [4.03, 7.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [0.23, 5.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration of motor block: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.04 [3.07, 7.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.96 [4.03, 7.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.10 [0.23, 5.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Duration of motor block: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall incidence of block‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.69, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Numbness/tingling 14 days after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>101</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.69 [0.31, 9.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Residual motor block/muscle weakness 24 hours after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>265</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.68 [0.80, 8.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Horner syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.63, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Hoarsenss <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>215</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.45, 1.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Dyspnoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.11, 3.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Cranial nerve 12 palsy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.02, 8.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Overall non‐block‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>258</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.38, 3.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Postoperative nausea and vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.12, 3.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Dermatological symptoms <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>124</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.88 [0.09, 40.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Dizziness/wrist, hand or finger pain, constipation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.02, 8.77]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Incidence of mild to moderate adverse events: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 12 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐2.44, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 12 hours: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐2.44, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐3.16, ‐0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐1.41, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.24 [‐2.44, ‐0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.5 [‐1.41, 0.41]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐3.16, ‐0.44]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Postoperative pain intensity at 12 hours: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.26 [‐2.23, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 24 hours: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.26 [‐2.23, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐2.75, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.33 [‐2.48, ‐0.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 24 hours: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.26 [‐2.23, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.31 [‐2.54, ‐0.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.1 [‐2.49, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative pain intensity at 24 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>257</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.26 [‐2.23, ‐0.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.1 [‐2.49, 0.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.31 [‐2.54, ‐0.07]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Postoperative pain intensity at 24 hours: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Postoperative pain intensity at 48 hours: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.80, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 48 hours: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.80, 0.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐1.60, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>123</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐0.87, 0.52]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Postoperative pain intensity at 48 hours: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Postoperative opioid consumption at 24 hours: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 24‐hour opioid consumption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.58 [‐10.56, ‐2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 24‐hour opioid consumption: additive verus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>287</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.58 [‐10.56, ‐2.60]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.0 [‐13.33, 5.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.93 [‐11.41, ‐2.46]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Postoperative opioid consumption at 24 hours: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Postoperative opioid consumption at 48 hours: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative opioid consumption at 48 hours opioid consumption <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐22.5 [‐39.85, ‐5.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Postoperative opioid consumption at 48 hours: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Participant satisfaction with pain control: intravenous dexamethasone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Participant satisfaction with pain control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [‐0.08, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Participant satisfaction with pain control: intravenous dexamethasone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Duration of sensory block: perineural versus intravenous dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of sensory block <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [1.68, 4.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of sensory block additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [1.68, 4.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>331</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.94 [2.66, 5.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>389</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.67 [0.00, 5.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Duration sensory block high‐dose versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [1.68, 4.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>508</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.35 [0.04, 4.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.14 [2.48, 5.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration sensory block high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>720</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [1.68, 4.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.67 [2.29, 7.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>558</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [0.23, 4.37]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Duration of sensory block: perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Duration of motor block: perineural versus intravenous dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Duration of motor block <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [0.99, 5.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Duration of motor block: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.75 [0.32, 5.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.0 [‐0.03, 8.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.39 [‐0.58, 5.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Duration of motor block: high‐ versus low‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [0.99, 5.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.47 [‐0.25, 5.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [2.53, 7.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration of motor block: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.13 [0.99, 5.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 HIgh/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [2.53, 7.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>381</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.47 [‐0.25, 5.19]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Duration of motor block: perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Overall incidence of block‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>406</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.93, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Numbness/tingling 14 days after surgery <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.27, 3.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Residual motor block/weakness at 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>248</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.22 [0.62, 2.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Horner syndrome <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.2 [0.77, 1.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Hoarsness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>197</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.48, 2.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Cranial nerve 12 motor palsy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.01, 7.39]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Overall incidence of non block‐related adverse events <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>316</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.34 [0.37, 4.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Postoperative nausea and vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>312</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.22, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Dermatologicial symptoms (pruritus/rash) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.42 [0.22, 89.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Syncope/fainting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.42 [0.22, 89.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Dizziness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>178</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.06, 2.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Wrist, hand or finger pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.01, 7.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Headache, 10‐pound fluid gain/diarrhoea/frequent urination/ muscle soreness <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.65 [0.11, 63.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Incidence of mild to moderate adverse events: perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 12 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.01 [‐1.51, ‐0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 12 hours: low‐ versus high‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.01 [‐1.51, ‐0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐1.60, ‐0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐2.01, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 12 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>217</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.01 [‐1.51, ‐0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 HIgh/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.04 [‐1.60, ‐0.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.90 [‐2.01, 0.21]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Postoperative pain intensity at 12 hours: perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 24 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.51, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 24 hours: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.51, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.70 [‐3.32, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>259</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐1.41, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 24 hours: low‐ versus high‐dose dexamethasonesubgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.51, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.95 [‐2.01, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐1.95, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Intensity of postoperative pain at 24 hours: high/unclear risk of bias versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>309</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.79 [‐1.51, ‐0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.95 [‐2.01, 0.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.68 [‐1.95, 0.59]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Postoperative pain intensity at 24 hours: perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0025">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0026"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Postoperative pain intensity at 48 hours <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.35, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Postoperative pain intensity at 48 hours: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.35, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [‐0.51, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.50, 0.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Postoperative pain intensity at 48 hours: low‐ versus high‐dose dexamethasone subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.35, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Low‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.59, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 High‐dose dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐0.45, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Postoperative pain intensity at 48 hours: high/unclear versus low risk of bias subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>227</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.35, 0.61]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 High/unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐0.59, 0.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐0.45, 1.24]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Postoperative pain intensity at 48 hours: perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0026">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0027"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">Postoperative opioid consumption at 24 hours: perineural versus intravenous dexamethasone opioid consumption: perineural versus intravenous dexamethasone subgroups</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Opioid consumption at 24 hours: perineural versus intravenous dexamethasone <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.87 [‐9.93, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 24‐hour opioid consumption: additive versus no additive subgroups <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>242</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.87 [‐9.93, 2.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.00 [‐23.96, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 No additive</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>189</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.56 [‐6.34, 3.22]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 24.</span> <span class="table-title">Postoperative opioid consumption at 24 hours: perineural versus intravenous dexamethasone opioid consumption: perineural versus intravenous dexamethasone subgroups</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0027">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011770-tbl-0028"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">Participant satisfaction with pain control: perineural versus intravenous dexamethasone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Participant satisfaction with pain control <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [‐0.33, 0.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 25.</span> <span class="table-title">Participant satisfaction with pain control: perineural versus intravenous dexamethasone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011770.pub2/references#CD011770-tbl-0028">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011770.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011770-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011770-note-0005">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011770-note-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011770-note-0010">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011770-note-0007">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD011770-note-0011">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD011770-note-0003">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011770-note-0004">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD011770-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD011770-note-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011770-note-0017">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011770-note-0006">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011770\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011770\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011770\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011770\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011770\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=FKeXZrqu&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011770.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011770.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011770.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011770.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011770.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740727201860"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011770.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740727201864"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011770.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ea63d99d09365',t:'MTc0MDcyNzIwMi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 